,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,86163,10607,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,17,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
9,19,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
10,21,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
11,23,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
12,25,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
13,29,1,1,,86163,10607,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
14,31,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
15,33,1,1,,86163,10607,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
16,35,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
17,37,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
18,39,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
19,41,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
20,43,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
21,45,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
22,47,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
23,49,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
24,51,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
25,53,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
26,55,1,1,,86163,10607,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
27,57,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
28,59,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
29,61,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
30,63,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
31,65,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
32,67,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
33,69,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
34,71,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
35,73,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
36,77,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
37,79,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
38,81,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
39,83,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
40,85,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
41,87,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
42,89,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line,Confirmatory,,
43,91,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
44,93,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
45,95,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
46,97,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Confirmatory,,
47,99,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
48,101,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
49,103,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
50,105,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
51,107,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
52,109,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
53,113,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
54,115,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
55,119,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
56,121,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
57,123,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
58,125,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
59,129,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
60,131,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
61,133,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
62,137,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
63,139,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
64,141,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
65,143,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
66,145,1,1,,86163,10607,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
67,155,1,1,,86163,10607,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
68,157,1,1,,86163,10607,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
69,161,1,1,,86163,10607,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
70,165,1,1,,86163,10607,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
71,167,1,1,,86163,10607,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
72,175,1,1,,86163,10607,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
73,179,1,1,,86163,10607,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
74,180,1,1,,86163,10607,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Adenocarcinoma 755 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
75,192,1,1,,86163,10607,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
76,198,1,1,,86163,10607,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in C57BL/6 mice,Other,,
77,200,1,1,,86163,10607,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6C3F1 mice,Other,,
78,228,1,1,,86163,10607,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Friend Virus Leukemia (Solid) (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
79,248,1,1,,86163,10607,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
80,250,1,1,,86163,10607,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
81,256,1,1,,86163,10607,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
82,258,1,1,,86163,10607,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in CD2F1 (CDF1) mice,Other,,
83,268,1,1,,86163,10607,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1798 Lymphosarcoma (subcutaneous) in CD2F1 (CDF1) mice,Other,,
84,270,1,1,,86163,10607,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
85,272,1,1,,86163,10607,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice,Other,,
86,292,1,1,,86163,10607,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (intraperitoneal) in B6C3F1 mice,Other,,
87,328,1,1,,86163,10607,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
88,330,1,1,,86163,10607,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
89,342,1,1,,86163,10607,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma 180 (subcutaneous) in Swiss mice,Other,,
90,357,2,1,,855658,10607,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
91,361,1,2,,855658,10607,Inactive,285623.0,,,,Pyruvate Kinase,Confirmatory,,
92,364,1,3,,855658,10607,Active,,,,,Cell Proliferation & Viability (Cytotoxicity) Assay,Confirmatory,,
93,368,2,3,,855658,10607,Inactive,4757950.0,994.0,,,Cdc25B Catalytic Domain protein tyrosine phosphatase  HTS,Screening,,
94,371,1,1,,855658,10607,Active,,,,,Human A549 Lung Tumor Cell Growth Inhibition Assay,Screening,,
95,373,1,4,,855658,10607,Inactive,38788193.0,1903.0,,,S1P3 Agonist Primary HTS and Confirmation Assays,Screening,,
96,374,2,3,,855658,10607,Inactive,4758204.0,1843.0,,,In vitro Primary HTS Assay for MKP-1,Screening,,
97,375,2,3,,855658,10607,Inactive,90108679.0,,,,Mycobacterium tuberculosis Pantothenate Synthetase Assay,Confirmatory,,
98,377,1,3,,10321927,10607,Inconclusive,42741659.0,5243.0,,,MDR-1,Other,,
99,411,2,1,,855658,10607,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
100,422,1,5,,855658,10607,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
101,425,3,2,,855658,10607,Inactive,16758752.0,116663.0,,IC50,MKP-3 in vitro HTS assay,Confirmatory,,
102,429,1,5,,855658,10607,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
103,429,1,5,,855658,10607,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
104,430,2,4,,855658,10607,Active,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells),Confirmatory,,
105,431,2,4,,855658,10607,Active,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells),Confirmatory,,
106,432,2,4,,855658,10607,Inactive,11024684.0,12044.0,,IC50,HTS discovery of chemical inhibitors of anti-apoptotic protein Bfl-1,Confirmatory,,
107,436,2,1,,855658,10607,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
108,438,1,4,,855658,10607,Active,223468676.0,5970.0,,,Cellular assay for TNF alpha induced NFkappaB translocation,Screening,,
109,440,3,3,,855658,10607,Inactive,4503779.0,2357.0,,,Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands,Screening,,
110,441,3,3,,855658,10607,Inactive,54112388.0,2358.0,,,Primary HTS Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands,Screening,,
111,444,1,1,,855658,10607,Inconclusive,,,,,NFAT Signaling Pathway,Confirmatory,,
112,446,1,1,,855658,10607,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
113,449,1,5,,855658,10607,Inactive,13027636.0,1901.0,,,Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators,Screening,,
114,450,1,2,,855658,10607,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
115,453,2,2,,855658,10607,Inactive,63102437.0,1508.0,,,Cathepsin B,Screening,,
116,454,1,7,,855658,10607,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
117,455,1,7,,855658,10607,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression,Screening,,
118,456,1,7,,855658,10607,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
119,457,1,7,,855658,10607,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression.,Screening,,
120,460,2,2,,855658,10607,Inactive,4503155.0,1514.0,,,Cathepsin L,Screening,,
121,462,1,5,,855658,10607,Active,,,,,Confirmatory screen for Cellular assay for TNF alpha induced NFkappaB translocation,Confirmatory,,
122,483,1,6,,855658,10607,Inactive,296434520.0,3064.0,,,Aggregation and Clearance of Mutant Huntingtin Protein,Screening,,
123,485,1,8,,855658,10607,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
124,487,1,2,,855658,10607,Inactive,,,,,TNFalpha Induced E-Selectin Expression -  Primary screen,Screening,,
125,488,2,1,,855658,10607,Inactive,63102437.0,1508.0,,,Cathepsin B compound mixture screening,Screening,,
126,501,2,2,,855658,10607,Inactive,23110962.0,1520.0,,,Cathepsin S,Screening,,
127,518,2,6,,855658,10607,Inactive,116734717.0,249.0,,IC50,TNAP luminescent HTS assay,Confirmatory,,
128,521,2,5,,855658,10607,Inactive,18375660.0,5778.0,,IC50,"HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target",Confirmatory,,
129,522,1,2,,855658,10607,Inactive,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
130,524,1,3,,855658,10607,Inactive,4506055.0,5566.0,,,Primary biochemical high-throughput screening assay for inhibitors of protein kinase A (PKA) activity,Screening,,
131,525,1,3,,855658,10607,Active,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
132,527,3,1,,855658,10607,Inactive,,,,,Primary HTS Assay for Inhibitors of Bacterial Quorum Sensing,Screening,,
133,528,1,4,,855658,10607,Inactive,67191027.0,3676.0,,,Allosteric Agonists for the VLA-4 Integrin,Screening,,
134,529,1,4,,855658,10607,Inactive,67191027.0,3676.0,,,Allosteric Antagonists for the VLA-4 Integrin,Screening,,
135,538,2,2,,855658,10607,Inactive,4502495.0,716.0,,,Complement factor C1s,Screening,,
136,539,1,2,,855658,10607,Inactive,116077694.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - PMK,Screening,,
137,552,1,3,,855658,10607,Inactive,,,,,Antimicrobial HTS Assay for E. coli BW25113 (wild type),Screening,,
138,555,1,2,,855658,10607,Inactive,116516899.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK,Screening,,
139,556,1,3,,855658,10607,Inactive,116076351.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC,Screening,,
140,559,2,2,,855658,10607,Inactive,147728.0,,,,RNA polymerase,Screening,,
141,560,1,2,,855658,10607,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
142,561,1,3,,855658,10607,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
143,565,1,4,,855658,10607,Inactive,1431733.0,,,,HIV-1 RT-RNase H  MLSCN HTS MH077605,Screening,,
144,567,1,4,,855658,10607,Inactive,55956923.0,3350.0,,,Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) agonists,Screening,,
145,568,1,7,,855658,10607,Inactive,5729877.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
146,568,1,7,,855658,10607,Inactive,24234686.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
147,570,1,4,,855658,10607,Inactive,4505209.0,4322.0,,,Primary biochemical high-throughput screening assay for inhibitors of Matrix Metalloproteinase 13 (MMP13) activity,Screening,,
148,571,1,4,,855658,10607,Active,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
149,572,1,5,,855658,10607,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay (Pilot Screen),Screening,,
150,573,1,4,,855658,10607,Inactive,,,,,Primary Antimicrobial Assay for E. coli BW25113 &#8710;tolC::kan Protocol for 384-well HTS,Screening,,
151,574,1,3,,855658,10607,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Agonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
152,575,1,4,,855658,10607,Inactive,,,,,Human Endothelial Cell Proliferation Assay,Screening,,
153,576,1,2,,855658,10607,Inactive,67191027.0,3676.0,,,Auto-fluorescence of compounds effecting screening of VLA-4 Integrin,Other,,
154,577,1,1,,855658,10607,Inactive,11528014.0,912267.0,,,HTS to identify Inhibitors of West Nile Virus NS2bNS3 Proteinase,Screening,,
155,580,1,5,,855658,10607,Inconclusive,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay,Screening,,
156,581,2,2,,855658,10607,Inactive,15680217.0,1511.0,,,Cathepsin G,Screening,,
157,583,2,6,,855658,10607,Inactive,123271505.0,,,IC50,High Throughput Screening Assay for Hsp70 Inhibitors,Confirmatory,,
158,587,1,5,,855658,10607,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
159,588,1,4,,855658,10607,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
160,589,1,3,,855658,10607,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
161,590,1,3,,855658,10607,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
162,591,1,4,,855658,10607,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
163,592,1,6,,855658,10607,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
164,593,1,4,,855658,10607,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
165,594,1,4,,855658,10607,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
166,597,1,3,,855658,10607,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
167,598,1,4,,855658,10607,Active,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen,Screening,,
168,599,1,2,,855658,10607,Active,548814.0,6095.0,,,Counterscreen for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1): A cell-based dose-response assay for inhibition of the RAR-related orphan receptor A (RORA),Confirmatory,,
169,600,2,1,,855658,10607,Active,20070193.0,2516.0,,,Dose-response cell-based assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1),Confirmatory,,
170,601,1,4,,855658,10607,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance Pilot Screen,Screening,,
171,602,1,4,,855658,10607,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance,Screening,,
172,604,1,3,,855658,10607,Inactive,41872583.0,9475.0,,,Primary biochemical high-throughput screening assay for inhibitors of Rho kinase 2 (Rhok2),Screening,,
173,606,1,3,,855658,10607,Inactive,224586929.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
174,606,1,3,,855658,10607,Inactive,301171662.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
175,608,1,6,,11537914,10607,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
176,609,1,2,,855658,10607,Inactive,,,,,Chemical Complementation Assay for MKP-3,Screening,,
177,614,1,6,,855658,10607,Inactive,116734717.0,249.0,,,HTS colorimetric detection of phosphate released in TNAP reaction,Screening,,
178,615,1,6,,855658,10607,Inactive,116734717.0,249.0,,,HTS colorimetric detection of p-nitrophenol released in TNAP reaction,Screening,,
179,618,2,6,,855658,10607,Inactive,6690534.0,4323.0,,EC50,Luminescent HTS for small molecule inhibitors of MT1-MMP transcription,Confirmatory,,
180,620,2,5,,855658,10607,Active,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HT1080 cells),Confirmatory,,
181,622,1,2,,855658,10607,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Negative Modulator Primary Screen,Screening,,
182,623,1,3,,855658,10607,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Positive Modulator: Primary Screen,Screening,,
183,624,1,2,,855658,10607,Inactive,,,,,Measurement of GPCR-mediated thallium flux through GIRK channels: Primary Screen,Screening,,
184,625,1,2,,855658,10607,Inactive,,,,,Discovery of Novel Allosteric Agonists of the M4 Muscarinic Receptor: Primary Screen,Screening,,
185,626,1,3,,855658,10607,Inactive,,,,,Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist  Primary Screen,Screening,,
186,628,2,4,,855658,10607,Inactive,113121.0,25229.0,,,Discovery of novel allosteric modulators of the M1 muscarinic receptor: Antagonist Primary Screen,Screening,,
187,629,1,3,,855658,10607,Inactive,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors,Screening,,
188,630,1,1,,855658,10607,Inactive,5174513.0,4088.0,,,HTS of Smad transcription factor inhibitors,Screening,,
189,631,1,4,,855658,10607,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
190,631,1,4,,855658,10607,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
191,633,1,3,,855658,10607,Inactive,10835013.0,2100.0,,,HTS for Estrogen Receptor-beta Coactivator Binding inhibitors,Screening,,
192,636,1,4,,855658,10607,Inactive,,,,,Modulators of Post-Golgi Transport - 384-well pilot screen,Screening,,
193,637,1,4,,855658,10607,Inactive,,,,,Modulators of Post-Golgi Transport - 1536-well pilot screen,Screening,,
194,639,1,2,,855658,10607,Inactive,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators,Screening,,
195,641,1,4,,855658,10607,Active,,,,,Allosteric Modulators of D1 Receptors: Primary Screen,Screening,,
196,642,1,4,,855658,10607,Active,,,,,Allosteric Modulators of D1 Receptors: Confirmation Screen,Other,,
197,645,1,4,,855658,10607,Inactive,,,,,Isolation of Inhibitors of Her-Kinase Expression - 66K library screen,Screening,,
198,646,1,3,,855658,10607,Inactive,,,,,Allosteric Modulators of D1 Receptors: Secondary Assay 1,Other,,
199,647,1,4,,855658,10607,Active,,,,,Allosteric Modulators of D1 Receptors: Secondary Assay 2,Other,,
200,648,1,3,,855658,10607,Inactive,,,,,Human Endothelial Cell Proliferation Assay in 384-well format,Screening,,
201,680,1,10,,855658,10607,Inactive,180352.0,,,,Factor XIa Mixture HTS,Screening,,
202,684,1,12,,855658,10607,Inactive,317373446.0,2161.0,,,Factor XIIa Mixture HTS,Screening,,
203,686,1,1,,855658,10607,Inactive,,,,,Zebrafish Lipid Metabolism Assay---Primary Screen,Screening,,
204,687,1,17,,855658,10607,Inactive,180352.0,,,,Factor XIa Single Well HTS,Screening,,
205,701,1,17,,855658,10607,Inactive,317373446.0,2161.0,,,Factor XIIa Single Well HTS,Screening,,
206,708,1,4,,855658,10607,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Absorbance at 340 nm,Screening,,
207,709,1,2,,855658,10607,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm,Screening,,
208,719,1,3,,855658,10607,Inactive,,,,,Human Lung Fibroblast Proliferation Assay,Screening,,
209,731,1,5,,855658,10607,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
210,731,1,5,,855658,10607,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
211,746,1,1,,855658,10607,Inactive,2507196.0,5602.0,,,Primary biochemical high-throughput screening assay for inhibitors of the c-Jun N-Terminal Kinase 3 (JNK3),Screening,,
212,750,1,3,,855658,10607,Inactive,,,,,Luminescent HTS for small molecule activators of MT1-MMP transcription,Screening,,
213,751,1,3,,855658,10607,Inactive,,,,,Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent),Screening,,
214,757,1,4,,855658,10607,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype,Screening,,
215,758,1,4,,855658,10607,Inactive,164058.0,404007.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype,Screening,,
216,759,1,4,,855658,10607,Inactive,190938.0,3265.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype,Screening,,
217,760,1,4,,855658,10607,Inactive,46577642.0,404009.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype,Screening,,
218,761,1,4,,855658,10607,Inactive,56202836.0,,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype,Screening,,
219,764,1,4,,855658,10607,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant,Screening,,
220,770,1,1,,855658,10607,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (24 Hour Treatment Protocol),Screening,,
221,771,1,2,,855658,10607,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (48 Hour Treatment Protocol),Screening,,
222,772,1,2,,855658,10607,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (72 Hour Treatment Protocol),Screening,,
223,774,1,2,,855658,10607,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Inhibition of Enzymes Frequently Used to reach a NAD/NADH Endpoint,Other,,
224,775,1,3,,855658,10607,Inactive,,,,,Screen for Chemicals that Extend Yeast Lifespan,Screening,,
225,781,1,1,,855658,10607,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
226,782,1,2,,855658,10607,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
227,782,1,2,,855658,10607,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
228,793,1,2,,855658,10607,Inactive,4505447.0,4887.0,,,Primary cell based high-throughput screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2),Screening,,
229,795,1,1,,855658,10607,Inactive,,,,,MLSCN Assay for Activators of Prostate Cell Differentiation,Screening,,
230,797,1,1,,855658,10607,Inactive,115529463.0,5587.0,,,Fluorescence polarization assay for PKD inhibitors,Screening,,
231,798,2,12,,855658,10607,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
232,799,1,5,,855658,10607,Inactive,134142337.0,4363.0,,,Identification of Molecular Probes that Activate MRP-1,Screening,,
233,800,2,11,,855658,10607,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
234,803,1,4,,855658,10607,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2),Screening,,
235,804,1,3,,855658,10607,Inactive,,,,,Screen for Chemicals that Shorten Yeast Lifespan,Screening,,
236,813,1,4,,855658,10607,Inactive,116734717.0,249.0,,,HTS identification of compounds activating TNAP at intermediate concentration of phosphate acceptor detected in luminescent assay,Screening,,
237,817,1,1,,855658,10607,Inactive,1360328.0,,,,Identification and characterization of compounds for addressing human bone marrow failure,Other,,
238,818,1,2,,855658,10607,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression,Screening,,
239,827,1,2,,855658,10607,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor,Screening,,
240,828,1,5,,855658,10607,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify antagonists of Galanin Receptor 2 (GALR2),Screening,,
241,834,1,3,,855658,10607,Inactive,,,,,C. albicans biofilm killing,Screening,,
242,841,1,1,,855658,10607,Inactive,,,,,Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library),Screening,,
243,847,1,2,,855658,10607,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay,Screening,,
244,861,1,1,,855658,10607,Inactive,55662034.0,,,,Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding,Screening,,
245,862,1,2,,855658,10607,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 inhibition,Screening,,
246,868,1,3,,855658,10607,Inactive,,,,,Screen for Chemicals that Inhibit the RAM Network,Screening,,
247,871,1,2,,855658,10607,Active,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 activation,Screening,,
248,873,1,13,,855658,10607,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
249,875,1,2,,855658,10607,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
250,878,1,2,,855658,10607,Inactive,,,,,NIH Compound Library Profiling: Compound and DTT Dependent Redox Cycling H2O2 Generation.,Screening,,
251,880,2,1,,855658,10607,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
252,880,2,1,,855658,10607,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
253,880,2,1,,29215001,10607,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
254,880,2,1,,29215001,10607,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
255,880,2,1,,50103982,10607,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
256,880,2,1,,50103982,10607,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
257,880,2,1,,50103983,10607,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
258,880,2,1,,50103983,10607,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
259,881,2,2,,855658,10607,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
260,881,2,2,,29215001,10607,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
261,884,1,2,,855658,10607,Active,13435386.0,1576.0,1.9953,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
262,885,1,2,,855658,10607,Inactive,13435386.0,1576.0,1.9953,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
263,887,1,2,,855658,10607,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
264,889,1,3,,855658,10607,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
265,892,1,2,,855658,10607,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
266,893,1,2,,855658,10607,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
267,893,1,2,,855658,10607,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
268,894,2,1,,855658,10607,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
269,894,2,1,,29215001,10607,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
270,894,2,1,,50103982,10607,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
271,894,2,1,,50103983,10607,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
272,898,1,1,,855658,10607,Inactive,28373018.0,1239205.0,,,YopH  HTS,Screening,,
273,900,1,3,,855658,10607,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
274,901,1,2,,855658,10607,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
275,902,1,2,,855658,10607,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
276,914,1,3,,855658,10607,Inconclusive,32879895.0,3091.0,0.0158,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
277,915,1,3,,855658,10607,Inconclusive,32879895.0,3091.0,0.0158,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
278,920,1,2,,855658,10607,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 inhibition,Screening,,
279,923,1,2,,855658,10607,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
280,924,1,2,,855658,10607,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
281,932,1,4,,855658,10607,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 activation,Screening,,
282,940,1,2,,855658,10607,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
283,942,1,2,,855658,10607,Active,21392848.0,,0.7943,Potency,Confirmation Concentration-Response Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
284,950,1,1,,855658,10607,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
285,951,1,1,,855658,10607,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
286,952,1,1,,855658,10607,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
287,995,1,2,,855658,10607,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
288,999,1,1,,46487972,10607,Inactive,,,,,A Validation Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor Using a Diverse Compound Set,Screening,,
289,1001,2,2,,855658,10607,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
290,1004,1,1,,46487972,10607,Inactive,,,,,A Validation Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression Using a Diverse Compound Set,Screening,,
291,1006,1,6,,855658,10607,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
292,1007,1,1,,855658,10607,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
293,1008,1,2,,855658,10607,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
294,1009,1,2,,855658,10607,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
295,1012,1,4,,855658,10607,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
296,1016,1,4,,855658,10607,Active,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
297,1018,2,5,,855658,10607,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
298,1019,1,4,,855658,10607,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
299,1020,1,5,,855658,10607,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
300,1021,1,1,,855658,10607,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
301,1022,1,1,,855658,10607,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
302,1027,1,3,,855658,10607,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
303,1030,2,1,,855658,10607,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
304,1030,2,1,,29215001,10607,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
305,1030,2,1,,50103982,10607,Inactive,30582681.0,216.0,19.9526,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
306,1030,2,1,,50103983,10607,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
307,1032,1,2,,855658,10607,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
308,1032,1,2,,855658,10607,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
309,1033,2,2,,11537914,10607,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
310,1040,1,2,,855658,10607,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
311,1046,1,6,,855658,10607,Inactive,339641.0,2147.0,,,Thrombin 1536 HTS,Screening,,
312,1048,1,1,,855658,10607,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
313,1048,1,1,,855658,10607,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
314,1049,1,1,,855658,10607,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
315,1049,1,1,,855658,10607,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
316,1051,1,1,,855658,10607,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
317,1051,1,1,,855658,10607,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
318,1063,1,1,,855658,10607,Inactive,,,,,Leishmania major promastigote HTS,Screening,,
319,1066,1,2,,855658,10607,Inactive,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
320,1085,1,1,,855658,10607,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
321,1135,1,3,,855658,10607,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
322,1136,1,3,,855658,10607,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
323,1203,1,3,,855658,10607,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
324,1209,2,2,,855658,10607,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
325,1214,1,4,,855658,10607,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
326,1216,1,5,,855658,10607,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
327,1217,1,4,,855658,10607,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
328,1220,2,2,,855658,10607,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
329,1222,1,6,,855658,10607,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
330,1229,1,3,,855658,10607,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
331,1235,1,2,,855658,10607,Inactive,,,,,Alternative Pathway ELISA_orthogonal screening,Screening,,
332,1236,1,1,,855658,10607,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
333,1239,1,3,,855658,10607,Active,34577122.0,4790.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
334,1239,1,3,,855658,10607,Active,223468676.0,5970.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
335,1242,1,1,,855658,10607,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
336,1251,1,1,,855658,10607,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
337,1267,1,2,,855658,10607,Inactive,13272532.0,6774.0,,,Confirmation cell-based high throughput screening assay to measure STAT3 activation,Screening,,
338,1273,1,1,,855658,10607,Inactive,59036749.0,3630.0,,,Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells,Screening,,
339,1274,1,2,,855658,10607,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
340,1276,1,1,,855658,10607,Inactive,257380.0,351.0,,,Primary screen for compounds that activate Alzheimer's amyloid precursor,Screening,,
341,1285,1,1,,855658,10607,Active,257380.0,351.0,,,Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation,Screening,,
342,1296,1,1,,855658,10607,Inactive,59036749.0,3630.0,,,Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells,Screening,,
343,1304,1,2,,855658,10607,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
344,1309,1,4,,855658,10607,Active,34577122.0,4790.0,,,Counterscreen assay for STAT3 activators: Cell-based high throughput assay to measure NF-kappaB activation,Screening,,
345,1318,1,3,,855658,10607,Inactive,6274552.0,6772.0,,,Counterscreen assay for STAT3 activators: Cell-based high throughput assay to measure STAT1 activation,Screening,,
346,1321,1,2,,855658,10607,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
347,1325,1,2,,855658,10607,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
348,1326,1,4,,855658,10607,Inactive,42741659.0,5243.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen",Screening,,
349,1332,1,1,,49698638,10607,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
350,1359,1,4,,855658,10607,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
351,1362,1,2,,855658,10607,Inactive,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
352,1376,1,2,,855658,10607,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
353,1377,1,1,,855658,10607,Inactive,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
354,1379,1,2,,855658,10607,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
355,1379,1,2,,29215001,10607,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
356,1379,1,2,,50103982,10607,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
357,1379,1,2,,50103983,10607,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
358,1381,1,1,,855658,10607,Inactive,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
359,1385,2,2,,855658,10607,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
360,1415,1,2,,855658,10607,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
361,1415,1,2,,855658,10607,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
362,1416,1,2,,855658,10607,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
363,1422,1,1,,855658,10607,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
364,1423,1,2,,855658,10607,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
365,1423,1,2,,855658,10607,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
366,1424,1,1,,855658,10607,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
367,1430,1,1,,855658,10607,Inactive,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
368,1434,2,3,,855658,10607,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
369,1434,2,3,,855658,10607,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
370,1439,1,1,,855658,10607,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
371,1439,1,1,,855658,10607,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
372,1440,1,1,,855658,10607,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
373,1440,1,1,,855658,10607,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
374,1441,1,1,,855658,10607,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
375,1441,1,1,,855658,10607,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
376,1443,1,3,,855658,10607,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
377,1445,1,1,,855658,10607,Inactive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
378,1446,1,3,,855658,10607,Active,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
379,1448,1,3,,855658,10607,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
380,1452,1,1,,855658,10607,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
381,1452,1,1,,29215001,10607,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
382,1454,1,1,,50103982,10607,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
383,1454,1,1,,50103983,10607,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
384,1456,1,1,,855658,10607,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
385,1457,1,1,,855658,10607,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
386,1457,1,1,,29215001,10607,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
387,1457,1,1,,50103982,10607,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
388,1457,1,1,,50103983,10607,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
389,1458,1,1,,855658,10607,Inactive,10937869.0,6607.0,0.4467,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
390,1458,1,1,,50103983,10607,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
391,1460,1,3,,855658,10607,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
392,1460,1,3,,29215001,10607,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
393,1460,1,3,,50103982,10607,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
394,1460,1,3,,50103983,10607,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
395,1461,1,2,,855658,10607,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
396,1463,1,1,,855658,10607,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
397,1463,1,1,,29215001,10607,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
398,1463,1,1,,50103982,10607,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
399,1463,1,1,,50103983,10607,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
400,1465,1,1,,855658,10607,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
401,1466,1,2,,855658,10607,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
402,1467,1,3,,855658,10607,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
403,1467,1,3,,29215001,10607,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
404,1467,1,3,,50103982,10607,Inconclusive,757912.0,2717.0,50.1187,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
405,1467,1,3,,50103983,10607,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
406,1468,1,1,,855658,10607,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
407,1468,1,1,,29215001,10607,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
408,1468,1,1,,50103982,10607,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
409,1468,1,1,,50103983,10607,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
410,1469,1,1,,855658,10607,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
411,1469,1,1,,29215001,10607,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
412,1469,1,1,,50103982,10607,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
413,1469,1,1,,50103983,10607,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
414,1471,2,1,,29215001,10607,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
415,1471,2,1,,50103982,10607,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
416,1471,2,1,,50103983,10607,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
417,1476,2,1,,855658,10607,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
418,1476,2,1,,29215001,10607,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
419,1476,2,1,,50103982,10607,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
420,1476,2,1,,50103983,10607,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
421,1477,1,1,,855658,10607,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
422,1477,1,1,,29215001,10607,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
423,1477,1,1,,50103982,10607,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
424,1477,1,1,,50103983,10607,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
425,1478,2,1,,855658,10607,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
426,1478,2,1,,29215001,10607,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
427,1478,2,1,,50103982,10607,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
428,1478,2,1,,50103983,10607,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
429,1479,1,2,,855658,10607,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
430,1479,1,2,,29215001,10607,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
431,1479,1,2,,50103982,10607,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
432,1479,1,2,,50103983,10607,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
433,1481,1,2,,855658,10607,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
434,1486,1,3,,855658,10607,Active,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
435,1487,1,1,,855658,10607,Inconclusive,27436948.0,4000.0,0.0282,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
436,1487,1,1,,29215001,10607,Inconclusive,27436948.0,4000.0,0.0316,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
437,1490,2,1,,855658,10607,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
438,1490,2,1,,29215001,10607,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
439,1490,2,1,,50103982,10607,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
440,1490,2,1,,50103983,10607,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
441,1496,1,4,,855658,10607,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
442,1496,1,4,,855658,10607,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
443,1509,1,2,,855658,10607,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
444,1510,1,3,,855658,10607,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
445,1511,1,3,,855658,10607,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
446,1515,1,2,,855658,10607,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
447,1519,1,3,,50103982,10607,Inconclusive,,,1.122,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
448,1527,1,3,,855658,10607,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
449,1529,1,1,,855658,10607,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
450,1530,1,1,,855658,10607,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
451,1531,1,1,,855658,10607,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
452,1532,1,1,,855658,10607,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
453,1549,1,2,,11537914,10607,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
454,1552,1,3,,11537914,10607,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
455,1554,1,1,,855658,10607,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
456,1556,1,4,,855658,10607,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
457,1565,2,2,,855658,10607,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
458,1566,2,3,,855658,10607,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
459,1578,3,2,,855658,10607,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
460,1580,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
461,1581,1,1,,8150177,10607,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
462,1582,1,1,,8150177,10607,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
463,1583,1,1,,8150177,10607,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
464,1584,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
465,1585,1,1,,8150177,10607,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
466,1586,1,1,,8150177,10607,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
467,1587,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
468,1588,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
469,1589,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
470,1590,1,1,,8150177,10607,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
471,1593,1,1,,8150177,10607,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
472,1594,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
473,1595,1,1,,8150177,10607,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
474,1596,1,1,,8150177,10607,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
475,1597,1,1,,8150177,10607,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
476,1598,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
477,1599,1,1,,8150177,10607,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
478,1600,1,1,,8150177,10607,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
479,1601,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
480,1602,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
481,1603,1,1,,8150177,10607,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
482,1604,1,1,,8150177,10607,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
483,1605,1,1,,8150177,10607,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
484,1606,1,1,,8150177,10607,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
485,1607,1,1,,8150177,10607,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
486,1608,1,1,,8150177,10607,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
487,1609,1,1,,8150177,10607,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
488,1610,1,1,,8150177,10607,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
489,1611,1,1,,8150177,10607,Unspecified,,,,,Screen for compounds that induce the human heat shock transcriptional response (HSEluc),Other,,
490,1612,1,1,,8150177,10607,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
491,1613,1,1,,8150177,10607,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
492,1614,1,1,,8150177,10607,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
493,1616,1,1,,8150177,10607,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
494,1619,1,2,,855658,10607,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
495,1621,1,2,,855658,10607,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
496,1626,1,2,,855658,10607,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
497,1631,3,1,,855658,10607,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
498,1634,3,1,,855658,10607,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
499,1637,1,2,,11537914,10607,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
500,1648,1,2,,11537914,10607,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
501,1654,2,2,,855658,10607,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
502,1656,2,2,,855658,10607,Inconclusive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
503,1662,1,2,,855658,10607,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
504,1663,1,2,,855658,10607,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
505,1672,1,3,,855658,10607,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
506,1688,1,1,,855658,10607,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
507,1688,1,1,,29215001,10607,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
508,1700,1,2,,855658,10607,Active,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
509,1706,1,2,,855658,10607,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
510,1721,1,2,,855658,10607,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
511,1722,1,2,,855658,10607,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
512,1766,1,1,,855658,10607,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
513,1766,1,1,,855658,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
514,1766,1,1,,29215001,10607,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
515,1766,1,1,,29215001,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
516,1766,1,1,,50103982,10607,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
517,1766,1,1,,50103982,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
518,1766,1,1,,50103983,10607,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
519,1766,1,1,,50103983,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
520,1768,1,1,,855658,10607,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
521,1768,1,1,,855658,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
522,1768,1,1,,29215001,10607,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
523,1768,1,1,,29215001,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
524,1768,1,1,,50103982,10607,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
525,1768,1,1,,50103982,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
526,1768,1,1,,50103983,10607,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
527,1768,1,1,,50103983,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
528,1775,1,2,,855658,10607,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
529,1776,1,2,,855658,10607,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
530,1777,3,2,,855658,10607,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
531,1778,3,3,,855658,10607,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
532,1779,2,2,,855658,10607,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
533,1789,1,2,,855658,10607,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
534,1800,1,2,,855658,10607,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
535,1813,1,2,,855658,10607,Active,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
536,1814,1,2,,855658,10607,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
537,1817,2,2,,855658,10607,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
538,1822,1,3,,855658,10607,Inactive,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
539,1825,1,1,,855658,10607,Active,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
540,1832,2,1,,855658,10607,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
541,1834,1,2,,855658,10607,Active,124263658.0,688.0,,,Luminescence-based confirmation cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
542,1845,1,2,,855658,10607,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
543,1850,2,1,,855658,10607,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
544,1850,2,1,,56463668,10607,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
545,1861,2,1,,855658,10607,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
546,1862,1,4,,855658,10607,Unspecified,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_RPL19A,Screening,,
547,1863,2,1,,855658,10607,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
548,1863,2,1,,56463668,10607,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
549,1865,1,1,,855658,10607,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
550,1865,1,1,,29215001,10607,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
551,1865,1,1,,50103982,10607,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
552,1865,1,1,,50103983,10607,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
553,1867,1,4,,855658,10607,Inconclusive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_MEP2,Screening,,
554,1868,1,4,,855658,10607,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
555,1870,1,4,,855658,10607,Unspecified,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_CIT2,Screening,,
556,1873,1,4,,855658,10607,Inconclusive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_LAP4,Screening,,
557,1875,2,1,,855658,10607,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
558,1885,2,1,,855658,10607,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
559,1887,1,4,,855658,10607,Inconclusive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_AGP1,Screening,,
560,1899,1,3,,56463668,10607,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
561,1903,2,3,,855658,10607,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
562,1903,2,3,,56463668,10607,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
563,1905,1,1,,855658,10607,Active,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line in triplicate.,Screening,,
564,1906,1,3,,56463668,10607,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
565,1907,1,2,,855658,10607,Active,,,,,Luminescence-based confirmation cell-based assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
566,1910,1,2,,855658,10607,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
567,1947,1,2,,56463668,10607,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
568,1948,1,1,,29215001,10607,Inactive,,,0.02,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
569,1948,1,1,,50103982,10607,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
570,1950,1,3,,56463668,10607,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
571,1956,1,1,,855658,10607,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
572,1961,2,2,,855658,10607,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
573,1962,1,2,,56463668,10607,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
574,1972,1,1,,855658,10607,Active,,,0.04682,IC50,Luminescence-based dose response cell-based high throughput screening assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Confirmatory,,
575,1974,1,2,,56463668,10607,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
576,1984,1,3,,855658,10607,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
577,1986,1,2,,855658,10607,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
578,1987,1,2,,56463668,10607,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
579,1988,1,2,,855658,10607,Active,,,0.1,EC50,Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells,Confirmatory,,
580,1990,1,2,,855658,10607,Active,,,0.1,EC50,Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells,Confirmatory,,
581,1994,1,2,,855658,10607,Inconclusive,,,,EC50,Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells,Confirmatory,,
582,2006,3,2,,855658,10607,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
583,2006,3,2,,855658,10607,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
584,2006,3,2,,855658,10607,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
585,2012,3,2,,855658,10607,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
586,2013,2,2,,855658,10607,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
587,2014,3,2,,855658,10607,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
588,2016,1,3,,56463668,10607,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
589,2023,1,3,,56463668,10607,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
590,2025,1,3,,56463668,10607,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
591,2029,1,3,,56463668,10607,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
592,2052,2,1,,56463668,10607,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
593,2057,1,2,,56463668,10607,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
594,2058,3,2,,855658,10607,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
595,2066,1,4,,56463668,10607,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
596,2071,2,2,,855658,10607,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
597,2073,2,3,,855658,10607,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
598,2073,2,3,,855658,10607,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
599,2094,1,2,,855658,10607,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
600,2094,1,2,,855658,10607,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
601,2094,1,2,,855658,10607,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
602,2097,1,2,,855658,10607,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
603,2098,1,1,,855658,10607,Active,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
604,2099,1,1,,855658,10607,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
605,2100,1,1,,855658,10607,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
606,2101,1,1,,855658,10607,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
607,2101,1,1,,29215001,10607,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
608,2101,1,1,,50103982,10607,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
609,2101,1,1,,50103983,10607,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
610,2107,1,1,,855658,10607,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
611,2107,1,1,,29215001,10607,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
612,2107,1,1,,50103982,10607,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
613,2107,1,1,,50103983,10607,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
614,2112,1,1,,855658,10607,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
615,2112,1,1,,29215001,10607,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
616,2112,1,1,,50103982,10607,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
617,2112,1,1,,50103983,10607,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
618,2129,1,2,,56463668,10607,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
619,2130,1,3,,56463668,10607,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
620,2147,1,1,,855658,10607,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
621,2147,1,1,,50103982,10607,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
622,2147,1,1,,50103983,10607,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
623,2156,2,2,,855658,10607,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
624,2174,1,3,,56463668,10607,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
625,2177,1,3,,56463668,10607,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
626,2205,1,1,,855658,10607,Inactive,29788785.0,203068.0,,,HCS assay for microtubule stabilizers,Screening,,
627,2216,1,3,,855658,10607,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
628,2221,1,2,,855658,10607,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
629,2227,1,2,,855658,10607,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
630,2234,1,2,,56463668,10607,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
631,2235,1,2,,56463668,10607,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
632,2237,1,2,,855658,10607,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
633,2239,1,2,,855658,10607,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
634,2240,1,1,,85788487,10607,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
635,2241,1,1,,85788487,10607,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
636,2242,1,1,,855658,10607,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
637,2247,1,2,,855658,10607,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
638,2275,1,1,,85788487,10607,Active,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
639,2280,2,3,,56463668,10607,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
640,2288,1,1,,855658,10607,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
641,2289,1,1,,855658,10607,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
642,2300,1,3,,56463668,10607,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
643,2313,1,1,,85788487,10607,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
644,2314,1,2,,855658,10607,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
645,2314,1,2,,855658,10607,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
646,2314,1,2,,29215001,10607,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
647,2314,1,2,,29215001,10607,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
648,2315,1,2,,855658,10607,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
649,2315,1,2,,855658,10607,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
650,2315,1,2,,29215001,10607,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
651,2315,1,2,,29215001,10607,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
652,2322,1,1,,85788487,10607,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
653,2326,1,1,,855658,10607,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
654,2330,1,1,,85788487,10607,Active,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
655,2380,1,2,,56463668,10607,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
656,2382,1,1,,855658,10607,Inconclusive,62740231.0,15499.0,,EC50,Luminescence Cell-Based  Dose Confimation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1),Confirmatory,,
657,2391,1,1,,56463668,10607,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
658,2417,1,1,,855658,10607,Inactive,4506243.0,5725.0,,,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment,Screening,,
659,2435,1,2,,56463668,10607,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
660,2445,1,2,,56463668,10607,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
661,2451,1,2,,855658,10607,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
662,2451,1,2,,29215001,10607,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
663,2451,1,2,,50103982,10607,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
664,2451,1,2,,50103983,10607,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
665,2452,1,2,,855658,10607,Active,,,0.013999999999999999,EC50,Luminescence Cell-Based Dose Response to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4-C Neuroglioblastoma Cells,Confirmatory,,
666,2454,1,3,,855658,10607,Active,,,0.008,EC50,Luminescence Cell-Based HTS Dose Confimation  to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells,Confirmatory,,
667,2458,1,2,,855658,10607,Active,,,0.015,EC50,Luminescence Cell-Based Dose Response to Identify Inhibitors of Luciferase Translation or Activity in H4-C Neuroglioblastoma Cells,Confirmatory,,
668,2462,1,1,,56463668,10607,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
669,2462,1,1,,56463668,10607,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
670,2472,1,2,,855658,10607,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
671,2472,1,2,,29215001,10607,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
672,2472,1,2,,50103982,10607,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
673,2472,1,2,,50103983,10607,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
674,2517,2,1,,855658,10607,Inconclusive,6980812.0,,1.122,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
675,2517,2,1,,50103982,10607,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
676,2517,2,1,,50103983,10607,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
677,2517,2,1,,144204425,10607,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
678,2520,1,4,,56463668,10607,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
679,2521,1,3,,56463668,10607,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
680,2523,1,1,,855658,10607,Inactive,124486680.0,16408.0,,,HTS of MLPCN Validation Compound Set for developing T Cell Immune Modulators,Screening,,
681,2524,1,2,,56463668,10607,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
682,2528,1,2,,855658,10607,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
683,2528,1,2,,29215001,10607,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
684,2528,1,2,,50103982,10607,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
685,2528,1,2,,50103983,10607,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
686,2540,1,2,,56463668,10607,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
687,2544,1,2,,56463668,10607,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
688,2546,1,1,,855658,10607,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
689,2546,1,1,,29215001,10607,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
690,2546,1,1,,50103982,10607,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
691,2546,1,1,,50103983,10607,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
692,2549,1,1,,855658,10607,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
693,2549,1,1,,29215001,10607,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
694,2549,1,1,,50103982,10607,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
695,2549,1,1,,50103983,10607,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
696,2550,1,3,,855658,10607,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
697,2551,1,1,,855658,10607,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
698,2551,1,1,,29215001,10607,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
699,2551,1,1,,50103982,10607,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
700,2551,1,1,,50103983,10607,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
701,2553,1,2,,855658,10607,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
702,2557,1,3,,56463668,10607,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
703,2563,1,1,,855658,10607,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
704,2599,1,2,,56463668,10607,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
705,2606,1,2,,56463668,10607,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
706,2629,1,1,,56463668,10607,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
707,2642,1,2,,855658,10607,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
708,2648,1,2,,855658,10607,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
709,2650,2,1,,56463668,10607,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
710,2661,1,1,,56463668,10607,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
711,2662,2,1,,855658,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
712,2662,2,1,,29215001,10607,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
713,2674,1,1,,855658,10607,Inactive,34810098.0,,,,HTS for Identification of VLA-4 Allosteric Modulators from Validation Compound Set.,Screening,,
714,2675,1,1,,855658,10607,Inactive,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
715,2676,1,2,,855658,10607,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
716,2685,1,1,,855658,10607,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
717,2690,1,2,,56463668,10607,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
718,2706,1,1,,855658,10607,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide for Validation Compound Set,Screening,,
719,2716,1,1,,56463668,10607,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
720,2717,1,2,,56463668,10607,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
721,2718,1,1,,56463668,10607,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
722,2751,2,2,,56463668,10607,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
723,2796,1,4,,56463668,10607,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
724,2797,1,2,,56463668,10607,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
725,2805,2,2,,56463668,10607,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
726,2806,2,2,,56463668,10607,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
727,2825,1,2,,56463668,10607,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
728,8624,6,2,,103168084,10607,Active,,,0.08,GI50,In vitro cytotoxic activity against renal (A 498) cancer cell line.,Confirmatory,10465531.0,
729,8688,6,2,,103168084,10607,Active,,,0.012,IC50,In vitro cytotoxicity against A-549 (human lung carcinoma) cell line.,Confirmatory,14971901.0,
730,9018,6,3,,103168084,10607,Active,,,0.012,IC50,Antineoplastic activity against A-549 (human lung carcinoma) cell line.,Confirmatory,,
731,9023,6,3,,103168084,10607,Active,,,0.05,IC50,Compound was tested for inhibition of cell growth of A-549 cells,Confirmatory,,
732,9039,4,4,,103168084,10607,Active,,,2.9,IC50,In vitro cytotoxicity against the A-549 (human lung carcinoma) neoplastic cell line,Confirmatory,14980682.0,
733,9244,5,2,,103168084,10607,Active,,,0.007940000000000001,GI50,GI values against A549 cells (lung cancer),Confirmatory,11311065.0,
734,9253,6,2,,103168084,10607,Unspecified,,,,,Growth inhibition of A549 (human lung carcinoma) cell line.,Other,2002477.0,
735,23271,4,4,,103168084,10607,Unspecified,,,,,Partition coefficient (logD7.4),Other,2362268.0,
736,42665,6,8,,103168084,10607,Active,75053726.0,,2.1,IC50,Ability to inhibit Tubulin polymerization in Bovine brain,Confirmatory,1875350.0,
737,42665,6,8,,103168084,10607,Active,75053735.0,,2.1,IC50,Ability to inhibit Tubulin polymerization in Bovine brain,Confirmatory,1875350.0,
738,42665,6,8,,103168084,10607,Active,118573906.0,281555.0,2.1,IC50,Ability to inhibit Tubulin polymerization in Bovine brain,Confirmatory,1875350.0,
739,42742,5,2,,103168084,10607,Active,,,0.1,GI50,GI values against CAKI-1 cells(renal carcinoma),Confirmatory,11311065.0,
740,44201,3,4,,103168084,10607,Unspecified,,,,,Effect on cross resistance of CCRF-CEM cells resistant to vincristine expressed as log of ratio of molar concentration of compound inducing 50% growth inhibition in resistant to sensitive cells,Other,2362268.0,
741,47049,6,3,,103168084,10607,Active,,,0.028999999999999998,IC50,Antineoplastic activity against CV-1 (monkey kidney fibroblast) cell line.,Confirmatory,,
742,54295,6,4,,103168084,10607,Active,,,2.1,IC50,Inhibition of tubulin polymerization was determined at 1.2 mg/mL concentration,Confirmatory,12699385.0,
743,57054,8,4,,103168084,10607,Inconclusive,,,,,Concentration of compound at which inhibitory activity detected against DNA topoisomerase II; Not tested,Other,9804687.0,
744,57216,3,7,,103168084,10607,Unspecified,,,,,Compound was tested for percentage inhibition against DNA topoisomerase II,Other,3016271.0,
745,57541,4,5,,103168084,10607,Active,,,0.0134,IC50,Inhibitory concentration required for cytotoxicity in DOX-resistant (DOX/R) cells,Confirmatory,,
746,57731,6,2,,103168084,10607,Active,,,0.04,GI50,In vitro cytotoxic activity against prostate (DU-145) cancer cell line.,Confirmatory,10465531.0,
747,73177,6,2,,103168084,10607,Active,,,0.15,IC50,Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on 2 hr incubation,Confirmatory,7783142.0,
748,73178,6,2,,103168084,10607,Active,,,0.06,IC50,Cytotoxic effect against GLC4 (human small cell lung carcinoma cell line) using the microculture tetrazolium (MTT) assay based on continuous incubation,Confirmatory,7783142.0,
749,78724,6,2,,103168084,10607,Active,,,0.7,GI50,In vitro cytotoxic activity against lung (H 522) cancer cell line.,Confirmatory,10465531.0,
750,78949,8,3,,103168084,10607,Unspecified,,,,,The compound was evaluated for cytotoxicity against H9 cell line; Toxic,Other,,
751,79771,6,2,,103168084,10607,Active,,,0.2,GI50,In vitro cytotoxicity against human colon cancer HCC 2998 cell line,Confirmatory,9871772.0,
752,80116,8,1,,103168084,10607,Active,,,0.1,ID50,Inhibitory activity against human cytomegalovirus (HCMV),Confirmatory,11311065.0,
753,80250,6,2,,103168084,10607,Active,,,0.01,GI50,In vitro cytotoxicity against human colon cancer HCT 116 cell line,Confirmatory,9871772.0,
754,80367,6,2,,103168084,10607,Active,,,0.02,GI50,In vitro cytotoxicity against human colon cancer HCT 15 cell line,Confirmatory,9871772.0,
755,83615,4,4,,103168084,10607,Active,,,2.9,IC50,In vitro cytotoxicity against the HT-29 (human colon carcinoma) neoplastic cell line,Confirmatory,14980682.0,
756,83763,6,2,,103168084,10607,Active,,,0.024,IC50,In vitro cytotoxicity against HT-29 (human colon carcinoma) cell line.,Confirmatory,14971901.0,
757,83892,7,1,,103168084,10607,Active,,,,,Minimum inhibitory concentration against herpesvirus simplex 1,Other,11311065.0,
758,83949,6,3,,103168084,10607,Active,,,0.05,IC50,Compound was tested for inhibition of cell growth of HT-29 cells,Confirmatory,,
759,84091,6,2,,103168084,10607,Unspecified,,,,,Growth inhibition of HT-29 (human colon adenocarcinoma) cell line.,Other,2002477.0,
760,84936,3,3,,103168084,10607,Active,,,,,Effective dose required to inhibit 100% against herpesvirus simplex 2,Other,11311065.0,
761,84960,7,1,,103168084,10607,Active,,,,,Minimum inhibitory concentration against herpesvirus simplex 2,Other,11311065.0,
762,85223,6,2,,103168084,10607,Active,,,0.08,GI50,In vitro cytotoxicity against human breast cancer Hs 578.T cell line,Confirmatory,9871772.0,
763,85442,6,2,,103168084,10607,Active,,,0.01,GI50,In vitro cytotoxicity against human colon cancer HT 29 cell line,Confirmatory,9871772.0,
764,86025,3,3,,103168084,10607,Active,,,,,Effective dose required to inhibit 100% against herpesvirus simplex 1,Other,11311065.0,
765,86100,6,3,,103168084,10607,Active,,,0.028999999999999998,IC50,Antineoplastic activity against HT-29 (human colon carcinoma) cell line.,Confirmatory,,
766,87903,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G0/G1 phase of the cell cycle at 10E-6 M for 24 hr in HeLa cells,Other,14971901.0,
767,87904,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G0/G1 phase of the cell cycle at 10E-6 M for 48 hr in HeLa cells,Other,14971901.0,
768,87905,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G0/G1 phase of the cell cycle at 10E-6 M for 72 hr in HeLa cells,Other,14971901.0,
769,87906,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G0/G1 phase of the cell cycle at 10E-7 M for 24 hr in HeLa cells,Other,14971901.0,
770,87907,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G0/G1 phase of the cell cycle at 10E-7 M for 48 hr in HeLa cells,Other,14971901.0,
771,87908,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G0/G1 phase of the cell cycle at 10E-7 M for 72 hr in HeLa cells,Other,14971901.0,
772,87909,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G0/G1 phase of the cell cycle at 10E-8 M for 24 hr in HeLa cells,Other,14971901.0,
773,87910,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G0/G1 phase of the cell cycle at 10E-8 M for 48 hr in HeLa cells,Other,14971901.0,
774,87911,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G0/G1 phase of the cell cycle at 10E-8 M for 72 hr in HeLa cells,Other,14971901.0,
775,87912,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G2/M phase of the cell cycle at 10E-6 M for 24 hr in HeLa cells,Other,14971901.0,
776,87913,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G2/M phase of the cell cycle at 10E-6 M for 48 hr in HeLa cells,Other,14971901.0,
777,87914,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G2/M phase of the cell cycle at 10E-6 M for 72 hr in HeLa cells,Other,14971901.0,
778,87915,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G2/M phase of the cell cycle at 10E-7 M for 24 hr in HeLa cells,Other,14971901.0,
779,87916,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G2/M phase of the cell cycle at 10E-7 M for 48 hr in HeLa cells,Other,14971901.0,
780,87917,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G2/M phase of the cell cycle at 10E-7 M for 72 hr in HeLa cells,Other,14971901.0,
781,87918,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G2/M phase of the cell cycle at 10E-8 M for 24 hr in HeLa cells,Other,14971901.0,
782,87919,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in G2/M phase of the cell cycle at 10E-8 M for 48 hr in HeLa cells,Other,14971901.0,
783,87920,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycle at 10E-6 M for 24 hr in HeLa cells,Other,14971901.0,
784,87921,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycle at 10E-6 M for 48 hr in HeLa cells,Other,14971901.0,
785,87922,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycle at 10E-6 M for 72 hr in HeLa cells,Other,14971901.0,
786,87923,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycle at 10E-7 M for 24 hr in HeLa cells,Other,14971901.0,
787,87924,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycle at 10E-7 M for 48 hr in HeLa cells,Other,14971901.0,
788,87925,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycle at 10E-7 M for 72 hr in HeLa cells,Other,14971901.0,
789,88036,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycle at 10E-8 M for 24 hr in HeLa cells,Other,14971901.0,
790,88037,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycle at 10E-8 M for 48 hr in HeLa cells,Other,14971901.0,
791,88038,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycle at 10E-8 M for 72 hr in HeLa cells,Other,14971901.0,
792,88039,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in S phase of the cell cycleG2/M at 10E-8 M for 72 hr in HeLa cells,Other,14971901.0,
793,88040,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in sub-G1 (apoptic cells) phase of the cell cycle at 10E-6 M for 72 hr in HeLa cells,Other,14971901.0,
794,88041,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in sub-G1 (apoptic cells) phase of the cell cycle at 10E-7 M for 72 hr in HeLa cells,Other,14971901.0,
795,88042,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in sub-G1 phase (apoptic cells )of the cell cycle at 10E-8 M for 24 hr in HeLa cells,Other,14971901.0,
796,88043,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in sub-G1 phase (apoptic cells) of the cell cycle at 10E-6 M for 24 hr in HeLa cells,Other,14971901.0,
797,88044,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in sub-G1 phase (apoptic cells) of the cell cycle at 10E-7 M for 24 hr in HeLa cells,Other,14971901.0,
798,88045,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in sub-G1 phase (apoptic cells)of the cell cycle at 10E-8 M for 48 hr in HeLa cells,Other,14971901.0,
799,88046,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in sub-G1 phase of the cell cycle at 10E-7 M for 48 hr in HeLa cells,Other,14971901.0,
800,88047,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in sub-G1 phase(apoptic cells) of the cell cycle at 10E-8 M for 72 hr in HeLa cells,Other,14971901.0,
801,88048,3,4,,103168084,10607,Unspecified,,,,,Effect on cell cycle evaluated as proportion of cells in sub-G1 (apoptic cells) phase of the cell cycle at 10E-6 M for 48 hr in HeLa cells,Other,14971901.0,
802,91784,4,5,,103168084,10607,Active,,,0.0164,IC50,Inhibitory concentration required for cytotoxicity in J774.2 murine macrophage-like cells,Confirmatory,,
803,92128,5,2,,103168084,10607,Active,,,0.028839999999999998,GI50,"Cytotoxic effect in human tumor cell lines, tested by the National Cancer Institute",Confirmatory,9216846.0,
804,92265,3,5,,103168084,10607,Unspecified,,,,,In vitro antitumor activity against NCI 's human tumor cell lines,Other,9301667.0,
805,94686,6,2,,103168084,10607,Active,,,0.01,GI50,In vitro cytotoxicity against human colon cancer KM 12 cell line,Confirmatory,9871772.0,
806,95485,6,1,,103168084,10607,Unspecified,,,,,In vitro effective dose to inhibit KB cell growth from a human epidermoid carcinoma.,Other,1992152.0,
807,95672,5,1,,103168084,10607,Unspecified,,,,,Toxicity of the quinacrine derivatives was determined against the KB cell line in comparison to podophyllotoxin,Other,11551771.0,
808,96208,5,1,,103168084,10607,Active,,,0.0002,ED50,The toxicity was evaluated against KB cells,Confirmatory,11459645.0,
809,98932,5,4,,103168084,10607,Unspecified,,,,,Tested for in vitro cytotoxicity against L1210 murine leukemia cells in mice,Other,,
810,101493,3,4,,103168084,10607,Unspecified,,,,,In vitro inhibitory concentration against human chronic myelogenous leukemia K562 cell growth; Not determined,Other,12852768.0,
811,101632,6,2,,103168084,10607,Active,,,0.026000000000000002,IC50,Inhibition of the growth of MDA-MB 231 human breast cancer cells,Confirmatory,9357519.0,
812,101652,6,2,,103168084,10607,Active,,,0.04,GI50,In vitro cytotoxicity against human breast cancer MDA-MB 231 cell line,Confirmatory,9871772.0,
813,101653,6,2,,103168084,10607,Active,,,0.7,GI50,In vitro cytotoxicity against human breast cancer MDA-MB 435 cell line,Confirmatory,9871772.0,
814,103000,6,2,,103168084,10607,Active,,,0.07,GI50,In vitro cytotoxic activity against melanoma (M 14) cancer cell line.,Confirmatory,10465531.0,
815,103364,6,2,,103168084,10607,Active,,,0.6,GI50,In vitro cytotoxicity against human breast cancer MCF-7 ADR cell line,Confirmatory,9871772.0,
816,103732,6,2,,103168084,10607,Active,,,0.9,GI50,In vitro cytotoxicity against human breast cancer MCF-7 cell line,Confirmatory,9871772.0,
817,103762,6,3,,103168084,10607,Active,,,0.6,GI50,In vitro cytotoxic activity against ADR resistant breast cancer (MCF-7-ADR) cell line.,Confirmatory,10465531.0,
818,105226,6,2,,103168084,10607,Active,,,0.07,GI50,In vitro cytotoxicity against human breast cancer MDA-N cell line,Confirmatory,9871772.0,
819,106315,6,3,,103168084,10607,Active,,,0.06,IC50,Compound was tested for inhibition of cell growth of MEL-28 cells,Confirmatory,,
820,114448,6,2,,103168084,10607,Unspecified,,,,,Compound was tested for Immunosuppression activity by mixed lymphocyte reaction (MLR) in murine splenocytes of mice,Other,8709118.0,
821,115979,5,2,,103168084,10607,Inactive,,,,,In vivo antitumor activity against the B16 melanoma cell line expressed as percent increase in life span; IA means inactive,Other,2821258.0,
822,115982,3,4,,103168084,10607,Unspecified,,,,,In vivo antitumor activity against the B16 melanoma cell line expressed as percent increase in life span at 1 mg/kg dose,Other,2821258.0,
823,115986,5,2,,103168084,10607,Inactive,,,,,In vivo antitumor activity against the L1210 leukemia cell line expressed as percent increase in life span; IA means inactive,Other,2821258.0,
824,115987,5,2,,103168084,10607,Inconclusive,,,,,In vivo antitumor activity against the L1210 leukemia cell line expressed as percent increase in life span; ND means no data,Other,2821258.0,
825,115993,5,2,,103168084,10607,Inconclusive,,,,,In vivo antitumor activity against the M5076 reticulum cell sarcoma expressed as percent increase in life span; ND means no data,Other,2821258.0,
826,115996,3,3,,103168084,10607,Unspecified,,,,,In vivo antitumor activity against the M5076 reticulum cell sarcoma expressed as percent increase in life span at 4 mg/kg dose,Other,2821258.0,
827,116434,3,4,,103168084,10607,Unspecified,,,,,Percent increase in life span (ILS) was measured on P388 cells which were inoculated intraperitoneally in CD2F1 mice at 8 mg/kg,Other,2821258.0,
828,120004,2,4,,103168084,10607,Unspecified,,,,,Assayed for antitumor activity against P388 leukemia in mice at a dose of 10 mg/kg/injection,Other,,
829,120005,2,4,,103168084,10607,Unspecified,,,,,Assayed for antitumor activity against P388 leukemia in mice at a dose of 2.5 mg/kg/injection,Other,,
830,120008,2,4,,103168084,10607,Unspecified,,,,,Assayed for antitumor activity against P388 leukemia in mice at a dose of 25 mg/kg/injection,Other,,
831,120010,2,4,,103168084,10607,Unspecified,,,,,"Assayed for antitumor activity against P388 leukemia in mice at a dose of 50 mg/kg/injection; Toxic, T/C<85%",Other,,
832,120910,2,4,,103168084,10607,Unspecified,,,,,Tested for antitumor activity against B16 melanoma in mice at a dose of 25 mg/kg given intraperitoneally,Other,,
833,121057,2,5,,103168084,10607,Unspecified,,,,,"Tested for antitumor activity against vincristine-resistant P388 leukemia (P388/VCR) in mice at a dose 1 mg/kg, given intraperitoneally",Other,,
834,121058,2,5,,103168084,10607,Unspecified,,,,,"Tested for antitumor activity against vincristine-resistant P388 leukemia (P388/VCR) in mice at a dose 2.5 mg/kg, given intraperitoneally",Other,,
835,121059,2,5,,103168084,10607,Unspecified,,,,,"Tested for antitumor activity against vincristine-resistant P388 leukemia (P388/VCR) in mice at a dose 5 mg/kg, given intraperitoneally; Toxic, T/C<85%",Other,,
836,125972,6,3,,103168084,10607,Unspecified,,,,,Evaluated for the inhibition of microtubule assembly prepared from bovine brain,Other,,
837,132849,5,3,,103168084,10607,Unspecified,,,,,Tested for immunosuppressive activity in mouse using allogenic MLR method,Other,,
838,140792,6,2,,103168084,10607,Unspecified,,,,,Compound was tested for Cytotoxic activity by lymphocyte viability assay,Other,8709118.0,
839,150680,6,2,,103168084,10607,Active,,,0.012,IC50,Tested in vitro for antineoplastic activity against P-388 (lymphoid neoplasm from DBA/2 mouse) tumor cell line,Confirmatory,14971901.0,
840,152259,6,3,,103168084,10607,Active,,,0.012,IC50,Antineoplastic activity against P-388 (murine leukemia) cell line.,Confirmatory,,
841,152273,4,4,,103168084,10607,Active,,,2.9,IC50,In vitro cytotoxicity against the P-388 (from DBA/2 mouse) neoplastic cell line,Confirmatory,14980682.0,
842,152417,6,3,,103168084,10607,Active,,,0.05,IC50,Compound was tested for inhibition of cell growth of P-388 cells,Confirmatory,,
843,152447,6,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against P-388 leukemia cells,Other,10714489.0,
844,153376,6,2,,103168084,10607,Unspecified,,,,,Growth inhibition of P388-D1 (murine leukemia) cell line.,Other,2002477.0,
845,159533,6,7,,103168084,10607,Active,135435.0,100135051.0,0.35,IC50,In vitro inhibition of maximum porcine tubulin assembly rate after 20 min at 37 degrees C,Confirmatory,12852768.0,
846,159533,6,7,,103168084,10607,Active,135490.0,,0.35,IC50,In vitro inhibition of maximum porcine tubulin assembly rate after 20 min at 37 degrees C,Confirmatory,12852768.0,
847,201686,6,2,,103168084,10607,Active,,,2.0,GI50,In vitro cytotoxic activity against colon (SW 620) cancer cell line.,Confirmatory,10465531.0,
848,202655,6,2,,103168084,10607,Active,,,0.9,GI50,In vitro cytotoxic activity against Ovarian (SK-OV3) cell line.,Confirmatory,10465531.0,
849,211307,8,4,,103168084,10607,Inactive,,,,,In vitro activity against mammalian topoisomerase II measured as ATP-dependent unknotting of P4 DNA compared to enzyme and DNA control; Inactive,Other,9599244.0,
850,212934,7,2,,103168084,10607,Unspecified,,,,,In vitro minimum inhibition concentration to inhibit the regeneration of cilia in Tetrahymena pyriformis W.,Other,1992152.0,
851,213996,9,5,,103168084,10607,Active,75053726.0,,2.5,IC50,In vitro inhibition of purified bovine brain tubulin polymerisation in the absence of microtubule-associated proteins.,Confirmatory,,
852,213996,9,5,,103168084,10607,Active,75053735.0,,2.5,IC50,In vitro inhibition of purified bovine brain tubulin polymerisation in the absence of microtubule-associated proteins.,Confirmatory,,
853,213996,9,5,,103168084,10607,Active,118573906.0,281555.0,2.5,IC50,In vitro inhibition of purified bovine brain tubulin polymerisation in the absence of microtubule-associated proteins.,Confirmatory,,
854,213999,6,8,,103168084,10607,Active,75053726.0,,0.59,IC50,Concentration inhibiting tubulin polymerization (ITP),Confirmatory,10514278.0,
855,213999,6,8,,103168084,10607,Active,75053735.0,,0.59,IC50,Concentration inhibiting tubulin polymerization (ITP),Confirmatory,10514278.0,
856,213999,6,8,,103168084,10607,Active,118573906.0,281555.0,0.59,IC50,Concentration inhibiting tubulin polymerization (ITP),Confirmatory,10514278.0,
857,214009,6,8,,103168084,10607,Active,75053726.0,,1.2,IC50,Inhibition of tubulin polymerization using isolated calf brain,Confirmatory,9357519.0,
858,214009,6,8,,103168084,10607,Active,75053735.0,,1.2,IC50,Inhibition of tubulin polymerization using isolated calf brain,Confirmatory,9357519.0,
859,214009,6,8,,103168084,10607,Active,118573906.0,281555.0,1.2,IC50,Inhibition of tubulin polymerization using isolated calf brain,Confirmatory,9357519.0,
860,214013,6,3,,103168084,10607,Active,,,1.3,IC50,Inhibition of tubulin polymerization,Confirmatory,8387598.0,
861,214014,6,3,,103168084,10607,Active,,,0.46,IC50,Inhibition of tubulin polymerization,Confirmatory,8164254.0,
862,214015,6,8,,103168084,10607,Active,75053726.0,,0.46,IC50,Inhibition of tubulin polymerization,Confirmatory,9301667.0,
863,214015,6,8,,103168084,10607,Active,75053735.0,,0.46,IC50,Inhibition of tubulin polymerization,Confirmatory,9301667.0,
864,214015,6,8,,103168084,10607,Active,118573906.0,281555.0,0.46,IC50,Inhibition of tubulin polymerization,Confirmatory,9301667.0,
865,214030,6,7,,103168084,10607,Active,75053726.0,,0.46,IC50,Inhibition of bovine tubulin polymerization,Confirmatory,11087572.0,
866,214030,6,7,,103168084,10607,Active,75053735.0,,0.46,IC50,Inhibition of bovine tubulin polymerization,Confirmatory,11087572.0,
867,214030,6,7,,103168084,10607,Active,118573906.0,281555.0,0.46,IC50,Inhibition of bovine tubulin polymerization,Confirmatory,11087572.0,
868,214033,6,7,,103168084,10607,Active,75053726.0,,0.46,IC50,Inhibition of bovine tubulin polymerization,Confirmatory,7932568.0,
869,214033,6,7,,103168084,10607,Active,75053735.0,,0.46,IC50,Inhibition of bovine tubulin polymerization,Confirmatory,7932568.0,
870,214033,6,7,,103168084,10607,Active,118573906.0,281555.0,0.46,IC50,Inhibition of bovine tubulin polymerization,Confirmatory,7932568.0,
871,214039,9,5,,103168084,10607,Active,75053726.0,,0.46,IC50,Inhibition of bovine brain tubulin polymerization (ITP).,Confirmatory,9544215.0,
872,214039,9,5,,103168084,10607,Active,75053735.0,,0.46,IC50,Inhibition of bovine brain tubulin polymerization (ITP).,Confirmatory,9544215.0,
873,214039,9,5,,103168084,10607,Active,118573906.0,281555.0,0.46,IC50,Inhibition of bovine brain tubulin polymerization (ITP).,Confirmatory,9544215.0,
874,214163,3,10,,103168084,10607,Unspecified,75053726.0,,,,Inhibition of colchicine binding to tubulin isolated from bovine brain tissue,Other,8164254.0,
875,214163,3,10,,103168084,10607,Unspecified,75053735.0,,,,Inhibition of colchicine binding to tubulin isolated from bovine brain tissue,Other,8164254.0,
876,214163,3,10,,103168084,10607,Unspecified,118573906.0,281555.0,,,Inhibition of colchicine binding to tubulin isolated from bovine brain tissue,Other,8164254.0,
877,214170,3,10,,103168084,10607,Unspecified,75053726.0,,,,"Concentration inhibiting [3H]colchicine binding to tubulin, at a concentration of 5 uM",Other,10514278.0,
878,214170,3,10,,103168084,10607,Unspecified,75053735.0,,,,"Concentration inhibiting [3H]colchicine binding to tubulin, at a concentration of 5 uM",Other,10514278.0,
879,214170,3,10,,103168084,10607,Unspecified,118573906.0,281555.0,,,"Concentration inhibiting [3H]colchicine binding to tubulin, at a concentration of 5 uM",Other,10514278.0,
880,214171,3,11,,103168084,10607,Unspecified,75053726.0,,,,Effect on the binding of radiolabeled [3H]colchicine to tubulin,Other,1875350.0,
881,214171,3,11,,103168084,10607,Unspecified,75053735.0,,,,Effect on the binding of radiolabeled [3H]colchicine to tubulin,Other,1875350.0,
882,214171,3,11,,103168084,10607,Unspecified,118573906.0,281555.0,,,Effect on the binding of radiolabeled [3H]colchicine to tubulin,Other,1875350.0,
883,214173,3,10,,103168084,10607,Unspecified,75053726.0,,,,In vitro inhibition of binding of [3H]colchicine to tubulin (10 uM) at compound concentration of 5 mM,Other,9632366.0,
884,214173,3,10,,103168084,10607,Unspecified,75053735.0,,,,In vitro inhibition of binding of [3H]colchicine to tubulin (10 uM) at compound concentration of 5 mM,Other,9632366.0,
885,214173,3,10,,103168084,10607,Unspecified,118573906.0,281555.0,,,In vitro inhibition of binding of [3H]colchicine to tubulin (10 uM) at compound concentration of 5 mM,Other,9632366.0,
886,214176,3,10,,103168084,10607,Unspecified,75053726.0,,,,Inhibition of colchicine binding to tubulin was evaluated only when polymerization IC50 <=1.0 uM,Other,7932568.0,
887,214176,3,10,,103168084,10607,Unspecified,75053735.0,,,,Inhibition of colchicine binding to tubulin was evaluated only when polymerization IC50 <=1.0 uM,Other,7932568.0,
888,214176,3,10,,103168084,10607,Unspecified,118573906.0,281555.0,,,Inhibition of colchicine binding to tubulin was evaluated only when polymerization IC50 <=1.0 uM,Other,7932568.0,
889,214179,3,10,,103168084,10607,Unspecified,75053726.0,,,,Inhibition of radiolabeled colchicine binding to tubulin,Other,9301667.0,
890,214179,3,10,,103168084,10607,Unspecified,75053735.0,,,,Inhibition of radiolabeled colchicine binding to tubulin,Other,9301667.0,
891,214179,3,10,,103168084,10607,Unspecified,118573906.0,281555.0,,,Inhibition of radiolabeled colchicine binding to tubulin,Other,9301667.0,
892,214187,3,10,,103168084,10607,Unspecified,75053726.0,,,,Percentage inhibition of colchicine binding(1:1 ratio of inhibitor: colchicine) to tubulin,Other,8387598.0,
893,214187,3,10,,103168084,10607,Unspecified,75053735.0,,,,Percentage inhibition of colchicine binding(1:1 ratio of inhibitor: colchicine) to tubulin,Other,8387598.0,
894,214187,3,10,,103168084,10607,Unspecified,118573906.0,281555.0,,,Percentage inhibition of colchicine binding(1:1 ratio of inhibitor: colchicine) to tubulin,Other,8387598.0,
895,214346,9,5,,103168084,10607,Active,135435.0,100135051.0,2.18,Ki,Binding affinity against tubulin using [3H]colchicine as radioligand,Confirmatory,7381854.0,
896,214346,9,5,,103168084,10607,Active,135490.0,,2.18,Ki,Binding affinity against tubulin using [3H]colchicine as radioligand,Confirmatory,7381854.0,
897,214353,4,12,,103168084,10607,Unspecified,135435.0,100135051.0,,,Ratio of binding affinity to that of colchicine,Other,7381854.0,
898,214353,4,12,,103168084,10607,Unspecified,135490.0,,,,Ratio of binding affinity to that of colchicine,Other,7381854.0,
899,214361,6,8,,103168084,10607,Active,135435.0,100135051.0,1.65,IC50,Tested for the inhibition of polymerization rate of tubulin microtubule assembly.,Confirmatory,7381854.0,
900,214361,6,8,,103168084,10607,Active,135490.0,,1.65,IC50,Tested for the inhibition of polymerization rate of tubulin microtubule assembly.,Confirmatory,7381854.0,
901,214503,8,2,,103168084,10607,Active,,,3.0,IC50,in vitro inhibitory activity against tubulin polymerization.,Confirmatory,9804687.0,
902,214524,3,7,,103168084,10607,Unspecified,,,,,Percentage control on Tubulin- Dependent GTP hydrolysis was evaluated at 10 micro M concentration,Other,10328289.0,
903,214525,3,7,,103168084,10607,Unspecified,,,,,Percentage control on Tubulin- Dependent GTP hydrolysis was evaluated at 50 micro M concentration,Other,10328289.0,
904,214548,9,3,,103168084,10607,Active,,,1.0,IC50,In vitro inhibition of mammalian tubulin polymerization by 50%,Confirmatory,9599244.0,
905,214555,6,3,,103168084,10607,Active,,,0.46,IC50,Inhibition of bovine tubulin polymerization,Confirmatory,9216846.0,
906,214687,9,2,,103168084,10607,Active,,,0.46,IC50,Inhibition of tubulin polymerization. (ITP),Confirmatory,11689079.0,
907,214692,8,1,,103168084,10607,Unspecified,,,460.0,IC50,Inhibitory concentration required against tubulin polymerization in the antimicrotubule activity test,Confirmatory,11354375.0,
908,214711,3,7,,103168084,10607,Unspecified,,,,,Inhibition of colchicine binding and evaluated only when polymerization IC50 <=1 uM,Other,9216846.0,
909,214713,3,7,,103168084,10607,Unspecified,,,,,Inhibition of colchicine binding to tubulin,Other,9357519.0,
910,214728,3,9,,103168084,10607,Unspecified,,,,,Tested for the inhibition using the binding of 5 uM [3H]colchicine to purified tubulin at 37 degree Centigrade,Other,,
911,216262,4,5,,103168084,10607,Active,,,0.0113,IC50,Inhibitory concentration required for cytotoxicity in hydroxyrubicin-resistant (WP159/R) cells,Confirmatory,,
912,217565,3,4,,103168084,10607,Active,,,,,Effective dose required to inhibit 25% of cell growth (Herpesvirus activity),Other,11311065.0,
913,217897,7,1,,103168084,10607,Active,,,,,Minimum inhibitory concentration for cell growth inhibition (Herpesvirus activity),Other,11311065.0,
914,228502,5,1,,103168084,10607,Unspecified,,,,,Tested in vitro for cytotoxicity against leukocytoclastic vasculitis(LcV) in cells,Other,,
915,231043,3,4,,103168084,10607,Unspecified,,,,,Non-cytotoxic IMS activity (ratio LcV/MLR) was determined,Other,,
916,231477,3,4,,103168084,10607,Unspecified,,,,,Ratio between IC50 value of DOX/R and WP159/R was determined,Other,,
917,232657,4,3,,103168084,10607,Unspecified,,,,,Ratio of inhibitory activity to inhibitory activity of colchicine,Other,7381854.0,
918,235703,3,3,,103168084,10607,Unspecified,,,,,Selectivity index is the ratio of IC50 of P-388 cell line to that of HT-29,Other,14971901.0,
919,235867,3,3,,103168084,10607,Unspecified,,,,,Non cytotoxic IM activity index which is the ratio of IC50 of LcV to IC50 of MLR,Other,8709118.0,
920,247402,8,1,,103168084,10607,Active,,,0.01,GI50,Growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program,Confirmatory,15743190.0,
921,257597,6,2,,103168084,10607,Active,,,0.013000000000000001,IC50,Antiproliferative activity against androgen-independent prostate cancer PC3 cell line by MTS assay,Confirmatory,16213720.0,
922,257598,6,2,,103168084,10607,Inconclusive,,,,IC50,Antiproliferative activity against estrogen-dependent breast cancer MCF7 cell line by MTS assay,Confirmatory,16213720.0,
923,257599,6,2,,103168084,10607,Active,,,0.008,IC50,Antiproliferative activity against estrogen-independent breast cancer MDA-MB-231 cell line by MTS assay,Confirmatory,16213720.0,
924,257600,9,5,,103168084,10607,Active,135435.0,100135051.0,1.56,IC50,Inhibition of porcine brain tubulin polymerization by GTP-induced assembly,Confirmatory,16213720.0,
925,257600,9,5,,103168084,10607,Active,135490.0,,1.56,IC50,Inhibition of porcine brain tubulin polymerization by GTP-induced assembly,Confirmatory,16213720.0,
926,261763,6,2,,103168084,10607,Active,,,0.0036,IC50,Cytotoxicity against KB cell line,Confirmatory,16343898.0,
927,262911,9,5,,103168084,10607,Active,20455316.0,7278.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
928,262911,9,5,,103168084,10607,Active,20455316.0,113457.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
929,262911,9,5,,103168084,10607,Active,20455322.0,84790.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
930,262911,9,5,,103168084,10607,Active,20455526.0,10381.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
931,262911,9,5,,103168084,10607,Active,55977474.0,10376.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
932,262911,9,5,,103168084,10607,Active,55977476.0,7277.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
933,262911,9,5,,103168084,10607,Active,55977480.0,10383.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
934,262911,9,5,,103168084,10607,Active,55977864.0,7846.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
935,262911,9,5,,103168084,10607,Active,56757569.0,203068.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
936,262911,9,5,,103168084,10607,Active,62903515.0,81027.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
937,262911,9,5,,103168084,10607,Active,68776070.0,84617.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
938,262911,9,5,,103168084,10607,Active,74761283.0,347733.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
939,262911,9,5,,103168084,10607,Active,74762137.0,7280.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
940,262911,9,5,,103168084,10607,Active,93141323.0,10382.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
941,262911,9,5,,103168084,10607,Active,182705285.0,347688.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
942,262911,9,5,,103168084,10607,Active,224471855.0,112714.0,1.7,IC50,Inhibition of tubulin polymerization,Confirmatory,16570932.0,
943,262912,5,9,,103168084,10607,Unspecified,20455316.0,7278.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
944,262912,5,9,,103168084,10607,Unspecified,20455316.0,113457.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
945,262912,5,9,,103168084,10607,Unspecified,20455322.0,84790.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
946,262912,5,9,,103168084,10607,Unspecified,20455526.0,10381.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
947,262912,5,9,,103168084,10607,Unspecified,55977474.0,10376.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
948,262912,5,9,,103168084,10607,Unspecified,55977476.0,7277.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
949,262912,5,9,,103168084,10607,Unspecified,55977480.0,10383.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
950,262912,5,9,,103168084,10607,Unspecified,55977864.0,7846.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
951,262912,5,9,,103168084,10607,Unspecified,56757569.0,203068.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
952,262912,5,9,,103168084,10607,Unspecified,62903515.0,81027.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
953,262912,5,9,,103168084,10607,Unspecified,68776070.0,84617.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
954,262912,5,9,,103168084,10607,Unspecified,74761283.0,347733.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
955,262912,5,9,,103168084,10607,Unspecified,74762137.0,7280.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
956,262912,5,9,,103168084,10607,Unspecified,93141323.0,10382.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
957,262912,5,9,,103168084,10607,Unspecified,182705285.0,347688.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
958,262912,5,9,,103168084,10607,Unspecified,224471855.0,112714.0,,,Inhibition of [3H]colchicine binding to tubulin at 5 uM,Other,16570932.0,
959,266615,6,2,,103168084,10607,Active,,,0.15,IC50,Cytotoxicity against rat L6 cells,Confirmatory,16677813.0,
960,266932,9,5,,103168084,10607,Active,75053726.0,,1.7,IC50,Inhibition of tubulin polymerization in bovine brain by tubulin assembly assay,Confirmatory,16789746.0,
961,266932,9,5,,103168084,10607,Active,75053735.0,,1.7,IC50,Inhibition of tubulin polymerization in bovine brain by tubulin assembly assay,Confirmatory,16789746.0,
962,266932,9,5,,103168084,10607,Active,118573906.0,281555.0,1.7,IC50,Inhibition of tubulin polymerization in bovine brain by tubulin assembly assay,Confirmatory,16789746.0,
963,266933,3,12,,103168084,10607,Unspecified,20455316.0,7278.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
964,266933,3,12,,103168084,10607,Unspecified,20455316.0,113457.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
965,266933,3,12,,103168084,10607,Unspecified,20455322.0,84790.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
966,266933,3,12,,103168084,10607,Unspecified,20455526.0,10381.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
967,266933,3,12,,103168084,10607,Unspecified,55977474.0,10376.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
968,266933,3,12,,103168084,10607,Unspecified,55977476.0,7277.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
969,266933,3,12,,103168084,10607,Unspecified,55977480.0,10383.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
970,266933,3,12,,103168084,10607,Unspecified,55977864.0,7846.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
971,266933,3,12,,103168084,10607,Unspecified,56757569.0,203068.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
972,266933,3,12,,103168084,10607,Unspecified,62903515.0,81027.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
973,266933,3,12,,103168084,10607,Unspecified,68776070.0,84617.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
974,266933,3,12,,103168084,10607,Unspecified,74761283.0,347733.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
975,266933,3,12,,103168084,10607,Unspecified,74762137.0,7280.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
976,266933,3,12,,103168084,10607,Unspecified,93141323.0,10382.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
977,266933,3,12,,103168084,10607,Unspecified,182705285.0,347688.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
978,266933,3,12,,103168084,10607,Unspecified,224471855.0,112714.0,,,Inhibition of [3H]colchicine binding to tubulin at 1 uM,Other,16789746.0,
979,267896,6,2,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against rat L6 cells,Confirmatory,16821778.0,
980,270964,6,2,,103168084,10607,Active,,,0.028999999999999998,IC50,Cytotoxicity against proliferating RKOp27 cells after 72 hrs by Alamar Blue assay,Confirmatory,16970401.0,
981,270965,6,2,,103168084,10607,Unspecified,,,0.5,IC50,Cytotoxicity against cell cycle arrested RKOp27 cells after 72 hrs by alamar blue assay,Confirmatory,16970401.0,
982,270966,9,5,,103168084,10607,Active,20455316.0,7278.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
983,270966,9,5,,103168084,10607,Active,20455316.0,113457.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
984,270966,9,5,,103168084,10607,Active,20455322.0,84790.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
985,270966,9,5,,103168084,10607,Active,20455526.0,10381.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
986,270966,9,5,,103168084,10607,Active,55977474.0,10376.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
987,270966,9,5,,103168084,10607,Active,55977476.0,7277.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
988,270966,9,5,,103168084,10607,Active,55977480.0,10383.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
989,270966,9,5,,103168084,10607,Active,55977864.0,7846.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
990,270966,9,5,,103168084,10607,Active,56757569.0,203068.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
991,270966,9,5,,103168084,10607,Active,62903515.0,81027.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
992,270966,9,5,,103168084,10607,Active,68776070.0,84617.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
993,270966,9,5,,103168084,10607,Active,74761283.0,347733.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
994,270966,9,5,,103168084,10607,Active,74762137.0,7280.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
995,270966,9,5,,103168084,10607,Active,93141323.0,10382.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
996,270966,9,5,,103168084,10607,Active,182705285.0,347688.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
997,270966,9,5,,103168084,10607,Active,224471855.0,112714.0,4.0,IC50,Inhibition of [3H]colchicine binding to beta tubulin,Confirmatory,16970401.0,
998,272983,8,1,,103168084,10607,Active,,,0.1,ED50,Antimalarial activity against Plasmodium falciparum K1,Confirmatory,17004723.0,
999,272984,8,1,,103168084,10607,Active,,,0.001,TD50,Cytotoxicity against KB cell line,Confirmatory,17004723.0,
1000,273079,4,4,,103168084,10607,Active,,,0.0072,IC50,Antiproliferative activity against human CEM cells after 72 hrs,Confirmatory,17034133.0,
1001,273080,4,4,,103168084,10607,Active,,,0.013999999999999999,IC50,Antiproliferative activity against human Molt3 cells after 72 hrs,Confirmatory,17034133.0,
1002,273081,4,4,,103168084,10607,Active,,,0.0091,IC50,Antiproliferative activity against human Bel7402 cells after 72 hrs,Confirmatory,17034133.0,
1003,273082,4,4,,103168084,10607,Active,,,0.015,IC50,Antiproliferative activity against human MCF7 cells after 72 hrs,Confirmatory,17034133.0,
1004,273083,4,4,,103168084,10607,Active,,,0.052000000000000005,IC50,Antiproliferative activity against human DU145 cells after 72 hrs,Confirmatory,17034133.0,
1005,273084,4,4,,103168084,10607,Active,,,0.01,IC50,Antiproliferative activity against human PC3 cells after 72 hrs,Confirmatory,17034133.0,
1006,273085,4,4,,103168084,10607,Active,,,0.012,IC50,Antiproliferative activity against human DND1 cells after 72 hrs,Confirmatory,17034133.0,
1007,273086,4,4,,103168084,10607,Active,,,0.023,IC50,Antiproliferative activity against human DMS79 cells after 72 hrs,Confirmatory,17034133.0,
1008,274747,6,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells,Other,17253841.0,
1009,274784,6,2,,103168084,10607,Inconclusive,,,,IC50,Antiproliferative activity against human K562 cell line,Confirmatory,17181164.0,
1010,274785,6,2,,103168084,10607,Active,,,0.35,IC50,Inhibition of tubulin polymerization in porcine brain,Confirmatory,17181164.0,
1011,277522,6,2,,103168084,10607,Active,,,0.031,IC50,Cytotoxicity against androgen sensitive human LNCaP cells,Confirmatory,17256902.0,
1012,277523,6,2,,103168084,10607,Active,,,0.034,IC50,Cytotoxicity against androgen-independent human PC3 cells,Confirmatory,17256902.0,
1013,282997,8,1,,103168084,10607,Active,,,0.07,ED50,Cytotoxicity against human KB cells by Alamar blue assay,Confirmatory,16279799.0,
1014,286671,6,2,,103168084,10607,Active,,,0.0186,IC50,Cytotoxicity against rat L6 cells,Confirmatory,17439202.0,
1015,290172,4,4,,103168084,10607,Active,,,0.0072,IC50,Cytotoxicity against human CEM cells,Confirmatory,17197178.0,
1016,290173,4,4,,103168084,10607,Active,,,0.013999999999999999,IC50,Antiproliferative activity against human Molt3 cells,Confirmatory,17197178.0,
1017,290174,4,4,,103168084,10607,Active,,,0.0091,IC50,Antiproliferative activity against human Bel-7402 cells,Confirmatory,17197178.0,
1018,290175,4,4,,103168084,10607,Active,,,0.015,IC50,Antiproliferative activity against human MCF7 cells,Confirmatory,17197178.0,
1019,290176,4,4,,103168084,10607,Active,,,0.052000000000000005,IC50,Antiproliferative activity against human DU145 cells,Confirmatory,17197178.0,
1020,290177,4,4,,103168084,10607,Active,,,0.01,IC50,Antiproliferative activity against human PC3 cells,Confirmatory,17197178.0,
1021,290178,4,4,,103168084,10607,Active,,,0.012,IC50,Antiproliferative activity against human DND1 cells,Confirmatory,17197178.0,
1022,293484,6,2,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against mouse P388 cells after 4 days,Confirmatory,17197187.0,
1023,293485,6,2,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against human A549 cells after 4 days,Confirmatory,17197187.0,
1024,293486,6,2,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against human HT29 cells after 4 days,Confirmatory,17197187.0,
1025,293487,6,3,,103168084,10607,Inconclusive,,,,IC50,Cytotoxicity against human MEL28 cells after 4 days,Confirmatory,17197187.0,
1026,298655,3,4,,103168084,10607,Unspecified,,,,,Antiproliferative activity against HeLa cells assessed as cell viability at 5 uM after 48 hrs by MTT assay relative to control,Other,17894480.0,
1027,298656,3,4,,103168084,10607,Unspecified,,,,,Antiproliferative activity against human MCF7/AZ cells assessed as cell viability at 5 uM after 48 hrs by MTT assay relative to control,Other,17894480.0,
1028,298657,3,4,,103168084,10607,Unspecified,,,,,Antiproliferative activity against human Jurkat cells assessed as cell viability at 5 uM after 48 hrs by MTT assay,Other,17894480.0,
1029,298658,3,4,,103168084,10607,Unspecified,,,,,Induction of apoptosis in Jurkat cells assessed as cell viability at 5 uM after 48 hrs by flow cytometry Annexin-V/propidium iodide assay,Other,17894480.0,
1030,298659,6,2,,103168084,10607,Active,,,0.02,GI50,Growth inhibition of HeLa cells after 48 hrs by MTT assay,Confirmatory,17894480.0,
1031,298660,3,4,,103168084,10607,Active,,,,,Increase in caspase 3 activation in Jurkat cells at 5 uM,Other,17894480.0,
1032,298666,3,4,,103168084,10607,Active,,,,,Effect on apoptosis in Jurkat cells assessed as cleavage of procaspase 3 to active enzyme at 5 uM,Other,17894480.0,
1033,298668,3,4,,103168084,10607,Active,,,,,Effect on apoptosis in Jurkat cells assessed as cleavage of PARP at 5 uM,Other,17894480.0,
1034,298672,3,4,,103168084,10607,Inactive,,,,,Induction of apoptosis in human whole blood lymphocytes after 24 hrs by flow cytometric Annexin-V/propidium iodide assay,Other,17894480.0,
1035,298673,3,4,,103168084,10607,Active,,,,,Induction of apoptosis in Jurkat cells after 24 hrs by flow cytometric Annexin-V/propidium iodide assay,Other,17894480.0,
1036,299202,4,4,,103168084,10607,Active,,,0.0072,IC50,Antiproliferative activity against human CEM cells,Confirmatory,17482458.0,
1037,299203,4,4,,103168084,10607,Active,,,0.013999999999999999,IC50,Antiproliferative activity against human Molt3 cells,Confirmatory,17482458.0,
1038,299204,4,4,,103168084,10607,Active,,,0.0091,IC50,Antiproliferative activity against human Bel7402 cells,Confirmatory,17482458.0,
1039,299205,4,4,,103168084,10607,Active,,,0.015,IC50,Antiproliferative activity against human MCF7 cells,Confirmatory,17482458.0,
1040,299206,4,4,,103168084,10607,Active,,,0.052000000000000005,IC50,Antiproliferative activity against human DU145 cells,Confirmatory,17482458.0,
1041,299207,4,4,,103168084,10607,Active,,,0.01,IC50,Antiproliferative activity against human PC3 cells,Confirmatory,17482458.0,
1042,299208,4,4,,103168084,10607,Active,,,0.012,IC50,Antiproliferative activity against human DND1 cells,Confirmatory,17482458.0,
1043,300105,6,2,,103168084,10607,Active,,,0.048,CC50,Cytotoxicity against human KB cells,Confirmatory,17548196.0,
1044,300657,6,2,,103168084,10607,Inconclusive,,,,IC50,Inhibition of Leishmania tarentolae tubulin assembly,Confirmatory,17618122.0,
1045,300658,6,2,,103168084,10607,Inconclusive,,,,IC50,Inhibition of porcine tubulin assembly,Confirmatory,17618122.0,
1046,300660,6,2,,103168084,10607,Inconclusive,,,,IC50,Growth inhibition against Leishmania donovani,Confirmatory,17618122.0,
1047,300661,6,2,,103168084,10607,Inconclusive,,,,IC50,Growth inhibition against Trypanosoma brucei brucei,Confirmatory,17618122.0,
1048,300662,6,2,,103168084,10607,Active,,,0.016,IC50,Toxicity against monkey Vero cells,Confirmatory,17618122.0,
1049,301310,8,1,,103168084,10607,Active,,,0.006999999999999999,IC50,Cytotoxicity against SH-SY5Y cells assessed as cell viability after 48 hrs by MTT method,Confirmatory,17765552.0,
1050,301313,3,4,,103168084,10607,Active,20455316.0,7278.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1051,301313,3,4,,103168084,10607,Active,20455316.0,113457.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1052,301313,3,4,,103168084,10607,Active,20455322.0,84790.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1053,301313,3,4,,103168084,10607,Active,20455526.0,10381.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1054,301313,3,4,,103168084,10607,Active,55977474.0,10376.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1055,301313,3,4,,103168084,10607,Active,55977476.0,7277.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1056,301313,3,4,,103168084,10607,Active,55977480.0,10383.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1057,301313,3,4,,103168084,10607,Active,55977864.0,7846.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1058,301313,3,4,,103168084,10607,Active,56757569.0,203068.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1059,301313,3,4,,103168084,10607,Active,62903515.0,81027.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1060,301313,3,4,,103168084,10607,Active,68776070.0,84617.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1061,301313,3,4,,103168084,10607,Active,74761283.0,347733.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1062,301313,3,4,,103168084,10607,Active,74762137.0,7280.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1063,301313,3,4,,103168084,10607,Active,93141323.0,10382.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1064,301313,3,4,,103168084,10607,Active,182705285.0,347688.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1065,301313,3,4,,103168084,10607,Active,224471855.0,112714.0,,,Induction of tubulin depolymerization after 16 hrs,Other,17765552.0,
1066,303243,6,2,,103168084,10607,Active,,,0.01,IC50,Cytotoxicity against rat L6 cells,Confirmatory,17948982.0,
1067,303266,6,2,,103168084,10607,Active,,,0.01,IC50,Cytotoxicity against rat L6 cells,Confirmatory,17949068.0,
1068,303684,6,2,,103168084,10607,Inconclusive,,,,IC50,Antiproliferative activity against human K562 cells after 48 hrs,Confirmatory,17973361.0,
1069,303685,6,2,,103168084,10607,Active,,,0.35,IC50,Inhibition of porcine brain tubulin polymerization,Confirmatory,17973361.0,
1070,304045,6,2,,103168084,10607,Active,,,0.006999999999999999,IC50,Cytotoxicity against rat L6 cells,Confirmatory,17990865.0,
1071,305850,3,4,,103168084,10607,Unspecified,,,,,Cytotoxicity against human HeLa cells assessed as viability at 5 uM after 48 hrs by MTT method relative to control,Other,17188868.0,
1072,305851,3,4,,103168084,10607,Unspecified,,,,,Cytotoxicity against human MCF7AZ cells assessed as viability at 5 uM after 48 hrs by MTT method relative to control,Other,17188868.0,
1073,305852,3,4,,103168084,10607,Unspecified,,,,,Cytotoxicity against human Jurkat cells assessed as viability at 5 uM after 48 hrs by MTT method relative to control,Other,17188868.0,
1074,305854,3,4,,103168084,10607,Unspecified,,,,,Induction of apoptosis in human Jurkat cells at 5 uM by flow cytometric annexin-V/propidium iodide assay,Other,17188868.0,
1075,305856,3,4,,103168084,10607,Unspecified,,,,,Induction of apoptosis in human Jurkat cells at 5 uM after 48 hrs by flow cytometric annexin-V/propidium iodide assay,Other,17188868.0,
1076,306629,6,2,,103168084,10607,Active,,,0.15,IC50,Cytotoxicity against C8166 cells assessed as reduction in total cell number,Confirmatory,17317161.0,
1077,306630,6,2,,103168084,10607,Active,,,0.0029,EC50,Antiviral activity against HIV1 in C8166 cells assessed as inhibition of syncytia formation,Confirmatory,17317161.0,
1078,306631,3,4,,103168084,10607,Unspecified,,,,,"Therapeutic index, IC50 for C8166 cells to EC50 for HIV1",Other,17317161.0,
1079,309303,6,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells after 72 hrs,Other,17765547.0,
1080,310755,6,3,,103168084,10607,Active,,,0.013999999999999999,IC50,Antiproliferative activity against human Molt3 cells,Confirmatory,17977727.0,
1081,310756,6,2,,103168084,10607,Active,,,0.015,IC50,Antiproliferative activity against human MCF7 cells,Confirmatory,17977727.0,
1082,310757,6,3,,103168084,10607,Active,,,0.009000000000000001,IC50,Antiproliferative activity against human Bel7402 cells,Confirmatory,17977727.0,
1083,310758,6,2,,103168084,10607,Active,,,0.052000000000000005,IC50,Antiproliferative activity against human DU145 cells,Confirmatory,17977727.0,
1084,310759,6,2,,103168084,10607,Active,,,0.01,IC50,Antiproliferative activity against human PC3 cells,Confirmatory,17977727.0,
1085,310760,6,3,,103168084,10607,Active,,,0.012,IC50,Antiproliferative activity against human DND1 cells,Confirmatory,17977727.0,
1086,311648,6,2,,103168084,10607,Active,,,0.019,IC50,Cytotoxicity against rat L6 cells by Alamar blue assay,Confirmatory,17922552.0,
1087,317959,7,1,,103168084,10607,Active,,,,IC50,Cytotoxicity against human KB cells by alamar blue assay,Confirmatory,18260613.0,
1088,321842,3,4,,103168084,10607,Unspecified,,,,,Induction of apoptosis in human Jurkat cells after 48 hrs at 5 uM by flow cytometry relative to control,Other,18221874.0,
1089,321843,3,4,,103168084,10607,Unspecified,,,,,Induction of apoptosis in human Jurkat cells assessed as viable cells at 5 uM after 48 hrs by flow cytometry relative to control,Other,18221874.0,
1090,326224,8,1,,103168084,10607,Active,,,0.003,IC50,Cytotoxicity against human 1A9 cells,Confirmatory,18314944.0,
1091,327981,3,3,,103168084,10607,Active,,,,,Inhibition of bovine tubulin polymerization at 25 uM,Other,18361483.0,
1092,332920,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human KB cells after 72 hrs,Other,8158163.0,
1093,333842,6,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human KB cells,Other,7130986.0,
1094,335769,6,3,,103168084,10607,Unspecified,,,,,Toxicity in brine shrimp,Other,8277312.0,
1095,335770,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity in mouse P388 cells,Other,8277312.0,
1096,335771,3,4,,103168084,10607,Unspecified,,,,,Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 100 ug/mL,Other,8277312.0,
1097,335772,3,4,,103168084,10607,Unspecified,,,,,Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 20 ug/mL,Other,8277312.0,
1098,335773,3,4,,103168084,10607,Unspecified,,,,,Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 4 ug/mL,Other,8277312.0,
1099,335774,3,4,,103168084,10607,Unspecified,,,,,Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.8 ug/mL,Other,8277312.0,
1100,335775,4,4,,103168084,10607,Unspecified,,,,,Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.16 ug/mL,Other,8277312.0,
1101,335776,4,4,,103168084,10607,Unspecified,,,,,Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.032 ug/mL,Other,8277312.0,
1102,335777,4,4,,103168084,10607,Unspecified,,,,,Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.0064 ug/mL,Other,8277312.0,
1103,335778,4,4,,103168084,10607,Inconclusive,,,,,Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.00128 ug/mL,Other,8277312.0,
1104,335779,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human A431 cells,Other,8277312.0,
1105,335780,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human BC1 cells,Other,8277312.0,
1106,335781,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human Col2 cells,Other,8277312.0,
1107,335782,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human HT cells,Other,8277312.0,
1108,335783,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human KBV1 cells,Other,8277312.0,
1109,335784,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human LNCAP cells,Other,8277312.0,
1110,335785,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human Lu1 cells,Other,8277312.0,
1111,335786,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human U373 cells,Other,8277312.0,
1112,335787,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human ZR-75-1 cells,Other,8277312.0,
1113,335788,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human KB cells,Other,8277312.0,
1114,336443,9,1,,103168084,10607,Inconclusive,,,,IC50,Antiprotozoal activity against Plasmodium falciparum K1,Confirmatory,12398543.0,
1115,336444,10,1,,103168084,10607,Inconclusive,,,,IC50,Antitrypanosomal activity against Trypanosoma brucei brucei S427 blood stream trypomastigotes,Confirmatory,12398543.0,
1116,336445,10,1,,103168084,10607,Unspecified,,,,IC50,Cytotoxicity against human KB cells,Confirmatory,12398543.0,
1117,336446,9,1,,103168084,10607,Inconclusive,,,,IC50,Antileishmanial activity against Leishmania donovani (MHOM/ET/67/L82) promastigotes,Confirmatory,12398543.0,
1118,336478,3,7,,103168084,10607,Unspecified,,,,,Inhibition of COX2 at 100 uM by scintillation proximity assay,Other,12444669.0,
1119,337694,3,4,,103168084,10607,Active,,,,,Antibacterial activity against Bacillus subtilis ATCC 6633 at 5 ug after 48 hrs by silica gel plate-based INT-formazan method,Other,3110376.0,
1120,337695,3,4,,103168084,10607,Active,,,,,Antibacterial activity against Escherichia coli ATCC 25922 at 5 ug after 48 hrs by silica gel plate-based INT-formazan method,Other,3110376.0,
1121,337714,8,1,,103168084,10607,Active,,,3.0,ID50,Inhibition of microtubule assembly by turbidimetry,Confirmatory,3598594.0,
1122,337715,3,4,,103168084,10607,Unspecified,,,,,Displacement of [3H]colchicine from tubulin after 10 mins relative to control,Other,3598594.0,
1123,338804,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against mouse EAT cells after 4 days by trypan blue assay,Other,1602298.0,
1124,338805,5,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human HeLa cells after 4 days by trypan blue assay,Other,1602298.0,
1125,338986,6,3,,103168084,10607,Active,,,4.0,IC50,Inhibition of microtubule assembly after 15 mins,Confirmatory,3404149.0,
1126,338987,4,4,,103168084,10607,Unspecified,,,,,Displacement of [3H]colchicine from tubulin at inhibitor and colchicine ratio 1:1 after 10 mins relative to control,Other,3404149.0,
1127,338988,4,4,,103168084,10607,Unspecified,,,,,Displacement of [3H]colchicine from tubulin at inhibitor and colchicine ratio 10:1 after 10 mins relative to control,Other,3404149.0,
1128,340101,6,3,,103168084,10607,Active,,,20.5,IC50,Cytotoxicity against human KB403 cells after 24 hrs by MTT assay,Confirmatory,18586491.0,
1129,340102,6,2,,103168084,10607,Active,,,4.8,IC50,Cytotoxicity against human WRL68 cells after 24 hrs by MTT assay,Confirmatory,18586491.0,
1130,340103,6,3,,103168084,10607,Active,,,0.002,IC50,Cytotoxicity against human CaCO2 cells after 24 hrs by MTT assay,Confirmatory,18586491.0,
1131,340104,6,2,,103168084,10607,Active,,,4.8,IC50,Cytotoxicity against human HEPG2 cells after 24 hrs by MTT assay,Confirmatory,18586491.0,
1132,340105,6,2,,103168084,10607,Active,,,8.5,IC50,Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay,Confirmatory,18586491.0,
1133,346047,6,2,,103168084,10607,Active,,,0.023,IC50,Cytotoxicity against african green monkey Vero cells after 3 days by tetrazolium dye based colorimetric assay,Confirmatory,19058972.0,
1134,347581,6,2,,103168084,10607,Inconclusive,,,,IC50,Antiproliferative activity against human K562 cells after 48 hrs,Confirmatory,19220018.0,
1135,347582,6,2,,103168084,10607,Active,,,0.35,IC50,Inhibition of pig brain tubulin polymerization after 30 mins by turbidimetric assay,Confirmatory,19220018.0,
1136,355578,9,1,,103168084,10607,Active,,,0.011000000000000001,IC50,Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay,Confirmatory,2778449.0,
1137,355580,3,5,,103168084,10607,Unspecified,,,,,Antiproliferative activity against human HT-29 cells at 1 ug after 48 hrs by two-layer agar-diffusion method,Other,2778449.0,
1138,355581,3,5,,103168084,10607,Unspecified,,,,,Antiproliferative activity against human HT-29 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method,Other,2778449.0,
1139,355582,3,5,,103168084,10607,Unspecified,,,,,Antiproliferative activity against human HT-29 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method,Other,2778449.0,
1140,355583,9,1,,103168084,10607,Active,,,0.0059,IC50,Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay,Confirmatory,2778449.0,
1141,355584,3,5,,103168084,10607,Unspecified,,,,,Antiproliferative activity against mouse P388 cells at 1 ug after 48 hrs by two-layer agar-diffusion method,Other,2778449.0,
1142,355585,3,5,,103168084,10607,Unspecified,,,,,Antiproliferative activity against mouse P388 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method,Other,2778449.0,
1143,355586,3,5,,103168084,10607,Unspecified,,,,,Antiproliferative activity against mouse P388 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method,Other,2778449.0,
1144,355597,3,4,,103168084,10607,Inactive,,,,,Inhibition of microtubule polymerization,Other,2550587.0,
1145,357845,4,4,,103168084,10607,Unspecified,,,,,Binding affinity to calf thymus DNA assessed as reduction in DNA peak by pre-incubation method,Other,1812211.0,
1146,357846,4,4,,103168084,10607,Unspecified,,,,,Binding affinity to yeast tRNA assessed as reduction in tRNA peak by pre-incubation method,Other,1812211.0,
1147,359892,11,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human SKOV3 cells by MTT assay,Other,7714533.0,
1148,359893,11,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human A498 cells by MTT assay,Other,7714533.0,
1149,359894,11,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human A431 cells by MTT assay,Other,7714533.0,
1150,359895,11,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human A549 cells by MTT assay,Other,7714533.0,
1151,359896,11,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human HT-29 cells by MTT assay,Other,7714533.0,
1152,359897,10,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human MCF7 cells by MTT assay,Other,7714533.0,
1153,359898,11,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human PC3 cells by MTT assay,Other,7714533.0,
1154,359899,11,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human SK-MEL-5 cells by MTT assay,Other,7714533.0,
1155,359900,6,3,,103168084,10607,Active,,,0.6,IC50,Inhibition of bovine brain tubulin polymerization by turbidity assay,Confirmatory,7714533.0,
1156,359901,6,3,,103168084,10607,Active,,,1.0,IC50,Inhibition of bovine brain tubulin polymerization by sedimentation assay,Confirmatory,7714533.0,
1157,360831,6,2,,103168084,10607,Active,,,0.0048,IC50,Cytotoxicity against human KB cells by alamar blue assay,Confirmatory,12141852.0,
1158,360862,6,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against human KB cells,Other,11421727.0,
1159,362356,6,2,,103168084,10607,Active,,,0.56,IC50,Binding affinity to pig brain tubulin at 10 uM after 15 mins relative to control,Confirmatory,18678497.0,
1160,362551,6,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells,Other,18683985.0,
1161,366960,6,2,,103168084,10607,Active,,,0.003,IC50,Cytotoxicity against human KB cells after 48 hrs by alamar blue assay,Confirmatory,18215443.0,
1162,372586,6,2,,103168084,10607,Active,,,0.013999999999999999,IC50,Cytotoxicity against rat L6 cells after 72 hrs by resazurin assay,Confirmatory,17709461.0,
1163,373526,6,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells by alamar blue assay,Other,19010569.0,
1164,378034,5,1,,103168084,10607,Unspecified,,,,,Toxicity in brine shrimp after 24 hrs,Other,16933860.0,
1165,378591,6,2,,103168084,10607,Inconclusive,,,,IC50,Antiplasmodial activity against multi drug-resistant Plasmodium falciparum K1 in erythrocytes by [3H]hypoxanthine uptake,Confirmatory,11141105.0,
1166,378592,6,2,,103168084,10607,Inconclusive,,,,IC50,Antiamnesic activity against Entamoeba histolytica NIH 200 after 72 hrs by microdilution technique,Confirmatory,11141105.0,
1167,378593,6,2,,103168084,10607,Active,,,0.008,IC50,Cytotoxicity against human KB cells after 72 hrs,Confirmatory,11141105.0,
1168,378965,6,2,,103168084,10607,Inconclusive,,,,IC50,Antileishmanial activity against Leishmania donovani MHOM/SD/62/IS-CL2D axenic amastigotes after 3 days,Confirmatory,16441066.0,
1169,378966,6,2,,103168084,10607,Inconclusive,,,,IC50,Antitrypanosomal activity against Trypanosoma brucei brucei MITat 1.2 variant 221 after 72 hrs,Confirmatory,16441066.0,
1170,378967,8,1,,103168084,10607,Inconclusive,,,,IC50,Cytotoxicity against african green monkey Vero cells,Confirmatory,16441066.0,
1171,378968,8,1,,103168084,10607,Active,,,0.0125,IC50,Cytotoxicity against human PC3 cells,Confirmatory,16441066.0,
1172,379324,6,3,,103168084,10607,Unspecified,,,,,Cytotoxicity against human KB cells,Other,10757714.0,
1173,379325,6,3,,103168084,10607,Unspecified,,,,,Cytotoxicity against human Caco-2 cells,Other,10757714.0,
1174,381228,2,5,,103168084,10607,Unspecified,,,,,In vivo antitumor activity against mouse P388 cells at 40 mg/kg,Other,,
1175,382473,6,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells after 4 days,Other,17475370.0,
1176,384944,4,4,,103168084,10607,Active,,,0.006999999999999999,IC50,Cytotoxicity against mouse L210 cells after 48 hrs,Confirmatory,18396405.0,
1177,384945,9,5,,103168084,10607,Active,3915902.0,,24.1,Kd,Binding affinity to HPV1a recombinant E2 protein by surface plasmon resonance method,Confirmatory,18396405.0,
1178,384946,6,7,,103168084,10607,Unspecified,3915902.0,,400.0,Kd,Binding affinity to HPV1a recombinant E2 protein activator domain by surface plasmon resonance assay,Confirmatory,18396405.0,
1179,384947,9,5,,103168084,10607,Active,3915902.0,,1.05,Kd,Binding affinity to HPV1a recombinant E2 protein hinge domain by surface plasmon resonance assay,Confirmatory,18396405.0,
1180,384948,6,7,,103168084,10607,Unspecified,3915902.0,,400.0,Kd,Binding affinity to HPV1a recombinant E2 protein DNA binding domain by surface plasmon resonance assay,Confirmatory,18396405.0,
1181,384949,9,5,,103168084,10607,Active,137671.0,,20.1,Kd,Binding affinity to HPV11 recombinant E2 protein by surface plasmon resonance method,Confirmatory,18396405.0,
1182,384950,3,10,,103168084,10607,Unspecified,3915902.0,,,,Inhibition of HPV1a E2-E7 protein interaction at 500 uM assessed as rate of E2 binding to E7 protein by surface plasmon resonance method,Other,18396405.0,
1183,384951,9,5,,103168084,10607,Unspecified,137672.0,1489080.0,70.5,Kd,Binding affinity to HPV16 recombinant E2 protein by surface plasmon resonance method,Confirmatory,18396405.0,
1184,384952,3,10,,103168084,10607,Inactive,3915902.0,,,,Inhibition of HPV1a recombinant E2 protein-DNA interaction by electron mobility shift assay,Other,18396405.0,
1185,384953,3,10,,103168084,10607,Unspecified,3915902.0,,,,Inhibition of HPV1a E2-E7 protein interaction at 250 uM assessed as rate of E2 binding to E7 protein by surface plasmon resonance method,Other,18396405.0,
1186,384954,6,3,,103168084,10607,Active,,,0.6,Kd,Binding affinity to pig brain tubulin,Confirmatory,18396405.0,
1187,386866,6,2,,103168084,10607,Active,,,2.97,IC50,Cytotoxicity against human DU145 cells by sulforhodamine B assay,Confirmatory,17988764.0,
1188,386867,6,2,,103168084,10607,Active,,,18.9,IC50,Cytotoxicity against human PC-3 cells by sulforhodamine B assay,Confirmatory,17988764.0,
1189,386868,6,2,,103168084,10607,Active,,,5.69,IC50,Cytotoxicity against human SF295 cells by sulforhodamine B assay,Confirmatory,17988764.0,
1190,386869,6,2,,103168084,10607,Active,,,1.0,IC50,Cytotoxicity against human HCT-15 cells by sulforhodamine B assay,Confirmatory,17988764.0,
1191,386870,6,3,,103168084,10607,Active,,,3.88,IC50,Cytotoxicity against human 502713 cells by sulforhodamine B assay,Confirmatory,17988764.0,
1192,386871,6,3,,103168084,10607,Active,,,1.42,IC50,Cytotoxicity against human HEP2 cells by sulforhodamine B assay,Confirmatory,17988764.0,
1193,386872,6,2,,103168084,10607,Active,,,7.63,IC50,Cytotoxicity against human A549 cells by sulforhodamine B assay,Confirmatory,17988764.0,
1194,389449,6,2,,103168084,10607,Active,,,0.019,IC50,Cytotoxicity against rat L6 cells,Confirmatory,18841956.0,
1195,398312,6,3,,103168084,10607,Inconclusive,,,,IC50,Inhibition of tubulin polymerization,Confirmatory,7623025.0,
1196,398313,3,4,,103168084,10607,Unspecified,,,,,Displacement of [3H]colchicine from tubulin at 5 uM,Other,7623025.0,
1197,398314,4,4,,103168084,10607,Inconclusive,,,,,Displacement of [3H]colchicine from tubulin at 50 uM,Other,7623025.0,
1198,398415,6,3,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against mouse P388 cells,Confirmatory,7673931.0,
1199,398416,6,3,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against human A549 cells,Confirmatory,7673931.0,
1200,398417,6,3,,103168084,10607,Active,,,0.0029,IC50,Cytotoxicity against human HT-29 cells,Confirmatory,7673931.0,
1201,400477,3,5,,103168084,10607,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells assessed as cell rounding at 1 uM,Other,6298369.0,
1202,400478,3,5,,103168084,10607,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells assessed as cell viability at 1 uM by trypan blue exclusion assay,Other,6298369.0,
1203,400479,3,5,,103168084,10607,Unspecified,,,,,Antiviral activity against measles virus infected in african green monkey Vero cells assessed as cell rounding at 1 uM,Other,6298369.0,
1204,400480,3,5,,103168084,10607,Unspecified,,,,,Antiviral activity against measles virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect at 1 uM,Other,6298369.0,
1205,400481,3,5,,103168084,10607,Unspecified,,,,,Antiviral activity against measles virus infected in african green monkey Vero cells assessed as plaque formation at 1 uM after 5 days by neutral red assay relative to control,Other,6298369.0,
1206,400482,3,5,,103168084,10607,Unspecified,,,,,Antiviral activity against HSV1 infected in african green monkey Vero cells assessed as plaque formation at 1 uM after 4 days by neutral red assay relative to control,Other,6298369.0,
1207,400913,6,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against human KB cells,Other,15104480.0,
1208,401641,9,1,,103168084,10607,Unspecified,,,,IC50,Cytotoxicity against rat L6 cells,Confirmatory,15921407.0,
1209,403984,3,3,,103168084,10607,Unspecified,,,,,"Therapeutic index, ratio of MTC for human primary amnion cells to lowest drug level causing inhibition of HSV1",Other,9834179.0,
1210,403985,3,4,,103168084,10607,Unspecified,,,,,Antiviral activity against Sindbis virus in mouse 3T3-L1 cells at 241 nM,Other,9834179.0,
1211,403989,3,4,,103168084,10607,Unspecified,,,,,Antiviral activity against Murine cytomegalovirus in mouse 3T3-L1 cells at 241 nM,Other,9834179.0,
1212,403993,6,2,,103168084,10607,Active,,,0.05,IC50,Antiviral activity against HSV1 infected in monkey CV-1 cells assessed as inhibition of plaque formation,Confirmatory,9834179.0,
1213,403994,6,2,,103168084,10607,Active,,,0.1,IC50,Antiviral activity against VSV infected in BHK cells assessed as inhibition of plaque formation,Confirmatory,9834179.0,
1214,404065,9,1,,103168084,10607,Active,,,,,Antiviral activity against HSV1 infected in human primary amnion cells assessed as inhibition of virus-induced pathogenic effect,Other,9834179.0,
1215,404066,7,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against human primary amnion cells assessed as morphological changes by microscopic examination,Other,9834179.0,
1216,404379,6,2,,103168084,10607,Active,,,0.02,IC50,Cytotoxicity against rat L6 cells,Confirmatory,18476684.0,
1217,408415,3,3,,103168084,10607,Unspecified,,,,,Inhibition of pig brain tubulin polymerization assessed as ratio of unpolymerized to polymerized tubulin at 10 uM,Other,18468444.0,
1218,415310,6,2,,103168084,10607,Unspecified,,,100.0,IC50,Cytotoxicity against human K562 cells after 48 hrs by MTT assay,Confirmatory,19324555.0,
1219,415311,6,2,,103168084,10607,Unspecified,,,50.8,IC50,Cytotoxicity against human AGS cells after 72 hrs by SRB method,Confirmatory,19324555.0,
1220,415312,6,2,,103168084,10607,Active,,,2.75,IC50,Cytotoxicity against human HL60 cells after 48 hrs by MTT assay,Confirmatory,19324555.0,
1221,415313,6,2,,103168084,10607,Active,,,7.38,IC50,Cytotoxicity against human A549 cells after 72 hrs by SRB method,Confirmatory,19324555.0,
1222,415314,3,3,,103168084,10607,Unspecified,,,,,"Octanol-water partition coefficient, log P of the compound",Other,19324555.0,
1223,416486,6,2,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against rat L6 cells,Confirmatory,18571774.0,
1224,418747,6,2,,103168084,10607,Active,,,0.01,IC50,Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay,Confirmatory,19267462.0,
1225,419683,6,2,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against rat L6 cells,Confirmatory,19414258.0,
1226,419752,6,2,,103168084,10607,Active,,,0.01,IC50,Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay,Confirmatory,19606902.0,
1227,421657,8,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against human erythrocytes,Other,19199815.0,
1228,432049,6,2,,103168084,10607,Active,,,0.017,IC50,Cytotoxicity against rat L6 cells,Confirmatory,19409677.0,
1229,434955,1,2,,56463668,10607,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
1230,434959,1,1,,85788487,10607,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
1231,434962,1,2,,56463668,10607,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
1232,434973,1,3,,56463668,10607,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
1233,434989,1,1,,56463668,10607,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
1234,435003,1,3,,56463668,10607,Active,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
1235,435005,1,1,,56463668,10607,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
1236,435020,1,2,,56463668,10607,Active,,,,,Single concentration confirmation of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
1237,435022,2,2,,56463668,10607,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
1238,435030,1,2,,56463668,10607,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
1239,435030,1,2,,56463668,10607,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
1240,441747,8,2,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay,Confirmatory,20047276.0,
1241,441772,7,2,,103168084,10607,Inconclusive,,,,GI50,Cytotoxicity against human MDA-MB-231 cells after 72 hrs by SRB assay,Confirmatory,20067289.0,
1242,441773,7,2,,103168084,10607,Active,,,0.012,GI50,Cytotoxicity against human A549 cells after 72 hrs by SRB assay,Confirmatory,20067289.0,
1243,441774,7,2,,103168084,10607,Active,,,0.024,GI50,Cytotoxicity against human HT-29 cells after 72 hrs by SRB assay,Confirmatory,20067289.0,
1244,443469,5,2,,103168084,10607,Active,,,0.5,IC50,Cytotoxicity against human A549 cells after 24 hrs by MTS assay,Confirmatory,19880222.0,
1245,443470,5,2,,103168084,10607,Active,,,0.5,IC50,Cytotoxicity against human Caco-2 cells after 24 hrs by MTS assay,Confirmatory,19880222.0,
1246,443471,5,2,,103168084,10607,Active,,,0.5,IC50,Cytotoxicity against human HepG2 cells after 24 hrs by MTS assay,Confirmatory,19880222.0,
1247,443472,3,3,,103168084,10607,Unspecified,,,,,Inhibition of bovine brain tubulin polymerization assessed as polymerized to unpolymerized ratio preincubated 15 mins before GTP addition measured after 30 mins by densitometry (Rvb= 1.82 +/- 0.06),Other,19880222.0,
1248,443475,4,4,,103168084,10607,Active,,,,,Inhibition of microtubule in human A549 cells assessed as network disappearane at 0.5 uM after 1 hr by immunofluorescence analysis,Other,19880222.0,
1249,443476,4,4,,103168084,10607,Active,,,,,Inhibition of microtubule in human A549 cells assessed as roundish cells at 0.5 uM after 24 hrs by immunofluorescence analysis,Other,19880222.0,
1250,443478,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse A2C12 cells by MTS assay,Confirmatory,19880222.0,
1251,443479,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse yB8 cells by MTS assay,Confirmatory,19880222.0,
1252,443480,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse yD12 cells by MTS assay,Confirmatory,19880222.0,
1253,443481,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse yD1 cells by MTS assay,Confirmatory,19880222.0,
1254,443482,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse betaD10 cells by MTS assay,Confirmatory,19880222.0,
1255,443483,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse betaD5 cells by MTS assay,Confirmatory,19880222.0,
1256,443484,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse A2B1 cells by MTS assay,Confirmatory,19880222.0,
1257,443485,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse yA7 cells by MTS assay,Confirmatory,19880222.0,
1258,443486,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse yA3 cells by MTS assay,Confirmatory,19880222.0,
1259,443487,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse B3 cells by MTS assay,Confirmatory,19880222.0,
1260,443488,5,3,,103168084,10607,Active,,,10.0,IC50,Cytotoxicity against c-myc/c-raf double transgenic mouse Craf/Cmyc cells by MTS assay,Confirmatory,19880222.0,
1261,445250,5,2,,103168084,10607,Active,,,0.02,IC50,Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay,Confirmatory,19928900.0,
1262,449728,1,2,,56463668,10607,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
1263,449739,1,2,,855658,10607,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
1264,449746,1,2,,56463668,10607,Inactive,,,,,Single concentration confirmation of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
1265,449762,1,2,,56463668,10607,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
1266,449763,1,3,,56463668,10607,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
1267,449768,1,1,,855658,10607,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
1268,453258,5,2,,103168084,10607,Active,,,0.012,IC50,Toxicity against rat L6 cells,Confirmatory,19781948.0,
1269,456263,5,2,,103168084,10607,Active,,,0.01,IC50,Cytotoxicity against rat L6 cells,Confirmatory,19942439.0,
1270,463073,1,2,,855658,10607,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4),Screening,,
1271,463075,1,1,,855658,10607,Inactive,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
1272,463079,1,2,,56463668,10607,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
1273,463082,1,1,,56463668,10607,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
1274,463104,1,2,,56463668,10607,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
1275,463111,1,1,,855658,10607,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
1276,463115,1,1,,855658,10607,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
1277,463141,1,2,,56463668,10607,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
1278,463165,1,1,,855658,10607,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
1279,463187,1,1,,855658,10607,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
1280,463189,1,1,,855658,10607,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
1281,463190,1,2,,56463668,10607,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
1282,463193,1,1,,855658,10607,Inactive,31563518.0,84557.0,,,High-content cell-based screening for modulators of autophagy,Screening,,
1283,463195,1,2,,56463668,10607,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
1284,463210,1,2,,56463668,10607,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
1285,463212,1,1,,56463668,10607,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
1286,463254,1,1,,855658,10607,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
1287,464323,5,2,,103168084,10607,Unspecified,,,50.0,IC50,Antitrypanosomal activity against Trypanosoma brucei brucei after 48 hrs by luminescence assay,Confirmatory,20129783.0,
1288,464324,5,2,,103168084,10607,Active,,,0.024,IC50,Cytotoxicity against human HepG2 cells after 72 hrs by luminescence assay,Confirmatory,20129783.0,
1289,464325,5,2,,103168084,10607,Active,,,0.017,IC50,Cytotoxicity against HEK293 cells after 72 hrs by luminescence assay,Confirmatory,20129783.0,
1290,464326,5,2,,103168084,10607,Active,,,0.018000000000000002,IC50,Cytotoxicity against human Raji cells after 72 hrs by luminescence assay,Confirmatory,20129783.0,
1291,464327,5,2,,103168084,10607,Unspecified,,,50.0,IC50,Cytotoxicity against human BJ cells after 72 hrs by luminescence assay,Confirmatory,20129783.0,
1292,464498,4,3,,103168084,10607,Unspecified,,,,,Inhibition of tubulin polymerization at 10 uM by fluorescence method,Other,20129783.0,
1293,464499,8,5,,103168084,10607,Unspecified,754286265.0,443551.0,4.0,IC50,Inhibition of ovine COX1,Confirmatory,20129783.0,
1294,464500,8,5,,103168084,10607,Unspecified,548483.0,19225.0,4.0,IC50,Inhibition of mouse COX2,Confirmatory,20129783.0,
1295,464501,4,1,,103168084,10607,Unspecified,,,,,Half life in mouse plasma by UPLC-MS analysis,Other,20129783.0,
1296,464511,3,4,,103168084,10607,Unspecified,,,,,Selectivity ratio for IC50 for human BJ cells to IC50 for Trypanosoma brucei brucei,Other,20129783.0,
1297,464512,3,3,,103168084,10607,Unspecified,,,,,Selectivity for Trypanosoma brucei brucei over human HMEC,Other,20129783.0,
1298,464513,3,4,,103168084,10607,Unspecified,,,,,Selectivity ratio for IC50 for human BJ cells to IC50 for human HepG2 cells,Other,20129783.0,
1299,464514,3,4,,103168084,10607,Unspecified,,,,,Selectivity for human HepG2 cells over human HMEC,Other,20129783.0,
1300,464515,3,4,,103168084,10607,Unspecified,,,,,Selectivity ratio for IC50 for human BJ cells to IC50 for human HEK293 cells,Other,20129783.0,
1301,464516,3,4,,103168084,10607,Unspecified,,,,,Selectivity for human HEK293 cells over human HMEC,Other,20129783.0,
1302,464517,3,4,,103168084,10607,Unspecified,,,,,Selectivity ratio for IC50 for human BJ cells to IC50 for human Raji cells,Other,20129783.0,
1303,464518,3,4,,103168084,10607,Unspecified,,,,,Selectivity for human Raji cells over human HMEC,Other,20129783.0,
1304,464519,3,3,,103168084,10607,Unspecified,,,,,Half life in stimulated gastric fluid of pH 1.0,Other,20129783.0,
1305,464873,7,1,,103168084,10607,Active,,,0.013999999999999999,EC50,Cytotoxicity against rat L6 cells,Confirmatory,20185305.0,
1306,477926,6,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay,Other,20307077.0,
1307,481678,5,2,,103168084,10607,Active,,,0.02,EC50,Antiproliferative activity against Paracentrotus lividus embryo assessed as cleavage alteration after 10 to 15 mins fertilization 45 to 60 mins before first mitotic cycle completeion,Confirmatory,20110137.0,
1308,481679,5,2,,103168084,10607,Active,,,0.05,EC50,Antimitotic activity against Paracentrotus lividus embryo assessed as cleavage arrest after 10 to 15 mins fertilization 45 to 60 mins before first mitotic cycle completeion,Confirmatory,20110137.0,
1309,481680,5,2,,103168084,10607,Active,,,0.5,EC50,Cytotoxicity against Paracentrotus lividus embryo assessed as embryo spinning after 9 to 12 hrs fertilization and 0.5 to 20 hrs treatment,Confirmatory,20110137.0,
1310,485270,1,1,,56463668,10607,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
1311,485272,1,1,,56463668,10607,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
1312,485273,2,1,,56463668,10607,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
1313,485275,1,3,,56463668,10607,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
1314,485281,1,1,,855658,10607,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
1315,485281,1,1,,29215001,10607,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
1316,485290,1,1,,855658,10607,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1317,485290,1,1,,26751476,10607,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1318,485290,1,1,,29215001,10607,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1319,485290,1,1,,50103982,10607,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1320,485290,1,1,,50103983,10607,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1321,485294,1,1,,855658,10607,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
1322,485297,1,1,,855658,10607,Inactive,4759012.0,9367.0,0.1122,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
1323,485298,1,1,,855658,10607,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
1324,485313,1,2,,855658,10607,Inactive,255652944.0,4864.0,0.5012,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
1325,485314,1,1,,855658,10607,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
1326,485341,1,1,,855658,10607,Inactive,119389684.0,,6.3096,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
1327,485344,1,1,,855658,10607,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
1328,485346,1,1,,56463668,10607,Active,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1329,485346,1,1,,56463668,10607,Active,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1330,485347,1,2,,855658,10607,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
1331,485349,1,1,,855658,10607,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
1332,485350,1,2,,92125850,10607,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
1333,485353,2,1,,855658,10607,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
1334,485358,1,1,,855658,10607,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
1335,485360,1,1,,855658,10607,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
1336,485364,1,1,,855658,10607,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
1337,485367,1,2,,855658,10607,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
1338,488806,1,2,,855658,10607,Inactive,148539876.0,156.0,,,RNA aptamer-based validation for inhibitors of GRK2,Screening,,
1339,488837,1,1,,855658,10607,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
1340,488839,1,1,,56463668,10607,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1341,488839,1,1,,56463668,10607,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1342,488847,1,3,,56463668,10607,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
1343,488862,1,1,,56463668,10607,Active,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1344,488890,1,2,,56463668,10607,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
1345,488895,1,2,,56463668,10607,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1346,488896,1,1,,56463668,10607,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1347,488899,1,1,,56463668,10607,Active,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1348,488922,1,2,,855658,10607,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
1349,488965,1,2,,56463668,10607,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1350,488966,1,1,,56463668,10607,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
1351,488975,1,2,,56463668,10607,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
1352,488977,1,2,,56463668,10607,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
1353,489026,1,2,,56463668,10607,Inactive,,,80.0,IC50_Mean,Dose response cytotoxicity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay,Confirmatory,,
1354,489028,1,2,,56463668,10607,Active,88702791.0,4194.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1355,489028,1,2,,56463668,10607,Active,89993689.0,4193.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1356,489030,2,1,,56463668,10607,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
1357,489031,2,1,,56463668,10607,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
1358,489033,1,2,,56463668,10607,Inactive,,,80.0,IC50_Mean,Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay,Confirmatory,,
1359,489035,1,1,,56463668,10607,Inactive,,,80.0,IC50_Mean,Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay,Confirmatory,,
1360,489041,1,2,,56463668,10607,Active,,,0.16,IC50_Mean,Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay,Confirmatory,,
1361,492477,5,3,,103168084,10607,Active,,,0.46,IC50,Antitumor activity against human OVCAR-3 cells xenografted in mouse assessed as increase in mouse life span,Confirmatory,20187635.0,
1362,492478,3,4,,103168084,10607,Unspecified,,,,,Displacement of [3H]colchicine from tubulin,Other,20187635.0,
1363,492947,1,1,,855658,10607,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
1364,492953,1,1,,56463668,10607,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
1365,492956,1,1,,56463668,10607,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
1366,492961,1,1,,29215001,10607,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
1367,492967,1,2,,92125850,10607,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
1368,492967,1,2,,99301380,10607,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
1369,492972,1,1,,56463668,10607,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
1370,493005,1,1,,56463668,10607,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
1371,493008,1,1,,56463668,10607,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1372,493008,1,1,,56463668,10607,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1373,493008,1,1,,56463668,10607,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1374,493008,1,1,,56463668,10607,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1375,493011,1,1,,56463668,10607,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
1376,493012,1,1,,56463668,10607,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
1377,493014,1,1,,855658,10607,Inconclusive,,,1.0323,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
1378,493027,1,2,,56463668,10607,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1)",Screening,,
1379,493027,1,2,,56463668,10607,Inactive,223718203.0,5346.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1)",Screening,,
1380,493033,1,2,,92125850,10607,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
1381,493035,1,2,,56463668,10607,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1382,493035,1,2,,56463668,10607,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1383,493036,1,2,,56463668,10607,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
1384,493056,1,1,,855658,10607,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
1385,493083,1,1,,855658,10607,Inactive,62740231.0,15499.0,,AC50_uM,HSF-1 induced GFP reporter and Doxycycline induced RFP reporter Measured in Cell-Based System Using Plate Reader - 2038-03_Inhibitor_DoseNoFile_CherryPick_Activity_Set3,Confirmatory,,
1386,493084,1,1,,855658,10607,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
1387,493085,1,1,,855658,10607,Inconclusive,62740231.0,15499.0,,AC50_uM,HSF-1 induced GFP reporter and Doxycycline induced RFP reporter Measured in Cell-Based System Using Plate Reader - 2038-03_Inhibitor_DoseNoFile_CherryPick_Internal-Standard_Set3,Confirmatory,,
1388,493087,1,1,,56463668,10607,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
1389,493091,1,1,,56463668,10607,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
1390,493098,1,1,,56463668,10607,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
1391,493131,1,1,,56463668,10607,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
1392,493140,1,1,,103914400,10607,Inactive,,,,,Screening small molecules to find regulators of human embryonic stem cell survival.,Screening,,
1393,493160,1,1,,56463668,10607,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
1394,493162,1,2,,99301380,10607,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
1395,493187,1,2,,56463668,10607,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
1396,493244,1,1,,56463668,10607,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1397,493244,1,1,,56463668,10607,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1398,493244,1,1,,56463668,10607,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1399,493244,1,1,,56463668,10607,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1400,494501,4,2,,103168084,10607,Inconclusive,,,,IC50,Antiproliferative activity against human K562 cells after 48 hrs,Confirmatory,20537765.0,
1401,494502,4,2,,103168084,10607,Active,,,0.35,IC50,Inhibition of pig brain tubulin polymerization after 30 mins by turbidimetry,Confirmatory,20537765.0,
1402,494520,4,2,,103168084,10607,Inconclusive,,,,IC50,Cell growth inhibition of human K562 cells after 48 hrs,Confirmatory,20546980.0,
1403,494521,5,1,,103168084,10607,Active,20455316.0,7278.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1404,494521,5,1,,103168084,10607,Active,20455316.0,113457.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1405,494521,5,1,,103168084,10607,Active,20455322.0,84790.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1406,494521,5,1,,103168084,10607,Active,20455526.0,10381.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1407,494521,5,1,,103168084,10607,Active,55977474.0,10376.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1408,494521,5,1,,103168084,10607,Active,55977476.0,7277.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1409,494521,5,1,,103168084,10607,Active,55977480.0,10383.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1410,494521,5,1,,103168084,10607,Active,55977864.0,7846.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1411,494521,5,1,,103168084,10607,Active,56757569.0,203068.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1412,494521,5,1,,103168084,10607,Active,62903515.0,81027.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1413,494521,5,1,,103168084,10607,Active,68776070.0,84617.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1414,494521,5,1,,103168084,10607,Active,74761283.0,347733.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1415,494521,5,1,,103168084,10607,Active,74762137.0,7280.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1416,494521,5,1,,103168084,10607,Active,93141323.0,10382.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1417,494521,5,1,,103168084,10607,Active,182705285.0,347688.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1418,494521,5,1,,103168084,10607,Active,224471855.0,112714.0,0.35,IC50,Inhibition of tubulin polymerization in human K562 cells,Confirmatory,20546980.0,
1419,497464,2,4,,103168084,10607,Active,,,,,Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay,Other,20614907.0,
1420,504326,1,2,,56463668,10607,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1421,504326,1,2,,56463668,10607,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1422,504327,1,1,,855658,10607,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1423,504327,1,1,,29215001,10607,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1424,504327,1,1,,50103982,10607,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1425,504329,1,1,,56463668,10607,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
1426,504332,1,1,,855658,10607,Inconclusive,168985070.0,,35.4813,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1427,504332,1,1,,29215001,10607,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1428,504333,1,1,,855658,10607,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
1429,504339,1,1,,26751476,10607,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
1430,504339,1,1,,56463668,10607,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
1431,504357,1,1,,56463668,10607,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1432,504357,1,1,,56463668,10607,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1433,504406,1,1,,56463668,10607,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
1434,504408,2,1,,855658,10607,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
1435,504411,1,1,,56463668,10607,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
1436,504414,1,1,,56463668,10607,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1437,504414,1,1,,56463668,10607,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1438,504423,1,1,,56463668,10607,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1439,504441,1,1,,56463668,10607,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1440,504444,1,1,,26751476,10607,Inconclusive,224028257.0,4780.0,16.3601,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
1441,504444,1,1,,56463668,10607,Inconclusive,224028257.0,4780.0,0.1158,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
1442,504454,1,3,,56463668,10607,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
1443,504459,1,3,,855658,10607,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method from Validation Set,Screening,,
1444,504462,1,1,,56463668,10607,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
1445,504466,1,1,,855658,10607,Inconclusive,116283940.0,79915.0,0.092,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1446,504467,1,1,,855658,10607,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1447,504490,1,2,,56463668,10607,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
1448,504523,1,1,,56463668,10607,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1449,504523,1,1,,56463668,10607,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1450,504539,2,1,,56463668,10607,Inconclusive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_Dose_CherryPick_Activity_Set2,Confirmatory,,
1451,504541,1,1,,855658,10607,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction for Validation Set,Screening,,
1452,504558,1,1,,56463668,10607,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1453,504577,2,2,,56463668,10607,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
1454,504582,2,1,,56463668,10607,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1455,504592,1,1,,56463668,10607,Active,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_CherryPick_Activity,Confirmatory,,
1456,504594,1,1,,56463668,10607,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1457,504600,1,2,,855658,10607,Active,6325022.0,855842.0,,,Validation of HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
1458,504607,1,1,,56463668,10607,Active,,,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay,Screening,,
1459,504621,1,1,,56463668,10607,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1460,504634,1,1,,56463668,10607,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
1461,504648,1,1,,26751476,10607,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
1462,504648,1,1,,56463668,10607,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
1463,504651,1,1,,855658,10607,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
1464,504652,1,1,,855658,10607,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
1465,504660,1,1,,855658,10607,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
1466,504668,1,1,,56463668,10607,Active,728984.0,672.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
1467,504668,1,1,,56463668,10607,Active,116241265.0,580.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
1468,504690,1,3,,56463668,10607,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
1469,504692,2,2,,56463668,10607,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
1470,504700,1,1,,56463668,10607,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
1471,504700,1,1,,56463668,10607,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
1472,504706,1,1,,855658,10607,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
1473,504707,1,1,,56463668,10607,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
1474,504707,1,1,,56463668,10607,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
1475,504720,1,1,,56463668,10607,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
1476,504734,1,1,,56463668,10607,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
1477,504749,1,3,,29215001,10607,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1478,504749,1,3,1.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1479,504749,1,3,2.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1480,504749,1,3,3.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1481,504749,1,3,4.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1482,504749,1,3,5.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1483,504749,1,3,6.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1484,504749,1,3,7.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1485,504749,1,3,8.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1486,504749,1,3,9.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1487,504749,1,3,10.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1488,504749,1,3,11.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1489,504749,1,3,12.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1490,504749,1,3,13.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1491,504749,1,3,14.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1492,504749,1,3,15.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1493,504749,1,3,16.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1494,504749,1,3,17.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1495,504749,1,3,18.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1496,504749,1,3,19.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1497,504749,1,3,20.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1498,504749,1,3,21.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1499,504749,1,3,22.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1500,504749,1,3,23.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1501,504749,1,3,24.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1502,504749,1,3,25.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1503,504749,1,3,26.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1504,504749,1,3,27.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1505,504749,1,3,28.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1506,504749,1,3,29.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1507,504749,1,3,30.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1508,504749,1,3,31.0,29215001,10607,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1509,504749,1,3,32.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1510,504749,1,3,33.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1511,504749,1,3,34.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1512,504749,1,3,35.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1513,504749,1,3,36.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1514,504749,1,3,37.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1515,504749,1,3,38.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1516,504749,1,3,39.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1517,504749,1,3,40.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1518,504749,1,3,41.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1519,504749,1,3,42.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1520,504749,1,3,43.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1521,504749,1,3,44.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1522,504749,1,3,45.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1523,504749,1,3,46.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1524,504749,1,3,47.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1525,504749,1,3,48.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1526,504749,1,3,49.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1527,504749,1,3,50.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1528,504749,1,3,51.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1529,504749,1,3,52.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1530,504749,1,3,53.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1531,504749,1,3,54.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1532,504749,1,3,55.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1533,504749,1,3,56.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1534,504749,1,3,57.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1535,504749,1,3,58.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1536,504749,1,3,59.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1537,504749,1,3,60.0,29215001,10607,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1538,504749,1,3,61.0,29215001,10607,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1539,504766,2,1,,56463668,10607,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
1540,504775,1,1,,56463668,10607,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
1541,504803,1,1,,56463668,10607,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
1542,504810,1,2,,855658,10607,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1543,504812,1,2,,855658,10607,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1544,504832,1,1,,855658,10607,Active,,,14.7157,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
1545,504832,1,1,,29215001,10607,Active,,,2.1331,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
1546,504834,1,1,,855658,10607,Inconclusive,,,16.5113,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
1547,504834,1,1,,29215001,10607,Active,,,1.0691,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
1548,504842,1,1,,855658,10607,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
1549,504845,1,1,,26751476,10607,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
1550,504845,1,1,,50103982,10607,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
1551,504845,1,1,,56463668,10607,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
1552,504847,1,1,,26751476,10607,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1553,504847,1,1,,29215001,10607,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1554,504847,1,1,,50103982,10607,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1555,504847,1,1,,50103983,10607,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1556,504847,1,1,,56463668,10607,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1557,504865,1,1,,29215001,10607,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
1558,504865,1,1,,50103982,10607,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
1559,504884,1,2,,56463668,10607,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1560,504891,1,1,,26751476,10607,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
1561,504891,1,1,,56463668,10607,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
1562,504894,1,1,,56463668,10607,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
1563,504937,1,2,,56463668,10607,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
1564,521220,3,3,,103168084,10607,Active,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
1565,524790,7,2,,103168084,10607,Active,,,15.8489,IC50,Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1566,524791,7,2,,103168084,10607,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1567,524792,7,2,,103168084,10607,Active,,,15.8489,IC50,Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1568,524793,7,2,,103168084,10607,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1569,524794,7,1,,103168084,10607,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1570,524795,7,2,,103168084,10607,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1571,524796,7,1,,103168084,10607,Active,,,10.0,IC50,Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1572,527279,4,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells after 72 hrs by microplate fluorometric analysis,Other,20855214.0,
1573,536767,1,4,,103168084,10607,Unspecified,,,,,Inhibition of tubulin polymerization at 3 uM,Other,20833451.0,
1574,536815,4,2,,103168084,10607,Active,,,0.017,IC50,Cytotoxicity against rat L6 cells,Confirmatory,20850207.0,
1575,540253,1,1,,56463668,10607,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1576,540253,1,1,,56463668,10607,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1577,540253,1,1,,56463668,10607,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1578,540256,1,2,,855658,10607,Inconclusive,,,0.0146,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1579,540263,1,1,,56463668,10607,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
1580,540263,1,1,,56463668,10607,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
1581,540267,1,1,,26751476,10607,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
1582,540267,1,1,,56463668,10607,Inconclusive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
1583,540275,1,1,,855658,10607,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
1584,540276,1,2,,855658,10607,Inconclusive,420597.0,,0.0326,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1585,540276,1,2,,26751475,10607,Inconclusive,420597.0,,0.0326,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1586,540276,1,2,,26751476,10607,Inconclusive,420597.0,,0.0326,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1587,540276,1,2,,29215001,10607,Inconclusive,420597.0,,0.0326,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1588,540277,1,1,,855658,10607,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
1589,540295,1,1,,56463668,10607,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
1590,540299,1,2,,92125850,10607,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
1591,540303,1,1,,56463668,10607,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1592,540303,1,1,,56463668,10607,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1593,540303,1,1,,56463668,10607,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1594,540308,1,1,,56463668,10607,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
1595,540317,1,1,,26751476,10607,Inactive,187960037.0,10951.0,100.0,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1596,540317,1,1,,56463668,10607,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1597,540336,1,1,,56463668,10607,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1598,540336,1,1,,56463668,10607,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1599,540364,1,2,,56463668,10607,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
1600,540370,1,3,,855658,10607,Inactive,6325022.0,855842.0,,,"Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin, Single Point, Cherry Pick 1",Other,,
1601,551373,4,2,,103168084,10607,Active,,,5.0,IC50,Cytotoxicity against human COLO205 assessed as inhibition of cell growth,Confirmatory,21144748.0,
1602,551374,4,2,,103168084,10607,Active,,,13.1,IC50,Cytotoxicity against human HOP62 assessed as inhibition of cell growth,Confirmatory,21144748.0,
1603,551375,4,2,,103168084,10607,Active,,,8.1,IC50,Cytotoxicity against human HT1080 assessed as inhibition of cell growth,Confirmatory,21144748.0,
1604,551376,4,2,,103168084,10607,Active,,,6.1,IC50,Cytotoxicity against human DWD assessed as inhibition of cell growth,Confirmatory,21144748.0,
1605,552695,4,2,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay,Confirmatory,21112788.0,
1606,552696,4,2,,103168084,10607,Inconclusive,,,,IC50,Antitrypanosomal activity against bloodstream form of Trypanosoma brucei s427 after 72 hrs by MTT assay,Confirmatory,21112788.0,
1607,552697,4,2,,103168084,10607,Inconclusive,,,,IC50,Antitrypanosomal activity against bloodstream form of Trypanosoma brucei rhodesiense STIB900 after 70 hrs by alamar blue assay,Confirmatory,21112788.0,
1608,558401,9,2,,103168084,10607,Active,121069.0,2908.0,0.013999999999999999,IC50,Inhibition of human glucocorticoid receptor,Confirmatory,19364854.0,
1609,560437,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in HPV-transformed human SiHa cells assessed as accumulation at G0/G1 phase at 10 times EC50 after 48 hrs by flow cytometry,Other,19398642.0,
1610,560438,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in HPV-transformed human SiHa cells assessed as accumulation at S phase at 10 times EC50 after 48 hrs by flow cytometry,Other,19398642.0,
1611,560439,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in HPV-transformed human SiHa cells assessed as accumulation at G2/M phase at 10 times EC50 after 48 hrs by flow cytometry,Other,19398642.0,
1612,560440,2,3,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human PHK cells assessed as accumulation at G0/G1 phase at 10 times EC50 after 48 hrs by flow cytometry,Other,19398642.0,
1613,560441,2,3,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human PHK cells assessed as accumulation at S phase at 10 times EC50 after 48 hrs by flow cytometry,Other,19398642.0,
1614,560442,2,3,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human PHK cells assessed as accumulation at G2/M phase at 10 times EC50 after 48 hrs by flow cytometry,Other,19398642.0,
1615,580717,7,1,,103168084,10607,Unspecified,,,,IC50,Cytotoxicity against rat L6 cells,Confirmatory,19015351.0,
1616,588211,2,3,,103168084,10607,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
1617,588212,2,3,,103168084,10607,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
1618,588213,2,3,,103168084,10607,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
1619,588214,2,3,,103168084,10607,Unspecified,,,,,"FDA HLAED, liver enzyme composite activity",Other,16472241.0,
1620,588215,2,3,,103168084,10607,Unspecified,,,,,"FDA HLAED, alkaline phosphatase increase",Other,16472241.0,
1621,588216,2,3,,103168084,10607,Unspecified,,,,,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",Other,16472241.0,
1622,588217,2,3,,103168084,10607,Unspecified,,,,,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",Other,16472241.0,
1623,588218,2,3,,103168084,10607,Unspecified,,,,,"FDA HLAED, lactate dehydrogenase (LDH) increase",Other,16472241.0,
1624,588219,2,3,,103168084,10607,Unspecified,,,,,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",Other,16472241.0,
1625,588334,1,1,,56463668,10607,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
1626,588335,1,1,,56463668,10607,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
1627,588342,1,1,,855658,10607,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
1628,588352,1,2,,56463668,10607,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
1629,588354,1,1,,56463668,10607,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
1630,588358,1,2,,56463668,10607,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
1631,588368,1,2,,855658,10607,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies from validation set,Screening,,
1632,588379,1,2,,50103982,10607,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
1633,588391,1,1,,56463668,10607,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1634,588405,1,1,,56463668,10607,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
1635,588413,1,2,,56463668,10607,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
1636,588436,1,1,,56463668,10607,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
1637,588453,1,1,,26751476,10607,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1638,588453,1,1,,56463668,10607,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1639,588456,1,1,,26751476,10607,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1640,588456,1,1,,56463668,10607,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1641,588458,1,1,,56463668,10607,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
1642,588459,1,2,,855658,10607,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,16604538.0,
1643,588459,1,2,,855658,10607,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20035615.0,
1644,588459,1,2,,855658,10607,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20938917.0,
1645,588460,1,2,,855658,10607,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,16604538.0,
1646,588460,1,2,,855658,10607,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20035615.0,
1647,588460,1,2,,855658,10607,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20938917.0,
1648,588461,1,2,,855658,10607,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,16604538.0,
1649,588461,1,2,,855658,10607,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20035615.0,
1650,588461,1,2,,855658,10607,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20938917.0,
1651,588473,1,1,,56463668,10607,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1652,588473,1,1,,56463668,10607,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1653,588475,1,2,,56463668,10607,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1654,588475,1,2,,56463668,10607,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1655,588478,1,2,,124801065,10607,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
1656,588489,1,1,,56463668,10607,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
1657,588492,1,1,,56463668,10607,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
1658,588493,1,2,,56463668,10607,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
1659,588497,1,2,,56463668,10607,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
1660,588497,1,2,,56463668,10607,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
1661,588497,1,2,,56463668,10607,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
1662,588499,1,3,,56463668,10607,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
1663,588499,1,3,,56463668,10607,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
1664,588499,1,3,,56463668,10607,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
1665,588501,1,2,,56463668,10607,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
1666,588501,1,2,,56463668,10607,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
1667,588501,1,2,,56463668,10607,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
1668,588506,1,2,,855658,10607,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors with Validation compound Set,Screening,,
1669,588511,1,2,,56463668,10607,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
1670,588519,1,2,,92125850,10607,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
1671,588549,1,1,,56463668,10607,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1672,588550,1,1,,855658,10607,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for Validation Compound Set,Screening,,
1673,588579,1,1,,26751476,10607,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1674,588579,1,1,,29215001,10607,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1675,588579,1,1,,50103982,10607,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1676,588579,1,1,,56463668,10607,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1677,588590,1,1,,26751476,10607,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1678,588590,1,1,,56463668,10607,Inconclusive,154350220.0,11201.0,11.2202,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1679,588591,1,1,,56463668,10607,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1680,588621,1,1,,56463668,10607,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
1681,588627,1,1,,56463668,10607,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
1682,588664,1,2,,56463668,10607,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1683,588664,1,2,,56463668,10607,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1684,588674,1,2,,56463668,10607,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1685,588675,1,1,,56463668,10607,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
1686,588676,1,1,,56463668,10607,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
1687,588685,1,1,,855658,10607,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with Validation compound set,Screening,,
1688,588689,1,1,,56463668,10607,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
1689,588692,2,1,,56463668,10607,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1690,588726,1,2,,56463668,10607,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
1691,588727,1,1,,56463668,10607,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
1692,588795,1,1,,26751476,10607,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1693,588795,1,1,,56463668,10607,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1694,588814,1,3,,56463668,10607,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
1695,588819,1,4,,56463668,10607,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
1696,588827,1,1,,855658,10607,Inconclusive,62740231.0,15499.0,,AC50_uM,HSF-1 induced GFP reporter and Doxycycline induced RFP reporter Measured in Cell-Based System Using Plate Reader - 2038-03_Inhibitor_Dose_CherryPick_Activity_Set4,Confirmatory,,
1697,588834,2,1,,144204425,10607,Inconclusive,325651834.0,3757.0,14.1254,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1698,588847,1,1,,855658,10607,Inactive,2190535.0,,,AC50_uM,Luciferase Inhibition Counter Screen Measured in Biochemical System Using Plate Reader - 2038-06_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1699,588850,1,1,,56463668,10607,Active,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
1700,588852,1,3,,56463668,10607,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
1701,588855,1,1,,26751476,10607,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1702,588855,1,1,,56463668,10607,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1703,588856,1,1,,26751476,10607,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1704,588856,1,1,,56463668,10607,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1705,592700,1,3,,103168084,10607,Unspecified,,,,,Inhibition of tubulin polymerization at 3 uM after 1 hr fluorescence analysis relative to control,Other,21402478.0,
1706,592701,2,5,,103168084,10607,Active,20455316.0,7278.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1707,592701,2,5,,103168084,10607,Active,20455316.0,113457.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1708,592701,2,5,,103168084,10607,Active,20455322.0,84790.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1709,592701,2,5,,103168084,10607,Active,20455526.0,10381.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1710,592701,2,5,,103168084,10607,Active,55977474.0,10376.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1711,592701,2,5,,103168084,10607,Active,55977476.0,7277.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1712,592701,2,5,,103168084,10607,Active,55977480.0,10383.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1713,592701,2,5,,103168084,10607,Active,55977864.0,7846.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1714,592701,2,5,,103168084,10607,Active,56757569.0,203068.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1715,592701,2,5,,103168084,10607,Active,62903515.0,81027.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1716,592701,2,5,,103168084,10607,Active,68776070.0,84617.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1717,592701,2,5,,103168084,10607,Active,74761283.0,347733.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1718,592701,2,5,,103168084,10607,Active,74762137.0,7280.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1719,592701,2,5,,103168084,10607,Active,93141323.0,10382.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1720,592701,2,5,,103168084,10607,Active,182705285.0,347688.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1721,592701,2,5,,103168084,10607,Active,224471855.0,112714.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 5 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1722,592702,2,5,,103168084,10607,Active,20455316.0,7278.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1723,592702,2,5,,103168084,10607,Active,20455316.0,113457.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1724,592702,2,5,,103168084,10607,Active,20455322.0,84790.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1725,592702,2,5,,103168084,10607,Active,20455526.0,10381.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1726,592702,2,5,,103168084,10607,Active,55977474.0,10376.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1727,592702,2,5,,103168084,10607,Active,55977476.0,7277.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1728,592702,2,5,,103168084,10607,Active,55977480.0,10383.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1729,592702,2,5,,103168084,10607,Active,55977864.0,7846.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1730,592702,2,5,,103168084,10607,Active,56757569.0,203068.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1731,592702,2,5,,103168084,10607,Active,62903515.0,81027.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1732,592702,2,5,,103168084,10607,Active,68776070.0,84617.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1733,592702,2,5,,103168084,10607,Active,74761283.0,347733.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1734,592702,2,5,,103168084,10607,Active,74762137.0,7280.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1735,592702,2,5,,103168084,10607,Active,93141323.0,10382.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1736,592702,2,5,,103168084,10607,Active,182705285.0,347688.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1737,592702,2,5,,103168084,10607,Active,224471855.0,112714.0,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,Other,21402478.0,
1738,592704,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human A549 cells assessed as accumulation at G1 phase at 1 uM after 48 hrs using propidium iodide staining by flow cytometry (Rvb = 71.6%),Other,21402478.0,
1739,592706,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 1 uM after 48 hrs using propidium iodide staining by flow cytometry (Rvb = 23.1%),Other,21402478.0,
1740,592708,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 1 uM after 48 hrs using propidium iodide staining by flow cytometry (Rvb = 5.2%),Other,21402478.0,
1741,592737,1,4,,103168084,10607,Unspecified,,,,,Induction of apoptosis in human A549 cells assessed as activation of caspase 3 at 1 uM after 48 hrs by fluorimetric assay relative to control,Other,21402478.0,
1742,593184,3,2,,103168084,10607,Active,,,0.012,EC50,Antimalarial activity against chloroquine-resistant erythrocytic stage of Plasmodium falciparum K1 assessed as inhibition of [3H}hypoxanthine incorporation after 24 hrs by liquid scintillation counter,Confirmatory,21411327.0,
1743,595455,3,2,,103168084,10607,Active,,,0.01,IC50,Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay,Confirmatory,21348447.0,
1744,596418,3,2,,103168084,10607,Active,,,0.021,IC50,Cytotoxicity against rat L6 cells by MTT assay,Confirmatory,21456549.0,
1745,597078,3,2,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against rat L6 cells after 72 hrs by microplate fluorimetry,Confirmatory,21438586.0,
1746,598807,3,2,,103168084,10607,Active,,,0.069,IC50,Cytotoxicity against human HeLa cells after 72 hrs by MTT assay,Confirmatory,21570846.0,
1747,598808,3,2,,103168084,10607,Active,,,0.055999999999999994,IC50,Cytotoxicity against human KB cells after 72 hrs by MTT assay,Confirmatory,21570846.0,
1748,602106,5,1,,103168084,10607,Active,,,0.02,GI50,Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay,Confirmatory,21615090.0,
1749,602107,5,1,,103168084,10607,Active,,,0.01,GI50,Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay,Confirmatory,21615090.0,
1750,602109,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human Jurkat cells assessed as cleavage of caspase 3 substrate DEVD-p-nitroanaline 2 hrs by spectrophotometric analysis,Other,21615090.0,
1751,602111,2,4,,103168084,10607,Active,,,,,Inhibition of purified bovine tubulin polymerization assessed as microtubule destabilization at 25 uM after 20 mins by fluorescence spectrophotometric analysis,Other,21615090.0,
1752,602116,1,4,,103168084,10607,Active,,,,,Antimitotic activity in human HeLa cells assessed as visible deffect in mitotic spindle formation at 10 uM after 3 hrs by inverted microscopic analysis,Other,21615090.0,
1753,602117,1,4,,103168084,10607,Inactive,,,,,Antimitotic activity in human HeLa cells assessed as disruption of interphase microtubule organization at 10 uM after 3 hrs by inverted microscopic analysis,Other,21615090.0,
1754,602123,1,1,,56463668,10607,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
1755,602141,1,1,,56463668,10607,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
1756,602162,1,1,,56463668,10607,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
1757,602163,1,1,,56463668,10607,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
1758,602179,1,2,,56463668,10607,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
1759,602229,1,1,,56463668,10607,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
1760,602233,1,1,,56463668,10607,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1761,602244,1,2,,56463668,10607,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
1762,602247,1,2,,56463668,10607,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1763,602248,1,2,,56463668,10607,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1764,602250,1,2,,56463668,10607,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
1765,602252,1,1,,56463668,10607,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1766,602252,1,1,,56463668,10607,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1767,602261,1,1,,56463668,10607,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
1768,602266,1,1,,855658,10607,Inconclusive,62740231.0,15499.0,,AC50_uM,Quantitative-PCR analysis for transcription inhibition of HSF-1 target gene Hsp90aa Measured in Cell-Based System Using RT-PCR - 2038-08_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1769,602274,1,2,,56463668,10607,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
1770,602276,1,1,,855658,10607,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-SeV Stimulus,Screening,,
1771,602277,1,1,,855658,10607,Active,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-Poly IC Stimulus,Screening,,
1772,602281,1,1,,56463668,10607,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1773,602281,1,1,,56463668,10607,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1774,602310,1,2,,26751476,10607,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1775,602310,1,2,,56463668,10607,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1776,602313,1,1,,56463668,10607,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
1777,602314,1,2,,92125850,10607,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
1778,602329,1,1,,56463668,10607,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1779,602332,1,1,,26751476,10607,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1780,602332,1,1,,29215001,10607,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1781,602332,1,1,,50103982,10607,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1782,602332,1,1,,56463668,10607,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1783,602340,1,2,,56463668,10607,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
1784,602342,2,1,,56463668,10607,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1785,602346,1,1,,56463668,10607,Active,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1786,602363,1,1,,56463668,10607,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
1787,602393,1,1,,56463668,10607,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1788,602396,1,2,,56463668,10607,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
1789,602399,1,2,,56463668,10607,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
1790,602405,1,1,,56463668,10607,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1791,602410,1,1,,56463668,10607,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
1792,602429,1,1,,56463668,10607,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
1793,602438,1,1,,56463668,10607,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
1794,602440,1,1,,56463668,10607,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
1795,602449,1,2,,56463668,10607,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
1796,602481,1,1,,56463668,10607,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1797,605844,3,2,,103168084,10607,Inconclusive,,,,IC50,Antiproliferative activity against human K562 cells after 48 hrs by hemocytometric analysis,Confirmatory,21563750.0,
1798,605956,3,2,,103168084,10607,Active,,,0.35,IC50,Inhibition of pig tubulin polymerization determined after 45 mins at 37 degC by turbidimetric analysis,Confirmatory,21563750.0,
1799,606847,3,2,,103168084,10607,Active,,,0.009000000000000001,IC50,Cytotoxicity at rat L6 cells after 72 hrs by microplate alamar blue assay,Confirmatory,21644541.0,
1800,608685,1,4,,103168084,10607,Unspecified,,,,,Cytotoxicity against human KB cells assessed as growth inhibition at 0.5 uM,Other,21705220.0,
1801,608686,3,2,,103168084,10607,Active,,,0.0005,IC50,Cytotoxicity against human KB cells assessed as growth inhibition,Confirmatory,21705220.0,
1802,611184,1,4,,103168084,10607,Inactive,,,,,Cytotoxicity against human MCF7 cells at 2 to 4 uM after 24 hrs by MTT assay,Other,21737288.0,
1803,611185,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human MCF7 cells assessed as accumulation at GO phase at 2 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 6.09%),Other,21737288.0,
1804,611186,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human MCF7 cells assessed as accumulation at G1 phase at 2 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 60.5%),Other,21737288.0,
1805,611187,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human MCF7 cells assessed as accumulation at S phase at 2 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 6.99%),Other,21737288.0,
1806,611188,1,4,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human MCF7 cells assessed as accumulation at G2/M phase at 2 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 26.42%),Other,21737288.0,
1807,611190,1,4,,103168084,10607,Inactive,,,,,Induction of apoptosis in human MCF7 cells assessed as double-strand DNA breaks at 2 uM after 24 hrs measured as phosphorylation at ser-139 on H2AX protein by immunostaining relative to control,Other,21737288.0,
1808,611267,3,2,,103168084,10607,Inconclusive,,,,IC50,Antiproliferative activity against human K562 cells after 48 hrs by hemocytometer,Confirmatory,21705223.0,
1809,611278,3,2,,103168084,10607,Active,,,0.35,IC50,Inhibition of pig brain tubulin polymerization after 30 mins by turbidimetry analysis,Confirmatory,21705223.0,
1810,616292,3,2,,103168084,10607,Active,,,0.019,IC50,Cytotoxicity against rat L6 cells incubated for 72 hrs by Alamar Blue staining based fluorometric assay,Confirmatory,21846091.0,
1811,618833,3,2,,103168084,10607,Active,,,0.1,IC50,Cytotoxicity against human HeLa cells after 2 days by MTT assay,Confirmatory,21821321.0,
1812,618834,3,2,,103168084,10607,Active,,,0.03,IC50,Cytotoxicity against human K562 cells after 2 days by MTT assay,Confirmatory,21821321.0,
1813,618835,3,3,,103168084,10607,Active,,,0.17,IC50,Cytotoxicity against human K562/A02 cells after 2 days by MTT assay,Confirmatory,21821321.0,
1814,621155,3,2,,103168084,10607,Active,,,0.02,IC50,Cytotoxicity against rat L6 cells,Confirmatory,21868222.0,
1815,623870,1,1,,56463668,10607,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1816,623870,1,1,,56463668,10607,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1817,623877,1,1,,56463668,10607,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
1818,623901,1,1,,56463668,10607,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
1819,624030,1,2,,29215001,10607,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
1820,624031,1,2,,29215001,10607,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
1821,624032,1,2,,29215001,10607,Active,8393992.0,24660.0,0.0128,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
1822,624037,1,3,,56463668,10607,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1823,624038,1,3,,56463668,10607,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1824,624040,1,3,,56463668,10607,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1825,624044,1,2,,29215001,10607,Active,8393992.0,24660.0,0.0224,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
1826,624125,1,4,,56463668,10607,Active,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1827,624126,1,3,,56463668,10607,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1828,624127,1,2,,56463668,10607,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1829,624156,1,1,,85788487,10607,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
1830,624168,1,1,,56463668,10607,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
1831,624169,1,1,,56463668,10607,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
1832,624170,1,1,,29215001,10607,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1833,624170,1,1,,56463668,10607,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1834,624171,1,1,,56463668,10607,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
1835,624172,1,1,,29215001,10607,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1836,624172,1,1,,56463668,10607,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1837,624173,1,3,,29215001,10607,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1838,624173,1,3,,56463668,10607,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1839,624178,1,1,,26751476,10607,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1840,624178,1,1,,56463668,10607,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1841,624202,1,1,,26751476,10607,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1842,624202,1,1,,56463668,10607,Inconclusive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1843,624204,1,2,,56463668,10607,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
1844,624246,1,1,,56463668,10607,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
1845,624256,1,2,,56463668,10607,Inconclusive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
1846,624263,1,1,,26751476,10607,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1847,624263,1,1,,26751476,10607,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1848,624263,1,1,,56463668,10607,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1849,624263,1,1,,56463668,10607,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1850,624267,1,2,,56463668,10607,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1851,624267,1,2,,56463668,10607,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1852,624268,1,3,,56463668,10607,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
1853,624288,1,1,,56463668,10607,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1854,624296,1,1,,855658,10607,Inconclusive,7705682.0,51053.0,0.0065,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1855,624296,1,1,,29215001,10607,Active,7705682.0,51053.0,0.0211,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1856,624296,1,1,,56463668,10607,Inconclusive,7705682.0,51053.0,0.0046,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1857,624297,1,1,,855658,10607,Active,7705682.0,51053.0,0.0231,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1858,624297,1,1,,29215001,10607,Active,7705682.0,51053.0,0.0168,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1859,624297,1,1,,56463668,10607,Inconclusive,7705682.0,51053.0,0.0517,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1860,624304,1,2,,56463668,10607,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
1861,624330,1,2,,56463668,10607,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
1862,624349,1,2,,92308146,10607,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1863,624349,1,2,,121362531,10607,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1864,624349,1,2,,121363521,10607,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1865,624352,1,1,,56463668,10607,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
1866,624354,1,1,,56463668,10607,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
1867,624377,1,1,,56422495,10607,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
1868,624414,1,1,,26751476,10607,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1869,624414,1,1,,56463668,10607,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1870,624415,1,2,,56463668,10607,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1871,624416,1,1,,56422495,10607,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
1872,624417,1,1,,56463668,10607,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
1873,624418,1,1,,56463668,10607,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
1874,624463,1,1,,56463668,10607,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
1875,624464,1,1,,56463668,10607,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
1876,624465,1,1,,56463668,10607,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
1877,624466,1,3,,56422495,10607,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1878,624467,1,1,,56422495,10607,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1879,624476,1,1,,50103983,10607,Inactive,,,0.0166,Potency,Cytotoxicity counterscreen for NFkB agonists and antagonists,Confirmatory,,
1880,624478,1,1,,50103983,10607,Inactive,,,,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway.,Confirmatory,,
1881,624479,1,1,,50103983,10607,Inactive,,,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway.,Confirmatory,,
1882,624483,1,1,,56463668,10607,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
1883,625144,5,5,,103168084,10607,Unspecified,239977155.0,,,IC50,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),Confirmatory,,
1884,625145,4,7,,103168084,10607,Unspecified,20138087.0,10800.0,,IC50,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),Confirmatory,,
1885,625146,5,5,,103168084,10607,Unspecified,126397.0,100009114.0,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),Confirmatory,,
1886,625147,4,7,,103168084,10607,Unspecified,395398606.0,4159.0,,IC50,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
1887,625148,4,7,,103168084,10607,Unspecified,60392672.0,4160.0,,IC50,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
1888,625149,4,7,,103168084,10607,Unspecified,729996.0,4161.0,,IC50,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
1889,625150,5,5,,103168084,10607,Unspecified,113978.0,4128.0,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),Confirmatory,,
1890,625151,4,7,,103168084,10607,Unspecified,113118.0,1128.0,,IC50,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1891,625152,4,7,,103168084,10607,Unspecified,113122.0,1129.0,,IC50,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1892,625153,4,7,,103168084,10607,Unspecified,113125.0,1131.0,,IC50,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1893,625154,4,7,,103168084,10607,Unspecified,23503039.0,1132.0,,IC50,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1894,625155,4,7,,103168084,10607,Unspecified,543761.0,1133.0,,IC50,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1895,625156,1,9,,103168084,10607,Unspecified,128997.0,4886.0,,,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),Other,,
1896,625157,6,2,,103168084,10607,Unspecified,1352610.0,4887.0,,IC50,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),Confirmatory,,
1897,625158,3,4,,103168084,10607,Unspecified,,,,IC50,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),Confirmatory,,
1898,625159,5,5,,103168084,10607,Unspecified,266646.0,24598.0,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",Confirmatory,,
1899,625160,1,9,,103168084,10607,Unspecified,266649.0,18126.0,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",Other,,
1900,625161,4,7,,103168084,10607,Unspecified,311033488.0,4985.0,,IC50,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",Confirmatory,,
1901,625162,4,7,,103168084,10607,Unspecified,116242691.0,4986.0,,IC50,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
1902,625163,4,7,,103168084,10607,Unspecified,2851402.0,4988.0,,IC50,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
1903,625164,1,6,,103168084,10607,Unspecified,,,,,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),Other,,
1904,625165,3,4,,103168084,10607,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
1905,625166,3,4,,103168084,10607,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
1906,625167,5,5,,103168084,10607,Unspecified,317373261.0,8654.0,,IC50,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),Confirmatory,,
1907,625168,4,7,,103168084,10607,Unspecified,129557.0,5724.0,,IC50,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),Confirmatory,,
1908,625169,1,6,,103168084,10607,Unspecified,,,,,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),Other,,
1909,625170,3,4,,103168084,10607,Unspecified,,,,IC50,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),Confirmatory,,
1910,625171,4,7,,103168084,10607,Unspecified,7531135.0,3757.0,,IC50,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Confirmatory,,
1911,625172,4,7,,103168084,10607,Unspecified,75071465.0,,,IC50,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),Confirmatory,,
1912,625173,5,5,,103168084,10607,Unspecified,2822103.0,100009274.0,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",Confirmatory,,
1913,625174,5,5,,103168084,10607,Unspecified,266321.0,834.0,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",Confirmatory,,
1914,625175,5,5,,103168084,10607,Unspecified,115725.0,1511.0,,IC50,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",Confirmatory,,
1915,625176,1,9,,103168084,10607,Unspecified,119292.0,1991.0,,,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",Other,,
1916,625177,5,5,,103168084,10607,Unspecified,116852.0,4312.0,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
1917,625178,5,5,,103168084,10607,Unspecified,269849668.0,4318.0,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
1918,625179,1,9,,103168084,10607,Unspecified,317373571.0,5578.0,,,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),Other,,
1919,625180,5,5,,103168084,10607,Unspecified,232066.0,5595.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
1920,625181,5,5,,103168084,10607,Unspecified,119554.0,5594.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
1921,625182,5,5,,103168084,10607,Unspecified,2499600.0,1432.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
1922,625183,5,5,,103168084,10607,Unspecified,1352673.0,5530.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",Confirmatory,,
1923,625184,5,5,,103168084,10607,Unspecified,2811086.0,1956.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
1924,625185,5,5,,103168084,10607,Unspecified,125370.0,2534.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
1925,625186,5,5,,103168084,10607,Unspecified,119533.0,2064.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
1926,625187,5,5,,103168084,10607,Unspecified,125474.0,3932.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
1927,625188,1,9,,103168084,10607,Unspecified,33112650.0,5788.0,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",Other,,
1928,625189,1,7,,103168084,10607,Unspecified,,,,,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",Other,,
1929,625190,4,5,,103168084,10607,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),Confirmatory,,
1930,625191,4,7,,103168084,10607,Unspecified,112815.0,25075.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
1931,625192,4,7,,103168084,10607,Unspecified,543727.0,3356.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),Confirmatory,,
1932,625193,5,5,,103168084,10607,Unspecified,113037.0,43.0,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Confirmatory,,
1933,625194,4,7,,103168084,10607,Unspecified,231473.0,134.0,,IC50,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),Confirmatory,,
1934,625195,4,7,,103168084,10607,Unspecified,543740.0,135.0,,IC50,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),Confirmatory,,
1935,625196,5,6,,103168084,10607,Unspecified,803374855.0,140.0,,IC50,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),Confirmatory,,
1936,625197,3,4,,103168084,10607,Unspecified,,,,IC50,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),Confirmatory,,
1937,625198,4,7,,103168084,10607,Unspecified,1168247.0,29412.0,,IC50,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
1938,625199,4,7,,103168084,10607,Unspecified,543734.0,24173.0,,IC50,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
1939,625200,4,7,,103168084,10607,Unspecified,1168243.0,146.0,,IC50,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
1940,625201,4,7,,103168084,10607,Unspecified,1351829.0,150.0,,IC50,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Confirmatory,,
1941,625202,4,7,,103168084,10607,Unspecified,613504690.0,151.0,,IC50,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),Confirmatory,,
1942,625203,4,7,,103168084,10607,Unspecified,20141211.0,152.0,,IC50,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),Confirmatory,,
1943,625204,4,7,,103168084,10607,Unspecified,48429211.0,153.0,,IC50,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
1944,625205,4,7,,103168084,10607,Unspecified,296439450.0,154.0,,IC50,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),Confirmatory,,
1945,625206,4,7,,103168084,10607,Unspecified,461604.0,155.0,,IC50,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
1946,625207,4,7,,103168084,10607,Unspecified,128616.0,6530.0,,IC50,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
1947,625208,5,5,,103168084,10607,Unspecified,1168407.0,24192.0,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),Confirmatory,,
1948,625209,4,7,,103168084,10607,Unspecified,1703214.0,186.0,,IC50,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),Confirmatory,,
1949,625210,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",Confirmatory,,
1950,625211,1,6,,103168084,10607,Unspecified,,,,,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),Other,,
1951,625212,3,4,,103168084,10607,Unspecified,,,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),Confirmatory,,
1952,625213,4,7,,103168084,10607,Unspecified,2506481.0,624.0,,IC50,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),Confirmatory,,
1953,625214,1,9,,103168084,10607,Unspecified,550544247.0,799.0,,,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),Other,,
1954,625215,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",Confirmatory,,
1955,625216,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",Confirmatory,,
1956,625217,4,7,,103168084,10607,Unspecified,1168220.0,3357.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
1957,625218,4,7,,103168084,10607,Unspecified,112816.0,3358.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),Confirmatory,,
1958,625219,3,4,,103168084,10607,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),Confirmatory,,
1959,625220,4,7,,103168084,10607,Unspecified,6224984.0,100135548.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),Confirmatory,,
1960,625221,4,7,,103168084,10607,Unspecified,1703010.0,3362.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
1961,625222,4,7,,103168084,10607,Unspecified,400630.0,6532.0,,IC50,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",Confirmatory,,
1962,625223,4,7,,103168084,10607,Unspecified,74752153.0,10280.0,,IC50,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),Confirmatory,,
1963,625224,3,4,,103168084,10607,Unspecified,,,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),Confirmatory,,
1964,625225,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",Confirmatory,,
1965,625226,4,7,,103168084,10607,Unspecified,128359.0,6869.0,,IC50,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),Confirmatory,,
1966,625227,4,7,,103168084,10607,Unspecified,229462950.0,6865.0,,IC50,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),Confirmatory,,
1967,625228,4,7,,103168084,10607,Unspecified,113832.0,24208.0,,IC50,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),Confirmatory,,
1968,625229,5,5,,103168084,10607,Unspecified,254763392.0,6916.0,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),Confirmatory,,
1969,625230,1,6,,103168084,10607,Unspecified,,,,,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",Other,,
1970,625231,4,7,,103168084,10607,Unspecified,143811474.0,2321.0,,IC50,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),Confirmatory,,
1971,625232,1,9,,103168084,10607,Unspecified,418253.0,7433.0,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),Other,,
1972,625233,4,7,,103168084,10607,Unspecified,586197.0,552.0,,IC50,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),Confirmatory,,
1973,625234,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",Confirmatory,,
1974,625235,4,7,,103168084,10607,Unspecified,115562.0,1268.0,,IC50,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),Confirmatory,,
1975,625236,5,5,,103168084,10607,Unspecified,115456.0,760.0,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),Confirmatory,,
1976,625237,4,7,,103168084,10607,Unspecified,1168965.0,729230.0,,IC50,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),Confirmatory,,
1977,625238,4,7,,103168084,10607,Unspecified,1705894.0,1233.0,,IC50,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),Confirmatory,,
1978,625239,4,7,,103168084,10607,Unspecified,1705896.0,1234.0,,IC50,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),Confirmatory,,
1979,625240,1,9,,103168084,10607,Unspecified,108936015.0,3577.0,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),Other,,
1980,625241,4,7,,103168084,10607,Unspecified,1352454.0,3579.0,,IC50,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),Confirmatory,,
1981,625242,4,7,,103168084,10607,Unspecified,416772.0,886.0,,IC50,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",Confirmatory,,
1982,625243,5,5,,103168084,10607,Unspecified,317373262.0,5742.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
1983,625244,5,5,,103168084,10607,Unspecified,3915797.0,5743.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
1984,625245,5,5,,103168084,10607,Unspecified,117144.0,1544.0,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1985,625246,1,9,,103168084,10607,Unspecified,308153612.0,1548.0,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Other,,
1986,625247,5,5,,103168084,10607,Active,60416369.0,1557.0,5.0,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1987,625248,5,5,,103168084,10607,Active,6686268.0,1559.0,4.0,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1988,625249,5,5,,103168084,10607,Unspecified,84028191.0,1565.0,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1989,625250,5,5,,103168084,10607,Unspecified,117250.0,1571.0,,IC50,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1990,625251,5,5,,103168084,10607,Active,116241312.0,1576.0,0.6,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",Confirmatory,,
1991,625252,4,7,,103168084,10607,Unspecified,118228.0,1812.0,,IC50,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),Confirmatory,,
1992,625253,4,7,,103168084,10607,Unspecified,118206.0,1813.0,,IC50,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
1993,625254,4,7,,103168084,10607,Unspecified,1169206.0,1814.0,,IC50,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
1994,625255,4,7,,103168084,10607,Unspecified,1345939.0,1815.0,,IC50,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
1995,625256,4,7,,103168084,10607,Unspecified,266667.0,6531.0,,IC50,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
1996,625257,4,7,,103168084,10607,Unspecified,119606.0,1909.0,,IC50,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),Confirmatory,,
1997,625258,4,7,,103168084,10607,Unspecified,544257.0,2099.0,,IC50,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
1998,625259,4,7,,103168084,10607,Unspecified,6166154.0,2100.0,,IC50,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
1999,625260,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",Confirmatory,,
2000,625261,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",Confirmatory,,
2001,625262,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",Confirmatory,,
2002,625263,4,7,,103168084,10607,Unspecified,121069.0,2908.0,,IC50,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),Confirmatory,,
2003,625264,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",Confirmatory,,
2004,625265,1,6,,103168084,10607,Unspecified,,,,,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",Other,,
2005,625266,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",Confirmatory,,
2006,625267,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",Confirmatory,,
2007,625268,4,2,,103168084,10607,Unspecified,121579.0,24397.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
2008,625268,4,2,,103168084,10607,Unspecified,121580.0,114516.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
2009,625268,4,2,,103168084,10607,Unspecified,121604.0,25456.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
2010,625268,4,2,,103168084,10607,Unspecified,12230887.0,25674.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
2011,625269,4,7,,103168084,10607,Unspecified,547645.0,3269.0,,IC50,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",Confirmatory,,
2012,625270,4,7,,103168084,10607,Unspecified,123120.0,3274.0,,IC50,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),Confirmatory,,
2013,625271,5,5,,103168084,10607,Unspecified,123343.0,3156.0,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),Confirmatory,,
2014,625272,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",Confirmatory,,
2015,625273,4,6,,103168084,10607,Unspecified,124531.0,24954.0,,IC50,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),Confirmatory,,
2016,625274,1,6,,103168084,10607,Unspecified,,,,,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),Other,,
2017,625275,3,4,,103168084,10607,Unspecified,,,,IC50,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",Confirmatory,,
2018,625279,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
2019,625280,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
2020,625281,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
2021,625282,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
2022,625283,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
2023,625284,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
2024,625285,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
2025,625286,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
2026,625287,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
2027,625288,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
2028,625289,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
2029,625290,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
2030,625291,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
2031,625292,1,3,,103168084,10607,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
2032,626320,3,2,,103168084,10607,Active,,,0.013999999999999999,IC50,Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay,Confirmatory,21937228.0,
2033,628068,1,3,,103168084,10607,Active,,,,,Antimitotic activity against Paracentrotus lividus embryo assessed as cleavage alteration treated 10 to 25 mins post fertilization followed by 45 to 60 mins before the first mitotic cycle completion by sea urchin embryo assay,Other,21916509.0,
2034,628069,1,3,,103168084,10607,Active,,,,,Antimitotic activity against Paracentrotus lividus embryo assessed as cleavage arrest treated 10 to 25 mins post fertilization followed by 45 to 60 mins before the first mitotic cycle completion by sea urchin embryo assay,Other,21916509.0,
2035,628070,1,3,,103168084,10607,Active,,,,,Antimitotic activity against Paracentrotus lividus embryo assessed as embryo spinning treated 10 to 25 mins post fertilization followed by 45 to 60 mins before the first mitotic cycle completion by sea urchin embryo assay,Other,21916509.0,
2036,628079,1,4,,103168084,10607,Active,,,0.00747,IC50,Cytotoxicity against human A549 cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,21916509.0,
2037,628080,2,3,,103168084,10607,Active,,,0.0104,IC50,Cytotoxicity against mouse P388 cells assessed as cell viability after 48 hrs by trypan blue exclusion assay,Confirmatory,21916509.0,
2038,628081,1,4,,103168084,10607,Active,,,0.025,IC50,Cytotoxicity against human Jurkat cells assessed as cell viability after 48 hrs by trypan blue exclusion assay,Confirmatory,21916509.0,
2039,628162,1,4,,103168084,10607,Active,,,,,Inhibition of microtubule polymerization in human A549 cells assessed as total disruption of interphase microtubule network at 0.1 uM after 8 hrs by immunofluorescence microscopy,Other,21916509.0,
2040,628163,1,4,,103168084,10607,Active,,,,,Inhibition of microtubule polymerization in human A549 cells assessed as total disruption of interphase microtubule network at 0.5 uM after 8 hrs by immunofluorescence microscopy,Other,21916509.0,
2041,628164,1,4,,103168084,10607,Active,,,,,Inhibition of microtubule polymerization in human A549 cells assessed as total disruption of interphase microtubule network at 1 uM after 8 hrs by immunofluorescence microscopy,Other,21916509.0,
2042,628165,1,4,,103168084,10607,Active,,,,,Inhibition of microtubule polymerization in human A549 cells assessed as total disruption of interphase microtubule network at 5 uM after 8 hrs by immunofluorescence microscopy,Other,21916509.0,
2043,628167,1,4,,103168084,10607,Active,,,,,Cell cycle arrest in human Jurkat cells assessed as accumulation of cells in G2/M phase at 25 nM after 24 hrs by propidium iodide staining-based flow cytometry,Other,21916509.0,
2044,628169,1,4,,103168084,10607,Active,,,0.0165,EC50,Cell cycle arrest in human A549 cells assessed as accumulation of cells in G2/M phase after 24 hrs by propidium iodide staining-based flow cytometry,Confirmatory,21916509.0,
2045,628171,1,4,,103168084,10607,Unspecified,,,,,Induction of apoptosis in human Jurkat cells assessed as hypodyploid cells at 50 nM after 48 hrs by annexin-V FITC/7-ADD staining-based flow cytometric analysis (Rvb = 12.2%),Other,21916509.0,
2046,628173,1,4,,103168084,10607,Unspecified,,,,,Induction of apoptosis in human Jurkat cells assessed as cells with active form of caspase-3 at 50 nM after 48 hrs by annexin-V FITC/7-ADD staining-based flow cytometric analysis (Rvb = 7.1%),Other,21916509.0,
2047,628174,1,4,,103168084,10607,Unspecified,,,,,Induction of apoptosis in human Jurkat cells assessed as PARP cleavage at 50 nM after 48 hrs by annexin-V FITC/7-ADD staining-based flow cytometric analysis (Rvb = 6.5%),Other,21916509.0,
2048,628175,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human Jurkat cells assessed as procaspase-9 cleavage at 50 nM after 24 hrs by Western blotting,Other,21916509.0,
2049,628176,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human Jurkat cells assessed as procaspase-9 cleavage at 50 nM after 48 hrs by Western blotting,Other,21916509.0,
2050,628177,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human Jurkat cells assessed as procaspase-2 cleavage at 50 nM after 24 hrs by Western blotting,Other,21916509.0,
2051,628178,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human Jurkat cells assessed as procaspase-2 cleavage at 50 nM after 48 hrs by Western blotting,Other,21916509.0,
2052,628179,1,4,,103168084,10607,Inactive,,,,,Induction of apoptosis in human Jurkat cells assessed as reduction in procaspase-8 levels at 50 nM after 48 hrs by Western blotting,Other,21916509.0,
2053,634094,3,2,,103168084,10607,Active,,,3.75,IC50,Anticancer activity against human A549 cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
2054,634095,3,2,,103168084,10607,Active,,,2.62,IC50,Anticancer activity against human A375 cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
2055,634096,3,2,,103168084,10607,Active,,,1.18,IC50,Anticancer activity against human MCF7 cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
2056,634097,3,2,,103168084,10607,Active,,,0.78,IC50,Anticancer activity against human HT-29 cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
2057,634098,3,2,,103168084,10607,Active,,,2.12,IC50,Anticancer activity against human ACHN cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
2058,635849,3,3,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against rat L6 cells after 72 hrs by resazurin-based spectrophotometric assay,Confirmatory,22061825.0,
2059,637703,3,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells after 72 hrs by resazurin assay,Other,22217867.0,
2060,640957,3,1,,103168084,10607,Unspecified,,,,,Toxicity against Brine shrimp nauplii after 24 hrs,Other,22200598.0,
2061,644055,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human A549 cells assessed as membrane blebbing at 0.5 uM after 24 hrs by Hoechst 33258 staining based fluorescence microscopy,Other,22244588.0,
2062,644056,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human A549 cells assessed as cell shrinkage at 0.5 uM after 24 hrs by Hoechst 33258 staining based fluorescence microscopy,Other,22244588.0,
2063,644057,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human A549 cells assessed as cell detachment at 0.5 uM after 24 hrs by Hoechst 33258 staining based fluorescence microscopy,Other,22244588.0,
2064,644058,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human A549 cells assessed as nuclear condensation at 0.5 uM after 24 hrs by Hoechst 33258 staining based fluorescence microscopy,Other,22244588.0,
2065,644059,1,4,,103168084,10607,Active,,,,,Induction of apoptosis in human A549 cells assessed as nuclear fragmentation at 0.5 uM after 24 hrs by Hoechst 33258 staining based fluorescence microscopy,Other,22244588.0,
2066,644369,3,3,,103168084,10607,Active,,,0.01,IC50,Cytotoxicity against rat L6 myoblasts after 72 hrs by alamar blue assay,Confirmatory,22285027.0,
2067,651550,1,1,,56463668,10607,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
2068,651558,1,1,,855658,10607,Active,,,0.0461,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling: Hit Validation in Primary Screen,Confirmatory,,
2069,651560,1,1,,56463668,10607,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
2070,651567,1,1,,855658,10607,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling: Hit Validation in OCI-Ly3 Assay,Confirmatory,,
2071,651568,1,1,,855658,10607,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling: Hit Validation in Renilla Reporter Assay,Confirmatory,,
2072,651572,1,2,,56422495,10607,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
2073,651582,1,1,,56463668,10607,Active,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
2074,651602,1,1,,56422495,10607,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
2075,651602,1,1,,56422495,10607,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
2076,651602,1,1,,56422495,10607,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
2077,651629,1,1,,56463668,10607,Active,,,,,Single concentration confirmation of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
2078,651630,1,1,,56463668,10607,Inactive,,,25.0,IC50_TAG_Mean,Dose Response confirmation of small molecule Triacylglycerol inhbitors in a panel assay,Confirmatory,,
2079,651630,1,1,1.0,56463668,10607,Inactive,,,25.0,IC50_TAG_Mean,Dose Response confirmation of small molecule Triacylglycerol inhbitors in a panel assay,Confirmatory,,
2080,651630,1,1,2.0,56463668,10607,Unspecified,,,25.0,IC50_1_TAG,Dose Response confirmation of small molecule Triacylglycerol inhbitors in a panel assay,Confirmatory,,
2081,651630,1,1,3.0,56463668,10607,Unspecified,,,25.0,IC50_2_TAG,Dose Response confirmation of small molecule Triacylglycerol inhbitors in a panel assay,Confirmatory,,
2082,651630,1,1,4.0,56463668,10607,Inactive,,,25.0,IC50_TAG_DAPI_Mean,Dose Response confirmation of small molecule Triacylglycerol inhbitors in a panel assay,Confirmatory,,
2083,651630,1,1,5.0,56463668,10607,Unspecified,,,25.0,IC50_1_TAG_DAPI,Dose Response confirmation of small molecule Triacylglycerol inhbitors in a panel assay,Confirmatory,,
2084,651630,1,1,6.0,56463668,10607,Unspecified,,,25.0,IC50_2_TAG_DAPI,Dose Response confirmation of small molecule Triacylglycerol inhbitors in a panel assay,Confirmatory,,
2085,651631,4,1,,144204425,10607,Inconclusive,269849759.0,7157.0,0.3349,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
2086,651631,4,1,,144210120,10607,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
2087,651632,4,1,,144204425,10607,Active,296439460.0,79915.0,0.0119,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
2088,651632,4,1,,144210120,10607,Inconclusive,296439460.0,79915.0,0.0217,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
2089,651633,4,1,,144204425,10607,Inactive,,,0.0094,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
2090,651633,4,1,,144210120,10607,Inactive,,,0.0193,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
2091,651634,4,1,,144204425,10607,Inconclusive,,,0.0106,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
2092,651634,4,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
2093,651635,1,3,,56463668,10607,Inconclusive,171543895.0,6311.0,100.0,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
2094,651636,1,1,,56463668,10607,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
2095,651640,1,1,,56422495,10607,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
2096,651644,1,1,,56463668,10607,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
2097,651645,1,1,,50103983,10607,Inactive,,,,Potency,Cell Proliferation Assay against the TMD8 Cell Line,Confirmatory,,
2098,651646,1,1,,50103983,10607,Inactive,,,,Potency,Cell Proliferation Assay against the HBL1 Cell Line,Confirmatory,,
2099,651647,1,1,,56463668,10607,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
2100,651654,1,1,,56463668,10607,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2101,651658,1,1,,56422495,10607,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2102,651660,1,1,,56422495,10607,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors             Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2103,651661,2,1,,56422495,10607,Active,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2104,651687,1,1,,56463668,10607,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2105,651696,1,1,,50103983,10607,Inactive,,,0.0042,Potency,Cell Proliferation Assay against a hMSC Cell Line,Confirmatory,,
2106,651699,1,1,,56463668,10607,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
2107,651699,1,1,,56463668,10607,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
2108,651702,1,2,,56463668,10607,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
2109,651704,2,1,,56422495,10607,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2110,651710,1,1,,56422495,10607,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
2111,651711,2,1,,56422495,10607,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2112,651712,1,1,,50103983,10607,Active,,,0.0037,Potency,Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 16 hrs),Confirmatory,,
2113,651713,1,1,,50103983,10607,Inconclusive,,,0.0148,Potency,Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 8 hrs),Confirmatory,,
2114,651718,1,2,,56422495,10607,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
2115,651723,1,1,,56463668,10607,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
2116,651724,1,1,,56463668,10607,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
2117,651725,1,1,,56463668,10607,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
2118,651768,1,2,,56463668,10607,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
2119,651800,1,1,,56422495,10607,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
2120,651819,1,1,,56463668,10607,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
2121,651820,1,1,,855658,10607,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
2122,651820,1,1,,56463668,10607,Inconclusive,,,11.2202,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
2123,651821,2,4,,56422495,10607,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
2124,651828,1,2,,121362531,10607,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
2125,651957,1,1,,56422495,10607,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
2126,651958,1,1,,56422495,10607,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
2127,651965,1,1,,26751476,10607,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
2128,651965,1,1,,56463668,10607,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
2129,651999,1,1,,56463668,10607,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
2130,652010,1,1,,56422495,10607,Active,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
2131,652017,1,1,,56422495,10607,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
2132,652025,1,1,,56463668,10607,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
2133,652039,1,1,,56422495,10607,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
2134,652048,1,2,,56463668,10607,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
2135,652048,1,2,,144204425,10607,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
2136,652051,1,1,,56463668,10607,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
2137,652051,1,1,,144204425,10607,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
2138,652054,1,1,,56463668,10607,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
2139,652067,1,4,,56422495,10607,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
2140,652104,1,1,,56463668,10607,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
2141,652105,1,1,,56463668,10607,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
2142,652106,1,1,,26751476,10607,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
2143,652106,1,1,,56463668,10607,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
2144,652115,1,1,,56422495,10607,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
2145,652126,1,3,,56422495,10607,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
2146,652134,1,1,,56422495,10607,Active,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput confirmation assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
2147,652136,1,2,,56422495,10607,Inactive,20070193.0,2516.0,,,"Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay",Screening,,
2148,652154,1,1,,56422495,10607,Active,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2149,652162,2,1,,56422495,10607,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2150,652163,1,1,,56422495,10607,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2151,652163,1,1,,56463668,10607,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2152,652197,1,1,,56422495,10607,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2153,652257,1,1,,56422495,10607,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
2154,655122,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human CCRF-CEM cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2155,655123,1,4,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human HL-60(TB) cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2156,655124,1,3,,103168084,10607,Active,,,0.2153,GI50,Cytotoxicity against human K562 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2157,655125,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human MOLT4 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2158,655126,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human RPMI8226 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2159,655127,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human SR cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2160,655128,1,3,,103168084,10607,Active,,,0.0138,GI50,Cytotoxicity against human A549 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2161,655129,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human EKVX cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2162,655130,1,3,,103168084,10607,Active,,,0.0211,GI50,Cytotoxicity against human HOP62 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2163,655131,1,3,,103168084,10607,Active,,,0.0341,GI50,Cytotoxicity against human HOP92 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2164,655132,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human NCI-H226 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2165,655133,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human NCI-H23 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2166,655134,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human NCI-H322M cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2167,655135,1,3,,103168084,10607,Active,,,0.0106,GI50,Cytotoxicity against human NCI-H460 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2168,655206,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human NCI-H522 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2169,655207,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human COLO205 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2170,655208,1,3,,103168084,10607,Active,,,0.0123,GI50,Cytotoxicity against human HCC2998 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2171,655209,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human HCT116 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2172,655210,1,3,,103168084,10607,Active,,,0.0135,GI50,Cytotoxicity against human HCT15 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2173,655211,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human HT-29 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2174,655212,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human KM12 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2175,655213,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human SW620 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2176,655214,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human SF268 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2177,655215,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human SF295 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2178,655216,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human SF539 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2179,655217,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human SNB19 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2180,655218,1,3,,103168084,10607,Active,,,0.6592,GI50,Cytotoxicity against human SNB75 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2181,655219,1,3,,103168084,10607,Active,,,0.0107,GI50,Cytotoxicity against human U251 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2182,655220,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human LOXIMVI cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2183,655221,1,3,,103168084,10607,Active,,,47.3151,GI50,Cytotoxicity against human MALME-3M cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2184,655222,1,3,,103168084,10607,Active,,,0.0131,GI50,Cytotoxicity against human M14 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2185,655223,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human MDA-MB-435 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2186,655224,1,3,,103168084,10607,Active,,,0.0149,GI50,Cytotoxicity against human SK-MEL-2 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2187,655225,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human SK-MEL-28 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2188,655226,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human SK-MEL-5 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2189,655227,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human UACC257 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2190,655228,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human UACC62 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2191,655229,1,3,,103168084,10607,Active,,,0.0132,GI50,Cytotoxicity against human IGROV1 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2192,655230,1,3,,103168084,10607,Active,,,0.0113,GI50,Cytotoxicity against human OVCAR3 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2193,655231,1,3,,103168084,10607,Active,,,0.0175,GI50,Cytotoxicity against human OVCAR4 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2194,655232,1,3,,103168084,10607,Inconclusive,,,,GI50,Cytotoxicity against human OVCAR5 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2195,655233,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human OVCAR8 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2196,655234,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human NCI/ADR-RES cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2197,655235,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human SKOV3 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2198,655236,1,3,,103168084,10607,Active,,,0.0169,GI50,Cytotoxicity against human 786-0 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2199,655237,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human A498 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2200,655238,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human ACHN cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2201,655239,1,3,,103168084,10607,Active,,,0.0897,GI50,Cytotoxicity against human CAKI-1 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2202,655240,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human RXF393 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2203,655241,1,3,,103168084,10607,Active,,,0.0171,GI50,Cytotoxicity against human SN12C cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2204,655242,1,3,,103168084,10607,Active,,,0.0305,GI50,Cytotoxicity against human TK10 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2205,655243,1,3,,103168084,10607,Active,,,0.0166,GI50,Cytotoxicity against human UO31 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2206,655244,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human PC3 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2207,655245,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human DU145 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2208,655246,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human MCF7 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2209,655247,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human MDA-MB-231 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2210,655248,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human Hs 578T cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2211,655249,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human BT549 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2212,655250,1,3,,103168084,10607,Unspecified,,,84.5279,GI50,Cytotoxicity against human T47D cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2213,655251,1,3,,103168084,10607,Active,,,0.01,GI50,Cytotoxicity against human MDA-MB-468 cells after 48 hrs by trypan blue dye exclusion assay,Confirmatory,22370267.0,
2214,655258,1,3,,103168084,10607,Active,,,0.025,IC50,Cytotoxicity against human Jurkat cells,Confirmatory,22370267.0,
2215,657123,2,2,,103168084,10607,Active,,,3.5,IC50,Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay,Confirmatory,22472045.0,
2216,657132,2,2,,103168084,10607,Active,,,0.74,IC50,Inhibition of tubulin polymerization after 1 hr by spectrophotometric analysis,Confirmatory,22472045.0,
2217,664491,2,2,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay,Other,22352841.0,
2218,666699,2,2,,103168084,10607,Active,,,0.012,EC50,Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay,Confirmatory,22390399.0,
2219,670481,2,2,,103168084,10607,Unspecified,,,100.0,IC50,Cytotoxicity against human DU145 cells after 72 hrs by MTT assay,Confirmatory,22687745.0,
2220,670482,2,3,,103168084,10607,Active,,,2.95,IC50,Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay,Confirmatory,22687745.0,
2221,670483,2,2,,103168084,10607,Active,,,13.62,IC50,Cytotoxicity against human A549 cells after 72 hrs by MTT assay,Confirmatory,22687745.0,
2222,670484,2,4,,103168084,10607,Active,,,2.54,IC50,Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay,Confirmatory,22687745.0,
2223,670485,2,2,,103168084,10607,Active,,,2.27,IC50,Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay,Confirmatory,22687745.0,
2224,670486,2,2,,103168084,10607,Active,,,7.58,IC50,Cytotoxicity against human HeLa cells after 72 hrs by MTT assay,Confirmatory,22687745.0,
2225,670487,2,2,,103168084,10607,Active,,,1.37,IC50,Cytotoxicity against mouse L929 cells after 72 hrs by MTT assay,Confirmatory,22687745.0,
2226,670488,2,2,,103168084,10607,Active,,,1.78,IC50,Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay,Confirmatory,22687745.0,
2227,671048,2,2,,103168084,10607,Active,,,0.019,IC50,Cytotoxicity against rat L6 cells,Confirmatory,22738640.0,
2228,677566,2,2,,103168084,10607,Active,,,0.022000000000000002,IC50,Cytotoxicity against rat L6 cells,Confirmatory,22550999.0,
2229,686940,1,1,,56422495,10607,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
2230,686947,2,2,,50103983,10607,Inactive,4885661.0,7525.0,,Potency,qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen,Confirmatory,23787099.0,
2231,686950,1,1,,50103983,10607,Inactive,,,,Potency,qHTS for small molecule inhibitors of Yes1 kinase: Counter Assay,Other,,
2232,686964,1,1,,56422495,10607,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
2233,686970,1,2,,56463668,10607,Inconclusive,49168486.0,3417.0,0.20600000000000002,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
2234,686971,1,2,,56463668,10607,Active,,,0.0065,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
2235,686977,2,1,,49698638,10607,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
2236,686978,1,1,,26751476,10607,Inconclusive,79154014.0,55775.0,0.0251,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
2237,686978,1,1,,50103982,10607,Active,79154014.0,55775.0,0.0473,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
2238,686978,1,1,,50103983,10607,Active,79154014.0,55775.0,0.0231,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
2239,686978,1,1,,56463668,10607,Active,79154014.0,55775.0,0.1458,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
2240,686978,1,1,,144204425,10607,Active,79154014.0,55775.0,0.0473,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
2241,686979,1,1,,26751476,10607,Active,79154014.0,55775.0,0.0251,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
2242,686979,1,1,,50103982,10607,Active,79154014.0,55775.0,0.0668,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
2243,686979,1,1,,50103983,10607,Active,79154014.0,55775.0,0.0461,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
2244,686979,1,1,,56463668,10607,Active,79154014.0,55775.0,0.1458,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
2245,686979,1,1,,144204425,10607,Active,79154014.0,55775.0,0.0668,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
2246,686992,2,1,,56422495,10607,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
2247,686996,1,1,,56422495,10607,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
2248,687014,1,1,,56422495,10607,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
2249,687016,1,1,,56422495,10607,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
2250,687017,1,1,,56422495,10607,Active,5016090.0,190.0,2.145,IC50,"Luminescence-based cell-based high throughput dose response assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Confirmatory,,
2251,687018,1,1,,56422495,10607,Inactive,20070193.0,2516.0,67.538,IC50,"Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay",Confirmatory,,
2252,687027,1,1,,56422495,10607,Active,998701.0,7849.0,0.26,AC50_uM,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
2253,687029,1,1,,56422495,10607,Inactive,998701.0,7849.0,,AC50_uM,PAX8: PAX8-dependent cytoxicity Measured in Cell-Based System Using Plate Reader - 7054-06_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
2254,687032,1,1,,56422495,10607,Inconclusive,998701.0,7849.0,,AC50_uM,SA5-Pax8: Cytotoxicity IOSE-T80 Measured in Cell-Based System Using Plate Reader - 7054-07_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
2255,690546,2,2,,103168084,10607,Active,,,0.02,IC50,Cytotoxicity against rat L6 cells,Confirmatory,22932312.0,
2256,690946,3,1,,103168084,10607,Unspecified,,,,,Cytotoxicity in brine shrimps larvae assessed as mortality after 24 hrs,Other,22981328.0,
2257,694345,1,2,,103168084,10607,Inconclusive,,,,IC50,Antileishmanial activity against amastigote form of Leishmania donovani LV82 expressing beta-lactamase infected in CD1 mouse macrophages after 72 hrs by nitrocefin-based spectrophotometric analysis,Confirmatory,22765899.0,
2258,694346,1,2,,103168084,10607,Inconclusive,,,,IC50,Antileishmanial activity against amastigote form of Leishmania amazonensis expressing beta-lactamase infected in CD1 mouse macrophages after 72 hrs by nitrocefin-based spectrophotometric analysis,Confirmatory,22765899.0,
2259,694347,1,2,,103168084,10607,Active,,,0.018000000000000002,IC50,Cytotoxicity against mouse J774 cells,Confirmatory,22765899.0,
2260,695789,2,2,,103168084,10607,Active,,,24.03,IC50,Inhibition of goat brain tubulin polymerization after 30 mins,Confirmatory,23022053.0,
2261,695812,2,2,,103168084,10607,Active,,,0.51,IC50,Cytotoxicity against human HepG2 cells after 48 hrs,Confirmatory,23022053.0,
2262,695930,2,2,,103168084,10607,Active,,,0.14,IC50,Cytotoxicity against human HeLa cells after 48 hrs,Confirmatory,23022053.0,
2263,695931,2,2,,103168084,10607,Active,,,4.51,IC50,Cytotoxicity against human K562 cells after 48 hrs,Confirmatory,23022053.0,
2264,695932,2,3,,103168084,10607,Active,,,0.34,IC50,Cytotoxicity against human SGC7901 cells after 48 hrs,Confirmatory,23022053.0,
2265,697852,1,7,,103168084,10607,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
2266,697853,1,7,,103168084,10607,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
2267,699777,1,2,,103168084,10607,Unspecified,,,,,Displacement of MTC from bovine brain tubulin colchicine binding site at 20 uM by fluorometric assay,Other,22607205.0,
2268,699778,1,2,,103168084,10607,Unspecified,,,,,Inhibition of bovine brain tubulin polymerization at 1 uM after 30 mins by spectrophotometric analysis,Other,22607205.0,
2269,699779,1,2,,103168084,10607,Active,,,,,Antimitotic activity in human A549 cells assessed as induction of microtubule depolymerization at 0.05 to 100 uM after 20 hrs by Hoechst 33342 staining-based fluorescence microscopy,Other,22607205.0,
2270,699780,1,2,,103168084,10607,Unspecified,,,,,Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 0.001 to 100 uM after 20 hrs by propidium iodide staining-based flow cytometry,Other,22607205.0,
2271,699781,1,2,,103168084,10607,Active,,,0.012,GI50,Growth inhibition of human A549 cells after 72 hrs by SRB assay,Confirmatory,22607205.0,
2272,699782,1,2,,103168084,10607,Active,,,0.012,GI50,Growth inhibition of human HT-29 cells after 72 hrs by SRB assay,Confirmatory,22607205.0,
2273,710592,2,2,,103168084,10607,Active,,,0.0017,IC50,Cytotoxicity against rat L6 cells assessed as growth inhibition after 72 hrs by inverted microscopy,Confirmatory,23153330.0,
2274,720504,1,1,,56463668,10607,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
2275,720508,1,1,,56422495,10607,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
2276,720509,1,1,,56422495,10607,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
2277,720511,1,1,,56422495,10607,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
2278,720516,2,1,,144204425,10607,Active,296439460.0,79915.0,0.012831200000000001,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
2279,720516,2,1,,144210120,10607,Inconclusive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
2280,720532,1,1,,50103982,10607,Inconclusive,420597.0,,25.1189,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
2281,720532,1,1,,50103983,10607,Inconclusive,420597.0,,0.3162,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
2282,720532,1,1,,144204425,10607,Inconclusive,420597.0,,0.0316,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
2283,720533,1,1,,50103982,10607,Inconclusive,,,2.5119,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
2284,720533,1,1,,50103983,10607,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
2285,720533,1,1,,144204425,10607,Inconclusive,,,2.5119,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
2286,720542,1,2,,56463668,10607,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
2287,720543,1,1,,56422495,10607,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
2288,720551,1,2,,56463668,10607,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
2289,720552,2,1,,144204425,10607,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
2290,720552,2,1,,144210120,10607,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
2291,720553,1,2,,56463668,10607,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
2292,720554,1,3,,121362531,10607,Inactive,52423132.0,3087402.0,,,Inhibition of the Burkholderia mallei acyl-homoserine lactone synthase BmaI1,Other,,
2293,720579,2,1,,26751476,10607,Inconclusive,222762.0,3707576.0,2.8184,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
2294,720579,2,1,,56463668,10607,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
2295,720580,1,1,,26751476,10607,Inconclusive,222762.0,3707576.0,35.4813,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
2296,720580,1,1,,56463668,10607,Inconclusive,222762.0,3707576.0,15.8489,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
2297,720582,1,1,,56422495,10607,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
2298,720596,1,1,,56422495,10607,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
2299,720634,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
2300,720634,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
2301,720635,2,1,,144204425,10607,Active,,,0.1496,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
2302,720635,2,1,,144210120,10607,Active,,,0.0769,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
2303,720637,2,1,,144204425,10607,Active,,,0.174422,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
2304,720637,2,1,,144210120,10607,Active,,,0.102522,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
2305,720641,1,2,,92308146,10607,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
2306,720647,1,2,,56422495,10607,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
2307,720648,1,1,,56422495,10607,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
2308,720674,2,2,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
2309,720674,2,2,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
2310,720675,2,2,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
2311,720675,2,2,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
2312,720678,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
2313,720678,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
2314,720679,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
2315,720679,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
2316,720680,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
2317,720680,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
2318,720681,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
2319,720681,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
2320,720682,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
2321,720682,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
2322,720683,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
2323,720683,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
2324,720684,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
2325,720684,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
2326,720685,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
2327,720685,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
2328,720686,2,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
2329,720686,2,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
2330,720687,2,2,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
2331,720687,2,2,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
2332,720691,4,1,,144204425,10607,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2333,720691,4,1,,144210120,10607,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2334,720692,3,1,,144204425,10607,Inconclusive,311348376.0,2908.0,0.0425,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2335,720692,3,1,,144210120,10607,Inconclusive,311348376.0,2908.0,0.0155,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2336,720693,3,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
2337,720693,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
2338,720700,1,4,,56422495,10607,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
2339,720702,1,1,,56422495,10607,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
2340,720704,1,4,,56422495,10607,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
2341,720706,1,2,,56422495,10607,Inactive,,,,,HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2342,720707,1,2,,56463668,10607,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
2343,720708,1,2,,56463668,10607,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
2344,720709,1,2,,56463668,10607,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
2345,720711,1,2,,56463668,10607,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
2346,720717,1,3,,92125850,10607,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
2347,720717,1,3,,92308146,10607,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
2348,720719,2,1,,144204425,10607,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2349,720719,2,1,,144210120,10607,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2350,720725,2,1,,144204425,10607,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2351,720725,2,1,,144210120,10607,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2352,720848,1,2,,103168084,10607,Active,,,0.0145,IC50,Cytotoxicity against rat L6 cells after 70 hrs by resazurin reduction assay,Confirmatory,23301592.0,
2353,721432,1,2,,103168084,10607,Unspecified,,,,,Toxicity against rat L6 cells after 72 hrs by Alamar blue assay,Other,23313632.0,
2354,723339,1,2,,103168084,10607,Unspecified,,,,,Induction of cell cycle arrest in human A549 cells assessed as G2/M phase cells at 1 uM by FACS analysis (Rvb = 9.89%),Other,23182091.0,
2355,723341,1,2,,103168084,10607,Unspecified,,,,,Induction of cell cycle arrest in human A549 cells assessed as S phase cells at 1 uM by FACS analysis (Rvb = 3.69%),Other,23182091.0,
2356,723343,1,2,,103168084,10607,Unspecified,,,,,Induction of cell cycle arrest in human A549 cells assessed as G1 phase cells at 1 uM by FACS analysis (Rvb = 85.33%),Other,23182091.0,
2357,723345,1,2,,103168084,10607,Unspecified,,,,,Induction of cell cycle arrest in human A549 cells assessed as sub G1 phase cells at 1 uM by FACS analysis (Rvb = 1.08%),Other,23182091.0,
2358,723346,1,2,,103168084,10607,Active,,,2.8,IC50,Cytotoxicity against human HeLa cells after 72 hrs by MTT assay,Confirmatory,23182091.0,
2359,723347,1,2,,103168084,10607,Active,,,2.3,IC50,Cytotoxicity against human ACHN cells after 72 hrs by MTT assay,Confirmatory,23182091.0,
2360,723348,1,2,,103168084,10607,Active,,,2.5,IC50,Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay,Confirmatory,23182091.0,
2361,723349,1,2,,103168084,10607,Active,,,1.02,IC50,Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay,Confirmatory,23182091.0,
2362,723350,1,2,,103168084,10607,Active,,,3.6,IC50,Cytotoxicity against human A549 cells after 72 hrs by MTT assay,Confirmatory,23182091.0,
2363,725214,1,2,,103168084,10607,Active,,,0.019,IC50,Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay,Confirmatory,23265884.0,
2364,727327,1,3,,103168084,10607,Active,,,0.0145,IC50,Toxicity against rat L6 cells after 72 hrs by Alamar blue assay,Confirmatory,23360309.0,
2365,732345,1,2,,103168084,10607,Active,,,0.009000000000000001,EC50,Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay,Confirmatory,23517371.0,
2366,732423,1,3,,103168084,10607,Active,,,0.0193,IC50,Cytotoxicity against rat L6 cells after 72 hrs by fluorometric analysis,Confirmatory,24900574.0,
2367,736389,1,2,,103168084,10607,Active,,,0.008,IC50,Cytotoxicity against rat L6 cells after 70 hrs by microscopic analysis,Confirmatory,23320609.0,
2368,740948,1,2,,103168084,10607,Active,,,0.017,IC50,Cytotoxicity against african green monkey Vero cells,Confirmatory,23167812.0,
2369,740949,1,2,,103168084,10607,Inconclusive,,,,IC50,Antitrypanosomal activity against Trypanosoma brucei brucei blood-stream forms,Confirmatory,23167812.0,
2370,740950,1,2,,103168084,10607,Inconclusive,,,,IC50,Antileishmanial activity against Leishmania donovani,Confirmatory,23167812.0,
2371,740951,1,3,,103168084,10607,Inconclusive,,,,IC50,Antimalarial activity against erythrocyte stage Plasmodium falciparum 3D7,Confirmatory,23167812.0,
2372,743012,3,1,,144204425,10607,Active,,,0.0266,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
2373,743012,3,1,,144210120,10607,Active,,,0.0243,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
2374,743014,3,1,,144204425,10607,Active,,,0.0298,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
2375,743014,3,1,,144210120,10607,Active,,,0.0193,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
2376,743015,3,1,,144204425,10607,Active,,,0.0298,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
2377,743015,3,1,,144210120,10607,Active,,,0.0217,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
2378,743020,1,2,,56422495,10607,Inconclusive,,,,AC50_uM,Counterscreen:CMV reporter Measured in Cell-Based System Using Plate Reader - 7054-04_Inhibitor_Dose_DryPowder_Activity,Confirmatory,,
2379,743021,1,2,,56422495,10607,Inactive,,,,AC50_uM,PAX8: non-specific cytotoxicity Measured in Cell-Based System Using Plate Reader - 7054-05_Inhibitor_Dose_DryPowder_Activity,Confirmatory,,
2380,743033,3,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
2381,743033,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
2382,743035,2,1,,144204425,10607,Active,124375976.0,367.0,0.0379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2383,743035,2,1,,144210120,10607,Inconclusive,124375976.0,367.0,0.0275,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2384,743036,2,1,,144204425,10607,Inconclusive,124375976.0,367.0,0.019,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2385,743036,2,1,,144210120,10607,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2386,743040,3,1,,144204425,10607,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2387,743040,3,1,,144210120,10607,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2388,743041,3,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
2389,743041,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
2390,743042,3,1,,144204425,10607,Inactive,124375976.0,367.0,1.6785,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2391,743042,3,1,,144210120,10607,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2392,743053,2,1,,144204425,10607,Inconclusive,124375976.0,367.0,0.0213138,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2393,743053,2,1,,144210120,10607,Inconclusive,124375976.0,367.0,0.012295200000000001,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2394,743054,2,1,,144204425,10607,Inconclusive,124375976.0,367.0,0.0943918,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
2395,743054,2,1,,144210120,10607,Inconclusive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
2396,743063,2,1,,144204425,10607,Active,124375976.0,367.0,0.036474900000000005,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2397,743063,2,1,,144210120,10607,Active,124375976.0,367.0,0.0180469,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2398,743064,3,1,,144204425,10607,Inconclusive,,,0.0335,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
2399,743064,3,1,,144210120,10607,Active,,,0.0432,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
2400,743065,3,1,,144204425,10607,Active,399498506.0,24831.0,0.0298,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2401,743065,3,1,,144210120,10607,Active,399498506.0,24831.0,0.0243,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2402,743066,3,1,,144204425,10607,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2403,743066,3,1,,144210120,10607,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2404,743067,2,1,,144204425,10607,Active,399498506.0,24831.0,0.027644,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
2405,743067,2,1,,144210120,10607,Inconclusive,399498506.0,24831.0,0.0159398,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
2406,743069,2,1,,144204425,10607,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2407,743069,2,1,,144210120,10607,Inconclusive,348019627.0,2099.0,0.0195,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2408,743074,2,1,,144204425,10607,Inconclusive,,,0.0169,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
2409,743074,2,1,,144210120,10607,Inconclusive,,,0.011000000000000001,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
2410,743075,2,1,,144204425,10607,Inconclusive,348019627.0,2099.0,0.0425,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2411,743075,2,1,,144210120,10607,Inconclusive,348019627.0,2099.0,0.0123,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2412,743077,2,1,,144204425,10607,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2413,743077,2,1,,144210120,10607,Inconclusive,348019627.0,2099.0,0.02597,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2414,743078,2,1,,144204425,10607,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2415,743078,2,1,,144210120,10607,Inconclusive,348019627.0,2099.0,0.0194866,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2416,743079,3,1,,144204425,10607,Inactive,348019627.0,2099.0,0.0668,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2417,743079,3,1,,144210120,10607,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2418,743080,3,1,,144204425,10607,Active,348019627.0,2099.0,0.2985,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2419,743080,3,1,,144210120,10607,Active,348019627.0,2099.0,0.0137,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2420,743081,3,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
2421,743081,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
2422,743083,3,1,,144204425,10607,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
2423,743083,3,1,,144210120,10607,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
2424,743084,3,1,,144204425,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
2425,743084,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
2426,743085,3,1,,144204425,10607,Inconclusive,51095037.0,196.0,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
2427,743085,3,1,,144210120,10607,Inconclusive,51095037.0,196.0,27.2783,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
2428,743086,3,1,,144204425,10607,Inconclusive,,,0.0944,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
2429,743086,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
2430,743091,2,1,,144204425,10607,Active,348019627.0,2099.0,0.101922,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
2431,743091,2,1,,144210120,10607,Active,348019627.0,2099.0,0.0144816,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
2432,743094,3,1,,144204425,10607,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2433,743094,3,1,,144210120,10607,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2434,743122,2,1,,144204425,10607,Inconclusive,51095037.0,196.0,4.73079,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
2435,743122,2,1,,144210120,10607,Active,51095037.0,196.0,13.6715,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
2436,743126,1,1,,56422495,10607,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
2437,743139,2,1,,144204425,10607,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
2438,743139,2,1,,144210120,10607,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
2439,743140,2,1,,144204425,10607,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2440,743140,2,1,,144210120,10607,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2441,743191,3,1,,144210120,10607,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2442,743191,3,1,,170464788,10607,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2443,743194,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
2444,743194,3,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
2445,743199,2,1,,144210120,10607,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2446,743199,2,1,,170464788,10607,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2447,743202,4,1,,144210120,10607,Inconclusive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
2448,743202,4,1,,170464788,10607,Inconclusive,20149576.0,4780.0,0.1188,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
2449,743203,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
2450,743203,3,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
2451,743209,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
2452,743209,3,1,,170464788,10607,Inconclusive,,,0.0211,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
2453,743210,4,1,,144210120,10607,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
2454,743210,4,1,,170464788,10607,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
2455,743211,3,1,,144210120,10607,Inconclusive,,,0.0309,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2456,743211,3,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2457,743212,3,1,,144210120,10607,Inconclusive,216409690.0,5467.0,0.0174,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2458,743212,3,1,,170464788,10607,Inconclusive,216409690.0,5467.0,0.3758,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2459,743213,3,1,,144210120,10607,Inconclusive,,,0.0087,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2460,743213,3,1,,170464788,10607,Inconclusive,,,0.2371,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2461,743215,3,1,,144210120,10607,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2462,743215,3,1,,170464788,10607,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2463,743217,3,1,,144210120,10607,Inconclusive,325495553.0,9971.0,0.0436,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2464,743217,3,1,,170464788,10607,Inconclusive,325495553.0,9971.0,0.1059,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2465,743218,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2466,743218,3,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2467,743219,3,1,,144210120,10607,Inconclusive,20149576.0,4780.0,0.024311799999999998,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
2468,743219,3,1,,170464788,10607,Inconclusive,20149576.0,4780.0,0.141221,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
2469,743220,3,1,,144210120,10607,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2470,743220,3,1,,170464788,10607,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2471,743221,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2472,743221,3,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2473,743222,3,1,,144210120,10607,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2474,743222,3,1,,170464788,10607,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2475,743223,3,1,,144210120,10607,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2476,743223,3,1,,170464788,10607,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2477,743224,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2478,743224,3,1,,170464788,10607,Inconclusive,,,0.006,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2479,743225,3,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2480,743225,3,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2481,743226,2,1,,144210120,10607,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2482,743226,2,1,,170464788,10607,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2483,743227,2,1,,144210120,10607,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2484,743227,2,1,,170464788,10607,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2485,743228,3,1,,144210120,10607,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
2486,743228,3,1,,170464788,10607,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
2487,743238,1,1,,56422495,10607,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
2488,743239,2,1,,144210120,10607,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2489,743239,2,1,,170464788,10607,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2490,743240,2,1,,144210120,10607,Active,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2491,743240,2,1,,170464788,10607,Active,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2492,743241,2,1,,144210120,10607,Inconclusive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2493,743241,2,1,,170464788,10607,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2494,743242,2,1,,144210120,10607,Active,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2495,743242,2,1,,170464788,10607,Active,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2496,743244,1,1,,50103983,10607,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
2497,743244,1,1,,144204425,10607,Inconclusive,,,10.0,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
2498,743247,1,2,,56422495,10607,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2499,743255,1,1,,56463668,10607,Inconclusive,118600387.0,7398.0,31.6228,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
2500,743266,1,2,,56463668,10607,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
2501,743268,1,1,,172080798,10607,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-labeled substrate oligonucliotide bound to E. coli SSB,Screening,,
2502,743269,1,1,,56422495,10607,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
2503,743269,1,1,,56422495,10607,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
2504,743270,1,1,,172080798,10607,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening  assay of the NIH Clinical Collections to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
2505,743271,1,1,,172080798,10607,Inactive,,,,,Biochemical high throughput counterscreening assay of the NIH Clinical Collection for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3): fluorescence polarization based assay to identify compounds that can displace E. coli single stranded binding protein,Screening,,
2506,743272,1,1,,172080798,10607,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: a biochemical high-throughput screening assay to identify compounds that cause fluorescent interference,Screening,,
2507,743279,1,2,,56463668,10607,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
2508,743322,2,1,,50103983,10607,Inactive,,,0.0017,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
2509,743322,2,1,,174007436,10607,Inactive,,,9.4329,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
2510,743323,2,1,,50103983,10607,Inactive,,,1.3324,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
2511,743323,2,1,,174007436,10607,Inactive,,,13.3244,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
2512,743324,2,1,,50103983,10607,Inactive,,,0.0017,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
2513,743324,2,1,,174007436,10607,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
2514,743344,1,1,,174007436,10607,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
2515,743345,1,1,,174007436,10607,Inactive,,,0.0015,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
2516,743346,1,1,,174007436,10607,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
2517,743347,1,1,,174007436,10607,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
2518,743397,1,1,,56422495,10607,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2519,743398,1,1,,56422495,10607,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
2520,748432,1,2,,103168084,10607,Active,,,0.001,IC50,Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay,Confirmatory,24900706.0,
2521,753998,1,1,,103168084,10607,Active,,,0.0145,IC50,Cytotoxicity against rat L6 cells assessed as growth inhibition after 70 hrs by Alamar blue staining-based inverted microscopic analysis,Confirmatory,23685569.0,
2522,754082,1,1,,103168084,10607,Unspecified,,,,,Solubility of the compound in water,Other,23711769.0,
2523,756583,1,2,,103168084,10607,Active,,,3.71,IC50,Competitive binding affinity to pig brain tubulin colchicine binding site after 1 hr by mass spectrophotometric analysis in presence of colchicine,Confirmatory,23750455.0,
2524,756886,1,2,,103168084,10607,Active,,,0.017,IC50,Cytotoxicity against rat L6 cells after 72 hrs by Alamar Blue assay,Confirmatory,23795673.0,
2525,760220,1,3,,103168084,10607,Active,,,0.0007,IC50,Cytotoxicity against human KB cells after 72 hrs by Alamar blue assay,Confirmatory,24900724.0,
2526,760424,1,2,,103168084,10607,Active,,,0.02,IC50,Cytotoxicity against rat L6 cells after 70 hrs by Alamar Blue assay,Confirmatory,24900723.0,
2527,762340,1,1,,103168084,10607,Active,,,,IC50,Cytotoxicity against rat L6 cells after 70 hrs by Alamar blue assay,Confirmatory,23831695.0,
2528,765718,1,2,,103168084,10607,Active,,,19.0,IC50,Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay,Confirmatory,23871911.0,
2529,766747,1,1,,103168084,10607,Active,,,0.012,EC50,Cytotoxicity against rat L6 cells after 72 hrs by Alamar Blue assay,Confirmatory,23916149.0,
2530,771677,1,1,,103168084,10607,Active,,,0.006,IC50,Cytotoxicity against rat L6 cells assessed as growth inhibition after 72 hrs by fluorometric analysis,Confirmatory,24063369.0,
2531,774784,1,1,,103168084,10607,Active,,,0.01,IC50,Cytotoxicity against rat L6 cells,Confirmatory,23968432.0,
2532,931696,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S020923,Other,,
2533,931697,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S020923,Other,,
2534,931698,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S020923,Other,,
2535,931699,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S020923,Other,,
2536,931700,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S020923,Other,,
2537,931701,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S020923,Other,,
2538,931702,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S020923,Other,,
2539,931703,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S020923,Other,,
2540,931704,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S020923,Other,,
2541,931705,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S020923",Other,,
2542,931706,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S020923,Other,,
2543,933723,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S020923,Other,,
2544,933724,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S020923,Other,,
2545,933725,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S020923,Other,,
2546,933726,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S020923,Other,,
2547,933727,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S020923,Other,,
2548,933728,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S020923,Other,,
2549,933729,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S020923,Other,,
2550,933730,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S020923,Other,,
2551,936372,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S020923,Other,,
2552,936373,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S020923,Other,,
2553,936374,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S020923,Other,,
2554,936375,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S020923,Other,,
2555,936376,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S020923,Other,,
2556,936377,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S020923,Other,,
2557,936378,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S020923,Other,,
2558,936379,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S020923,Other,,
2559,936380,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S020923,Other,,
2560,936381,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S020923,Other,,
2561,936382,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S020923,Other,,
2562,936383,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S020923,Other,,
2563,936384,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S020923,Other,,
2564,936385,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S020923,Other,,
2565,946437,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S020923,Other,,
2566,946438,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S020923",Other,,
2567,946439,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S020923,Other,,
2568,946440,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S020923,Other,,
2569,946441,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S020923,Other,,
2570,960049,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S020923,Other,,
2571,960050,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S020923,Other,,
2572,960051,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S020923,Other,,
2573,965406,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S020923,Other,,
2574,965407,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S020923,Other,,
2575,965408,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S020923,Other,,
2576,965409,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S020923,Other,,
2577,965410,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S020923,Other,,
2578,965411,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S020923,Other,,
2579,966792,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S020923,Other,,
2580,966793,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S020923,Other,,
2581,966794,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S020923,Other,,
2582,966795,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S020923,Other,,
2583,966796,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S020923,Other,,
2584,966797,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S020923,Other,,
2585,966798,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S020923,Other,,
2586,966799,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S020923,Other,,
2587,966800,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S020923,Other,,
2588,966801,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S020923,Other,,
2589,970098,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S020923,Other,,
2590,970099,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S020923,Other,,
2591,970100,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S020923,Other,,
2592,970101,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S020923,Other,,
2593,970102,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S020923,Other,,
2594,970103,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S020923,Other,,
2595,970104,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S020923,Other,,
2596,970105,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S020923,Other,,
2597,970106,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S020923,Other,,
2598,970107,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S020923,Other,,
2599,970108,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S020923,Other,,
2600,970109,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S020923,Other,,
2601,970110,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S020923,Other,,
2602,970111,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S020923,Other,,
2603,970112,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S020923,Other,,
2604,970113,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S020923,Other,,
2605,970114,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S020923,Other,,
2606,970115,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S020923,Other,,
2607,970116,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S020923,Other,,
2608,977599,1,1,,103168084,10607,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
2609,977602,1,2,,103168084,10607,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
2610,1005765,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Autolysis; Study_ID: S020923,Other,,
2611,1005766,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S020923",Other,,
2612,1005767,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: S020923",Other,,
2613,1005768,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Erythrophagocytosis; Study_ID: S020923",Other,,
2614,1005769,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: S020923",Other,,
2615,1005770,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S020923",Other,,
2616,1005771,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S020923",Other,,
2617,1005772,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S020923",Other,,
2618,1005773,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Polymorphonuclear Cell; Study_ID: S020923",Other,,
2619,1005774,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Mononuclear Cell; Study_ID: S020923",Other,,
2620,1005775,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Mineralization; Study_ID: S020923",Other,,
2621,1012500,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Dilatation; Study_ID: S020923",Other,,
2622,1012501,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020923",Other,,
2623,1012502,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: S020923",Other,,
2624,1012503,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S020923",Other,,
2625,1012504,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Multinucleated; Study_ID: S020923",Other,,
2626,1012505,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Malignant Lymphoma; Study_ID: S020923,Other,,
2627,1012506,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020923",Other,,
2628,1012507,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S020923",Other,,
2629,1012508,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Inflammation, Subacute; Study_ID: S020923",Other,,
2630,1012509,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Urothelial Hyperplasia; Study_ID: S020923",Other,,
2631,1012510,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Regeneration; Study_ID: S020923",Other,,
2632,1012511,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Degeneration; Study_ID: S020923",Other,,
2633,1012512,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: S020923",Other,,
2634,1012513,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Oval Cell, Hyperplasia; Study_ID: S020923",Other,,
2635,1012514,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Fibrosis; Study_ID: S020923",Other,,
2636,1012515,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Deposit; Study_ID: S020923",Other,,
2637,1012516,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Dilatation; Study_ID: S020923",Other,,
2638,1012517,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Hyaline Droplets; Study_ID: S020923",Other,,
2639,1012518,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Necrosis; Study_ID: S020923",Other,,
2640,1012519,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Cyst(S); Study_ID: S020923",Other,,
2641,1012520,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Thrombus; Study_ID: S020923",Other,,
2642,1012521,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: S020923,Other,,
2643,1012522,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Cytoplasm, Eosinophilia; Study_ID: S020923",Other,,
2644,1012523,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Granulomatous; Study_ID: S020923",Other,,
2645,1012524,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Cyst(S); Study_ID: S020923",Other,,
2646,1013106,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Autolysis; Study_ID: S020923,Other,,
2647,1013107,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct, Necrosis, Oncocytic; Study_ID: S020923",Other,,
2648,1013108,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Glycogen Accumulation; Study_ID: S020923",Other,,
2649,1013109,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S020923",Other,,
2650,1013110,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S020923",Other,,
2651,1013111,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S020923",Other,,
2652,1013112,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Edema; Study_ID: S020923",Other,,
2653,1013113,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Cast, Proteinaceous; Study_ID: S020923",Other,,
2654,1014346,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Tubule, Regeneration; Study_ID: S020923",Other,,
2655,1014347,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Dilatation; Study_ID: S020923,Other,,
2656,1014929,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Mesothelial Cell, Hyperplasia; Study_ID: S020923",Other,,
2657,1014930,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular Fibrosis; Study_ID: S020923,Other,,
2658,1014931,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Atrophy; Study_ID: S020923",Other,,
2659,1014932,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Cytoplasm, Eosinophilia; Study_ID: S020923",Other,,
2660,1014933,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S020923",Other,,
2661,1014934,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Mineralization; Study_ID: S020923",Other,,
2662,1014935,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S020923",Other,,
2663,1014936,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S020923",Other,,
2664,1014937,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Apoptotic; Study_ID: S020923",Other,,
2665,1014938,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Mineralization; Study_ID: S020923",Other,,
2666,1014939,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S020923",Other,,
2667,1014940,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Tubule, Dilatation; Study_ID: S020923",Other,,
2668,1014941,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Nephropathy; Study_ID: S020923,Other,,
2669,1014942,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020923",Other,,
2670,1014943,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Apoptotic; Study_ID: S020923",Other,,
2671,1014944,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Cytoplasm, Eosinophilia; Study_ID: S020923",Other,,
2672,1014945,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Macrovesicular; Study_ID: S020923",Other,,
2673,1014946,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Microvesicular; Study_ID: S020923",Other,,
2674,1014947,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Apoptotic; Study_ID: S020923",Other,,
2675,1014948,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S020923",Other,,
2676,1014949,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: S020923",Other,,
2677,1014950,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S020923",Other,,
2678,1014951,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: S020923",Other,,
2679,1014952,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Macrovesicular; Study_ID: S020923",Other,,
2680,1014953,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Inflammation, Chronic; Study_ID: S020923",Other,,
2681,1014954,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Mineralization; Study_ID: S020923",Other,,
2682,1014955,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Necrosis; Study_ID: S020923",Other,,
2683,1014956,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: S020923,Other,,
2684,1014957,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: S020923,Other,,
2685,1014958,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S020923",Other,,
2686,1014959,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S020923",Other,,
2687,1014960,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020923",Other,,
2688,1014961,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: S020923",Other,,
2689,1014962,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Vacuolation; Study_ID: S020923",Other,,
2690,1014963,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Fibrosis; Study_ID: S020923",Other,,
2691,1014964,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Mineralization; Study_ID: S020923",Other,,
2692,1014965,1,3,,103168084,10607,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Cyst(S); Study_ID: S020923",Other,,
2693,1014966,1,3,,103168084,10607,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: S020923,Other,,
2694,1053188,2,1,,56422495,10607,Inactive,,,,,Primary Screen Inhibitors of CD40 Signaling in BL2 Cells Measured in Cell-Based System Using Plate Reader - 7124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2695,1053194,1,1,,50103983,10607,Inactive,,,,Potency,Cell Proliferation Assay Versus the ED40515 IL2 Independent  ATL cell lines,Confirmatory,,
2696,1053195,1,1,,50103983,10607,Inactive,,,,Potency,Cell Proliferation Assay Versus the ED40515 IL2 Dependent  ATL cell lines,Confirmatory,,
2697,1053197,1,1,,56422495,10607,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
2698,1057257,1,1,,103168084,10607,Inconclusive,,,,,"Therapeutic index, ratio of IC50 for human KB cells to IC50 for chloroquine-resistant Plasmodium falciparum K1",Other,24148834.0,
2699,1057258,1,1,,103168084,10607,Active,,,0.0117,IC50,Cytotoxicity against human KB cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,24148834.0,
2700,1057259,1,1,,103168084,10607,Inconclusive,,,,IC50,Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 assessed as parasite growth inhibition after 48 hrs by SYBR green-1 dye-based fluorescence assay,Confirmatory,24148834.0,
2701,1062627,1,2,,103168084,10607,Active,,,0.017,IC50,Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay,Confirmatory,24268543.0,
2702,1067817,1,2,,103168084,10607,Active,,,0.013999999999999999,CC50,Cytotoxicity against rat L6 cells after 48 hrs by Alamar Blue assay,Confirmatory,24354316.0,
2703,1069844,1,2,,103168084,10607,Unspecified,,,50.0,IC50,Cytotoxicity against human HEK293 cells after 24 hrs by MTT assay,Confirmatory,24457094.0,
2704,1069845,1,2,,103168084,10607,Unspecified,,,64.99,IC50,Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay,Confirmatory,24457094.0,
2705,1069846,1,2,,103168084,10607,Active,,,35.7,IC50,Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay,Confirmatory,24457094.0,
2706,1070507,1,2,,103168084,10607,Active,,,0.017,IC50,Cytotoxicity against rat L6 cells assessed as growth inhibition after 70 hrs by Alamar Blue assay,Confirmatory,24471526.0,
2707,1082996,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against pre-third-instar larvae of Mythimna separata (Oriental armyworm) in wheat leaves at 1 mg/mL after 33 days by leaf-dipping method,Other,22891988.0,
2708,1082997,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against pre-third-instar larvae of Mythimna separata (Oriental armyworm) in wheat leaves at 1 mg/mL after 20 days by leaf-dipping method,Other,22891988.0,
2709,1082998,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against pre-third-instar larvae of Mythimna separata (Oriental armyworm) in wheat leaves at 1 mg/mL after 5 days by leaf-dipping method,Other,22891988.0,
2710,1091892,1,1,,103168084,10607,Unspecified,,,,,In vivo insecticidal activity against pre-third-instar larval stage of Mythimna separata (Oriental armyworm) in corn leaves assessed as corrected mortality rate at 1 mg/ml treated for 3 secs before larval infestation on corn leaves measured after 33 days by leaf-dipping method,Other,20584606.0,
2711,1091893,1,1,,103168084,10607,Unspecified,,,,,In vivo insecticidal activity against pre-third-instar larval stage of Mythimna separata (Oriental armyworm) in corn leaves assessed as corrected mortality rate at 1 mg/ml treated for 3 secs before larval infestation on corn leaves measured after 20 days by leaf-dipping method,Other,20584606.0,
2712,1091894,1,1,,103168084,10607,Unspecified,,,,,In vivo insecticidal activity against pre-third-instar larval stage of Mythimna separata (Oriental armyworm) in corn leaves assessed as corrected mortality rate at 1 mg/ml treated for 3 secs before larval infestation on corn leaves measured after 10 days by leaf-dipping method,Other,20584606.0,
2713,1092096,1,1,,103168084,10607,Unspecified,,,,,In vivo insecticidal activity against pre-third-instar larval stage of Mythimna separata (Oriental armyworm) in corn leaves assessed as corrected mortality rate at 1 mg/ml treated for 3 secs before larval infestation on corn leaves measured after 35 days by leaf-dipping method,Other,21835617.0,
2714,1092097,1,1,,103168084,10607,Unspecified,,,,,In vivo insecticidal activity against pre-third-instar larval stage of Mythimna separata (Oriental armyworm) in corn leaves assessed as corrected mortality rate at 1 mg/ml treated for 3 secs before larval infestation on corn leaves measured after 20 days by leaf-dipping method,Other,21835617.0,
2715,1092098,1,1,,103168084,10607,Unspecified,,,,,In vivo insecticidal activity against pre-third-instar larval stage of Mythimna separata (Oriental armyworm) in corn leaves assessed as corrected mortality rate at 1 mg/ml treated for 3 secs before larval infestation on corn leaves measured after 10 days by leaf-dipping method,Other,21835617.0,
2716,1098477,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against Mythimna separata (Oriental armyworm) pre-third-instar larvae fed on 1 mg/ml compound pre-treated wheat leaves assessed as insect mortality by leaf-dipping method,Other,23731643.0,
2717,1098478,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against Mythimna separata (Oriental armyworm) pre-third-instar larvae fed on 1 mg/ml compound pre-treated wheat leaves assessed as insect mortality measured after 34 days by leaf-dipping method,Other,23731643.0,
2718,1098479,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against Mythimna separata (Oriental armyworm) pre-third-instar larvae fed on 1 mg/ml compound pre-treated wheat leaves assessed as insect mortality measured after 20 days by leaf-dipping method,Other,23731643.0,
2719,1098480,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against Mythimna separata (Oriental armyworm) pre-third-instar larvae fed on 1 mg/ml compound pre-treated wheat leaves assessed as insect mortality measured after 10 days by leaf-dipping method,Other,23731643.0,
2720,1101794,1,1,,103168084,10607,Active,,,,,Insecticidal activity against fifth-instar larvae of Pieris rapae fed on compound treated cabbage leaf assessed as delay in metamorophosis at 250 ppm dipped for 3 secs relative to control,Other,11911206.0,
2721,1101795,1,1,,103168084,10607,Active,,,,,Insecticidal activity against fifth-instar larvae of Pieris rapae fed on compound treated cabbage leaf assessed as inhibition of reproduction in pupated adultoids at 250 ppm dipped for 3 secs relative to control,Other,11911206.0,
2722,1101796,1,1,,103168084,10607,Active,,,,,Insecticidal activity against fifth-instar larvae of Pieris rapae fed on compound treated cabbage leaf assessed as immobilization at 250 ppm dipped for 3 secs measured after 48 hr relative to control,Other,11911206.0,
2723,1101797,1,1,,103168084,10607,Active,,,,,Insecticidal activity against fifth-instar larvae of Pieris rapae fed on compound treated cabbage leaf assessed as loss of body fluid at 250 ppm dipped for 3 secs measured after 48 hr relative to control,Other,11911206.0,
2724,1101798,1,1,,103168084,10607,Active,,,,,Insecticidal activity against fifth-instar larvae of Pieris rapae fed on compound treated cabbage leaf assessed as paralysis at 250 ppm dipped for 3 secs measured after 48 hr relative to control,Other,11911206.0,
2725,1101799,1,1,,103168084,10607,Active,,,,,Insecticidal activity against fifth-instar larvae of Pieris rapae fed on compound treated cabbage leaf assessed as change in spontaneous movement at 250 ppm dipped for 3 secs measured after 24 hr relative to control,Other,11911206.0,
2726,1101800,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against fifth-instar larvae of Pieris rapae fed on compound treated cabbage leaf assessed as mortality at 250 ppm dipped for 3 secs measured after 15 days (Rvb = 10 1.22%),Other,11911206.0,
2727,1101801,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against fifth-instar larvae of Pieris rapae fed on compound treated cabbage leaf assessed as mortality at 250 ppm dipped for 3 secs measured after 10 days (Rvb = 6.67 1.56%),Other,11911206.0,
2728,1101802,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against fifth-instar larvae of Pieris rapae fed on compound treated cabbage leaf assessed as mortality at 250 ppm dipped for 3 secs measured after 5 days (Rvb = 0%),Other,11911206.0,
2729,1112939,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against pre-third-instar larvae of Mythimna separata (Oriental armyworm) assessed as corrected mortality rate at 1 mg/ml measured after 35 days by the leaf-dipping method,Other,23278333.0,
2730,1112940,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against pre-third-instar larvae of Mythimna separata (Oriental armyworm) assessed as corrected mortality rate at 1 mg/ml measured after 20 days by the leaf-dipping method,Other,23278333.0,
2731,1112941,1,1,,103168084,10607,Unspecified,,,,,Insecticidal activity against pre-third-instar larvae of Mythimna separata (Oriental armyworm) assessed as corrected mortality rate at 1 mg/ml measured after 10 days by the leaf-dipping method,Other,23278333.0,
2732,1117298,1,2,,170464788,10607,Inactive,,,50.1187,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
2733,1117304,1,2,,170464788,10607,Active,,,11.2202,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
2734,1117305,1,2,,170464788,10607,Active,,,5.0119,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
2735,1117310,1,1,,170464788,10607,Inactive,,,50.1187,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
2736,1117312,1,1,,170464788,10607,Active,,,5.01187,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
2737,1117314,1,1,,170464788,10607,Inactive,,,11.2202,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
2738,1117319,1,2,,855658,10607,Inconclusive,9629361.0,155459.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
2739,1117319,1,2,,855658,10607,Inconclusive,13399304.0,60489.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
2740,1117324,1,1,,170464788,10607,Inactive,,,10.0,IC50,VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50,Confirmatory,,
2741,1117325,1,1,,170464788,10607,Active,,,0.0131,IC50,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50,Confirmatory,,
2742,1117326,1,1,,170464788,10607,Active,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
2743,1117327,1,1,,170464788,10607,Active,,,0.0091,IC50,alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50,Confirmatory,,
2744,1117328,1,1,,170464788,10607,Inactive,,,,,human p70S6K1 kinase inhibition-screen,Screening,,
2745,1117329,1,1,,170464788,10607,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
2746,1117336,1,1,,170464788,10607,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
2747,1117337,1,1,,170464788,10607,Active,,,0.0081,IC50,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50,Confirmatory,,
2748,1117340,1,1,,170464788,10607,Active,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
2749,1117341,1,1,,170464788,10607,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
2750,1117342,1,1,,170464788,10607,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
2751,1117343,1,1,,170464788,10607,Inactive,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
2752,1117346,1,1,,170464788,10607,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
2753,1117347,1,1,,170464788,10607,Active,,,0.0048,IC50,Decreased HeLa cell count-IC50,Confirmatory,,
2754,1117348,1,1,,170464788,10607,Inactive,,,10.0,IC50,Increased HeLa cells in S-phase-IC50,Confirmatory,,
2755,1117349,1,1,,170464788,10607,Active,,,0.0089,IC50,Increased HeLa cells with 2N DNA content-IC50,Confirmatory,,
2756,1117350,1,1,,170464788,10607,Active,,,0.0112,IC50,Increased chromatin condensation in HeLa cells-IC50,Confirmatory,,
2757,1117351,1,1,,170464788,10607,Active,,,0.0077,IC50,Increased HeLa cells with 4N DNA content-IC50,Confirmatory,,
2758,1117353,1,1,,170464788,10607,Inactive,,,,,human KDR kinase inhibition-screen,Screening,,
2759,1117354,1,1,,170464788,10607,Inactive,,,,,human JAK2 kinase inhibition-screen,Screening,,
2760,1117355,1,1,,170464788,10607,Inactive,,,,,human GSK3B kinase inhibition-screen,Screening,,
2761,1117356,1,1,,170464788,10607,Inactive,,,,,human FLT3 kinase inhibition-screen,Screening,,
2762,1118162,1,1,,103168084,10607,Active,,,0.1,IC50,Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,,
2763,1118163,1,1,,103168084,10607,Active,,,0.1,IC50,Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,,
2764,1118164,1,1,,103168084,10607,Active,,,0.1,IC50,Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,,
2765,1118165,1,2,,103168084,10607,Active,,,0.1,IC50,Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,,
2766,1118166,1,1,,103168084,10607,Active,,,0.1,IC50,Cytotoxicity against human SK-N-SH cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,,
2767,1120593,1,1,,103168084,10607,Active,,,0.02,IC50,Cytotoxicity against rat L6 cells,Confirmatory,,
2768,1123832,1,1,,103168084,10607,Active,,,0.6,ID50,Inhibition of chicken brain microtubule polymerization after 30 mins,Confirmatory,423203.0,
2769,1126160,1,1,,103168084,10607,Active,,,0.02,IC50,Cytotoxicity against rat L6 cells,Confirmatory,24673206.0,
2770,1126573,1,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against brine shrimps larvae assessed as mortality after 24 hrs,Other,24681067.0,
2771,1140203,1,2,,103168084,10607,Active,,,0.0145,IC50,Cytotoxicity against rat L6 cells after 70 hrs by Alamar Blue assay,Confirmatory,24721829.0,
2772,1140297,1,1,,103168084,10607,Active,,,3.09,IC50,Anticancer activity against human A549 cells after 48 hrs by MTT assay,Confirmatory,24721832.0,
2773,1140298,1,1,,103168084,10607,Active,,,2.29,IC50,Anticancer activity against human HT-29 cells after 48 hrs by MTT assay,Confirmatory,24721832.0,
2774,1140299,1,1,,103168084,10607,Active,,,1.93,IC50,Anticancer activity against human ACHN cells after 48 hrs by MTT assay,Confirmatory,24721832.0,
2775,1140300,1,2,,103168084,10607,Active,,,3.21,IC50,Anticancer activity against human DU145 cells after 48 hrs by MTT assay,Confirmatory,24721832.0,
2776,1140301,1,1,,103168084,10607,Active,,,2.81,IC50,Anticancer activity against human HeLa cells after 48 hrs by MTT assay,Confirmatory,24721832.0,
2777,1140310,1,3,,103168084,10607,Unspecified,20455316.0,7278.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2778,1140310,1,3,,103168084,10607,Unspecified,20455316.0,113457.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2779,1140310,1,3,,103168084,10607,Unspecified,20455322.0,84790.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2780,1140310,1,3,,103168084,10607,Unspecified,20455526.0,10381.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2781,1140310,1,3,,103168084,10607,Unspecified,55977474.0,10376.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2782,1140310,1,3,,103168084,10607,Unspecified,55977476.0,7277.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2783,1140310,1,3,,103168084,10607,Unspecified,55977480.0,10383.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2784,1140310,1,3,,103168084,10607,Unspecified,55977864.0,7846.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2785,1140310,1,3,,103168084,10607,Unspecified,56757569.0,203068.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2786,1140310,1,3,,103168084,10607,Unspecified,62903515.0,81027.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2787,1140310,1,3,,103168084,10607,Unspecified,68776070.0,84617.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2788,1140310,1,3,,103168084,10607,Unspecified,74761283.0,347733.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2789,1140310,1,3,,103168084,10607,Unspecified,74762137.0,7280.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2790,1140310,1,3,,103168084,10607,Unspecified,93141323.0,10382.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2791,1140310,1,3,,103168084,10607,Unspecified,182705285.0,347688.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2792,1140310,1,3,,103168084,10607,Unspecified,224471855.0,112714.0,,,Inhibition of tubulin (unknown origin) polymerization at 3 uM measured for 1 hr by fluorescence assay relative to control,Other,24721832.0,
2793,1140311,1,3,,103168084,10607,Active,20455316.0,7278.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2794,1140311,1,3,,103168084,10607,Active,20455316.0,113457.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2795,1140311,1,3,,103168084,10607,Active,20455322.0,84790.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2796,1140311,1,3,,103168084,10607,Active,20455526.0,10381.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2797,1140311,1,3,,103168084,10607,Active,55977474.0,10376.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2798,1140311,1,3,,103168084,10607,Active,55977476.0,7277.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2799,1140311,1,3,,103168084,10607,Active,55977480.0,10383.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2800,1140311,1,3,,103168084,10607,Active,55977864.0,7846.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2801,1140311,1,3,,103168084,10607,Active,56757569.0,203068.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2802,1140311,1,3,,103168084,10607,Active,62903515.0,81027.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2803,1140311,1,3,,103168084,10607,Active,68776070.0,84617.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2804,1140311,1,3,,103168084,10607,Active,74761283.0,347733.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2805,1140311,1,3,,103168084,10607,Active,74762137.0,7280.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2806,1140311,1,3,,103168084,10607,Active,93141323.0,10382.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2807,1140311,1,3,,103168084,10607,Active,182705285.0,347688.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2808,1140311,1,3,,103168084,10607,Active,224471855.0,112714.0,3.03,IC50,Inhibition of tubulin (unknown origin) polymerization measured for 1 hr by fluorescence assay,Confirmatory,24721832.0,
2809,1142159,1,1,,103168084,10607,Unspecified,,,,,Binding affinity to rat brain tubulin at 37 degC after 1 to 2 mins by DEAE cellulose filter paper method,Other,24773591.0,
2810,1143880,1,1,,103168084,10607,Active,,,0.013999999999999999,IC50,Cytotoxicity against rat L6 cells,Confirmatory,24865793.0,
2811,1148909,1,3,,103168084,10607,Unspecified,75053726.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 2 uM after 90 mins by liquid scintillation counting in presence of 20 uM [3H]colchicine,Other,812990.0,
2812,1148909,1,3,,103168084,10607,Unspecified,75053735.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 2 uM after 90 mins by liquid scintillation counting in presence of 20 uM [3H]colchicine,Other,812990.0,
2813,1148909,1,3,,103168084,10607,Unspecified,118573906.0,281555.0,,,Displacement of [3H]colchicine from bovine brain tubulin at 2 uM after 90 mins by liquid scintillation counting in presence of 20 uM [3H]colchicine,Other,812990.0,
2814,1148910,1,3,,103168084,10607,Unspecified,75053726.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 4 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2815,1148910,1,3,,103168084,10607,Unspecified,75053735.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 4 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2816,1148910,1,3,,103168084,10607,Unspecified,118573906.0,281555.0,,,Displacement of [3H]colchicine from bovine brain tubulin at 4 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2817,1148911,1,3,,103168084,10607,Unspecified,75053726.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 8 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2818,1148911,1,3,,103168084,10607,Unspecified,75053735.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 8 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2819,1148911,1,3,,103168084,10607,Unspecified,118573906.0,281555.0,,,Displacement of [3H]colchicine from bovine brain tubulin at 8 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2820,1148912,1,3,,103168084,10607,Unspecified,75053726.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 16 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2821,1148912,1,3,,103168084,10607,Unspecified,75053735.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 16 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2822,1148912,1,3,,103168084,10607,Unspecified,118573906.0,281555.0,,,Displacement of [3H]colchicine from bovine brain tubulin at 16 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2823,1148913,1,3,,103168084,10607,Unspecified,75053726.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 20 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2824,1148913,1,3,,103168084,10607,Unspecified,75053735.0,,,,Displacement of [3H]colchicine from bovine brain tubulin at 20 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2825,1148913,1,3,,103168084,10607,Unspecified,118573906.0,281555.0,,,Displacement of [3H]colchicine from bovine brain tubulin at 20 uM after 90 mins by liquid scintillation counting in presence of 10 uM [3H]colchicine,Other,812990.0,
2826,1148921,1,1,,103168084,10607,Unspecified,,,,,Inhibition of colony formation in BDF1 mouse bone marrow cells assessed as percentage of colony forming cell at 5 nM after 7 days by microscopic analysis relative to control,Other,812990.0,
2827,1148922,1,1,,103168084,10607,Unspecified,,,,,Inhibition of colony formation in BDF1 mouse bone marrow cells assessed as percentage of colony forming cell at 50 nM after 7 days by microscopic analysis relative to control,Other,812990.0,
2828,1148923,1,1,,103168084,10607,Unspecified,,,,,Inhibition of colony formation in BDF1 mouse bone marrow cells assessed as percentage of colony forming cell at 0.5 uM after 7 days by microscopic analysis relative to control,Other,812990.0,
2829,1148926,1,1,,103168084,10607,Unspecified,,,,,Inhibition of colony formation in mouse P815 cells assessed as percentage of colony forming cell at 5 nM after 7 days by microscopic analysis relative to control,Other,812990.0,
2830,1148927,1,1,,103168084,10607,Unspecified,,,,,Inhibition of colony formation in mouse P815 cells assessed as percentage of colony forming cell at 50 nM after 7 days by microscopic analysis relative to control,Other,812990.0,
2831,1148928,1,1,,103168084,10607,Unspecified,,,,,Inhibition of colony formation in mouse P815 cells assessed as percentage of colony forming cell at 0.5 uM after 7 days by microscopic analysis relative to control,Other,812990.0,
2832,1154489,3,1,,103168084,10607,Active,,,0.25,EC50,Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay,Confirmatory,24874647.0,
2833,1156603,1,1,,103168084,10607,Active,,,0.017,IC50,Cytotoxicity against rat L6 cells after 3 days by Alamar blue assay,Confirmatory,24956553.0,
2834,1159509,1,1,,144210120,10607,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2835,1159509,1,1,,170464788,10607,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2836,1159510,3,1,,50103983,10607,Active,,,0.0037,Potency,Immunotoxin (HA22) sensitization/mitigation study. Vehicle arm (PBS),Confirmatory,,
2837,1159511,3,1,,50103983,10607,Active,,,0.0053,Potency,Immunotoxin (SS1P) sensitization/mitigation study - treatment arm,Confirmatory,,
2838,1159512,3,1,,50103983,10607,Active,,,0.0033,Potency,Immunotoxin (HA22) sensitization/mitigation study - treatment arm (low dose),Confirmatory,,
2839,1159513,3,1,,50103983,10607,Active,,,0.0083,Potency,Immunotoxin (SS1P) sensitization/mitigation study. Vehicle arm (DMEM),Confirmatory,,
2840,1159515,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2841,1159515,1,1,,170464788,10607,Inconclusive,,,4.7716,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2842,1159516,1,1,,144210120,10607,Inconclusive,119611100.0,22926.0,0.0549,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2843,1159516,1,1,,170464788,10607,Inconclusive,119611100.0,22926.0,0.0535,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2844,1159517,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2845,1159517,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2846,1159518,1,1,,144210120,10607,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2847,1159518,1,1,,170464788,10607,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2848,1159519,1,1,,144210120,10607,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2849,1159519,1,1,,170464788,10607,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2850,1159520,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2851,1159520,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2852,1159521,1,1,,144210120,10607,Active,15928672.0,19885.0,0.0306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2853,1159521,1,1,,170464788,10607,Inconclusive,15928672.0,19885.0,0.0422,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2854,1159523,1,1,,144210120,10607,Active,15928672.0,19885.0,0.0318041,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2855,1159523,1,1,,170464788,10607,Active,15928672.0,19885.0,0.0133332,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2856,1159524,1,1,,50103983,10607,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
2857,1159524,1,1,,56463668,10607,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
2858,1159525,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2859,1159525,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2860,1159526,1,1,,144210120,10607,Inconclusive,119627033.0,3725.0,0.1548,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2861,1159526,1,1,,170464788,10607,Inconclusive,119627033.0,3725.0,0.1345,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2862,1159527,1,1,,144210120,10607,Inconclusive,325495497.0,6256.0,0.0195,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2863,1159527,1,1,,170464788,10607,Inconclusive,325495497.0,6256.0,0.0338,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2864,1159528,1,1,,144210120,10607,Active,119627033.0,3725.0,0.0939876,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2865,1159528,1,1,,170464788,10607,Active,119627033.0,3725.0,0.072777,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2866,1159529,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2867,1159529,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2868,1159530,2,1,,50103983,10607,Active,,,,Potency,Immunotoxin (HA22) sensitization/mitigation study - treatment arm (High Dose),Confirmatory,,
2869,1159531,1,1,,144210120,10607,Inconclusive,325495497.0,6256.0,0.0218644,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2870,1159531,1,1,,170464788,10607,Inconclusive,325495497.0,6256.0,0.0239145,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2871,1159550,3,1,,252402770,10607,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
2872,1159551,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2873,1159551,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2874,1159552,1,1,,144210120,10607,Inconclusive,325495463.0,5914.0,0.0306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2875,1159552,1,1,,170464788,10607,Inconclusive,325495463.0,5914.0,0.0335,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2876,1159553,2,1,,144210120,10607,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2877,1159553,2,1,,170464788,10607,Inconclusive,325495463.0,5914.0,0.0422,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2878,1159555,1,1,,144210120,10607,Inconclusive,325495463.0,5914.0,0.027278300000000002,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2879,1159555,1,1,,170464788,10607,Active,325495463.0,5914.0,0.017442199999999998,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2880,1159580,2,1,,268734424,10607,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
2881,1159606,1,1,,56463668,10607,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
2882,1159607,2,1,,312309883,10607,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
2883,1159614,1,2,,170464788,10607,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
2884,1159620,1,1,,103168084,10607,Active,,,,,Summary of drug indications.,Other,,
2885,1162946,1,1,,103168084,10607,Active,,,9.2,IC50,Antiplasmodial activity against Plasmodium falciparum 3D7 asexual blood stages after 3 days by HRP2 detection based ELISA method,Confirmatory,25195945.0,
2886,1162947,1,2,,103168084,10607,Active,,,8.3,IC50,Antiplasmodial activity against Plasmodium falciparum Dd2 asexual blood stages after 3 days by HRP2 detection based ELISA method,Confirmatory,25195945.0,
2887,1162948,1,1,,103168084,10607,Inconclusive,,,,IC50,Gametocytocidal activity against transgenic Plasmodium falciparum NF54-pfs16-GFP late stage gametocytes after 72 hrs by mitotracker red CM-H2XRos dye based confocal imaging assay,Confirmatory,25195945.0,
2888,1162949,1,1,,103168084,10607,Active,,,0.0097,IC50,Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay,Confirmatory,25195945.0,
2889,1162950,1,1,,103168084,10607,Unspecified,,,,,"Selectivity index, ratio of IC50 for rat L6 cells to IC50 for Plasmodium falciparum 3D7 asexual blood stages",Other,25195945.0,
2890,1168738,1,1,,103168084,10607,Inconclusive,,,,,Inhibition of rat intestinal alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside substrate by spectrophotometry,Other,25305717.0,
2891,1168739,1,1,,103168084,10607,Unspecified,,,,,Anticancer activity against human MCF7 cells after 24 hrs by MTT assay,Other,25305717.0,
2892,1168740,1,1,,103168084,10607,Unspecified,,,,,Anticancer activity against human MDA-MB cells after 24 hrs by MTT assay,Other,25305717.0,
2893,1168741,1,1,,103168084,10607,Unspecified,,,,,Anticancer activity against human HeLa cells after 24 hrs by MTT assay,Other,25305717.0,
2894,1168742,1,1,,103168084,10607,Unspecified,,,,,Cytotoxic activity against HEK293 cells after 24 hrs by MTT assay,Other,25305717.0,
2895,1168743,1,1,,103168084,10607,Unspecified,,,,,Anticancer activity against human A498 cells after 24 hrs by MTT assay,Other,25305717.0,
2896,1168744,1,1,,103168084,10607,Unspecified,,,,,Anticancer activity against human K562 cells after 24 hrs by MTT assay,Other,25305717.0,
2897,1168745,1,1,,103168084,10607,Unspecified,,,,,Anticancer activity against human SH-SY5Y cells after 24 hrs by MTT assay,Other,25305717.0,
2898,1168746,1,1,,103168084,10607,Unspecified,,,,,Anticancer activity against human WRL68 cells after 24 hrs by MTT assay,Other,25305717.0,
2899,1168747,1,1,,103168084,10607,Inconclusive,,,,,Cytotoxicty against rat NRK cells after 24 hrs by MTT assay,Other,25305717.0,
2900,1168748,1,1,,103168084,10607,Unspecified,,,,,Induction of hemolysis in human erythrocytes assessed as mean erythrocyte fragility by measuring level of hemolysis at 50% PBS at 100 ug/mL by spectrophotomtery based erythrocyte osmotic fragility assay,Other,25305717.0,
2901,1169289,1,1,,103168084,10607,Active,,,0.02,IC50,Cytotoxicity against rat L6 cells,Confirmatory,25314007.0,
2902,1172520,1,1,,103168084,10607,Unspecified,,,,,Cytotoxicity in brine shrimps larvae assessed as mortality after 24 hrs,Other,25440883.0,
2903,1174229,1,1,,103168084,10607,Active,,,13.62,IC50,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,Confirmatory,25462233.0,
2904,1174230,1,2,,103168084,10607,Unspecified,,,100.0,IC50,Cytotoxicity against human DU145 cells after 48 hrs by MTT assay,Confirmatory,25462233.0,
2905,1174231,1,1,,103168084,10607,Active,,,2.27,IC50,Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay,Confirmatory,25462233.0,
2906,1174232,1,1,,103168084,10607,Active,,,7.58,IC50,Cytotoxicity against human HeLa cells after 48 hrs by MTT assay,Confirmatory,25462233.0,
2907,1174241,1,2,,103168084,10607,Unspecified,20455316.0,7278.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2908,1174241,1,2,,103168084,10607,Unspecified,20455316.0,113457.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2909,1174241,1,2,,103168084,10607,Unspecified,20455322.0,84790.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2910,1174241,1,2,,103168084,10607,Unspecified,20455526.0,10381.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2911,1174241,1,2,,103168084,10607,Unspecified,55977474.0,10376.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2912,1174241,1,2,,103168084,10607,Unspecified,55977476.0,7277.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2913,1174241,1,2,,103168084,10607,Unspecified,55977480.0,10383.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2914,1174241,1,2,,103168084,10607,Unspecified,55977864.0,7846.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2915,1174241,1,2,,103168084,10607,Unspecified,56757569.0,203068.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2916,1174241,1,2,,103168084,10607,Unspecified,62903515.0,81027.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2917,1174241,1,2,,103168084,10607,Unspecified,68776070.0,84617.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2918,1174241,1,2,,103168084,10607,Unspecified,74761283.0,347733.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2919,1174241,1,2,,103168084,10607,Unspecified,74762137.0,7280.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2920,1174241,1,2,,103168084,10607,Unspecified,93141323.0,10382.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2921,1174241,1,2,,103168084,10607,Unspecified,182705285.0,347688.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2922,1174241,1,2,,103168084,10607,Unspecified,224471855.0,112714.0,,,Inhibition of tubulin polymerization (unknown origin) at 5 uM measured every min for 1 hr by fluorescence-based assay,Other,25462233.0,
2923,1176979,1,1,,103168084,10607,Active,,,0.005,IC50,Cytotoxicity against rat L6 cells,Confirmatory,25547934.0,
2924,1177055,1,1,,103168084,10607,Active,,,0.019,IC50,Cytotoxicity against rat L6 cells,Confirmatory,25563890.0,
2925,1177595,1,1,,103168084,10607,Active,,,0.02,IC50,Cytotoxicity against rat L6 cells,Confirmatory,25080196.0,
2926,1180381,1,1,,103168084,10607,Active,,,0.5,GI50,Antiproliferative activity against human MiaPaCa cells after 48 hrs by SRB assay,Confirmatory,24953821.0,
2927,1180382,1,1,,103168084,10607,Active,,,0.23,GI50,Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay,Confirmatory,24953821.0,
2928,1180383,1,1,,103168084,10607,Active,,,0.71,GI50,Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay,Confirmatory,24953821.0,
2929,1180384,1,2,,103168084,10607,Active,75053726.0,,0.81,IC50,Inhibition of bovine brain tubulin polymerization measured for 1 hr at 1 min intervals by fluorescence assay,Confirmatory,24953821.0,
2930,1180384,1,2,,103168084,10607,Active,75053735.0,,0.81,IC50,Inhibition of bovine brain tubulin polymerization measured for 1 hr at 1 min intervals by fluorescence assay,Confirmatory,24953821.0,
2931,1180384,1,2,,103168084,10607,Active,118573906.0,281555.0,0.81,IC50,Inhibition of bovine brain tubulin polymerization measured for 1 hr at 1 min intervals by fluorescence assay,Confirmatory,24953821.0,
2932,1180388,1,2,,103168084,10607,Active,20455316.0,7278.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2933,1180388,1,2,,103168084,10607,Active,20455316.0,113457.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2934,1180388,1,2,,103168084,10607,Active,20455322.0,84790.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2935,1180388,1,2,,103168084,10607,Active,20455526.0,10381.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2936,1180388,1,2,,103168084,10607,Active,55977474.0,10376.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2937,1180388,1,2,,103168084,10607,Active,55977476.0,7277.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2938,1180388,1,2,,103168084,10607,Active,55977480.0,10383.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2939,1180388,1,2,,103168084,10607,Active,55977864.0,7846.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2940,1180388,1,2,,103168084,10607,Active,56757569.0,203068.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2941,1180388,1,2,,103168084,10607,Active,62903515.0,81027.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2942,1180388,1,2,,103168084,10607,Active,68776070.0,84617.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2943,1180388,1,2,,103168084,10607,Active,74761283.0,347733.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2944,1180388,1,2,,103168084,10607,Active,74762137.0,7280.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2945,1180388,1,2,,103168084,10607,Active,93141323.0,10382.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2946,1180388,1,2,,103168084,10607,Active,182705285.0,347688.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2947,1180388,1,2,,103168084,10607,Active,224471855.0,112714.0,,,Inhibition of tubulin polymerization in human HeLa cells assessed as increase of tubulin soluble fraction at 5 uM after 24 hrs by immunoblot analysis,Other,24953821.0,
2948,1181600,1,1,,103168084,10607,Unspecified,,,,IC50,Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay,Confirmatory,24978605.0,
2949,1182196,1,1,,103168084,10607,Active,,,,,Antimitotic microtubule destabilizing activity in Paracentrotus lividus L embryos assessed as induction of cleavage alteration,Other,24997684.0,
2950,1182197,1,1,,103168084,10607,Active,,,,,Antimitotic microtubule destabilizing activity in Paracentrotus lividus L embryos assessed as induction of cleavage arrest,Other,24997684.0,
2951,1182198,1,1,,103168084,10607,Active,,,,,Antimitotic microtubule destabilizing activity in Paracentrotus lividus L embryos assessed as induction of embryo spinning,Other,24997684.0,
2952,1182199,1,1,,103168084,10607,Active,,,0.021,GI50,Cytotoxicity against human NCI60 cells,Confirmatory,24997684.0,
2953,1186366,1,1,,103168084,10607,Active,,,,,Inhibition of microtubule bundle formation in human A549 cells assessed as cell shrinking at 200 ug/mL incubated for 1 hr by alpha-tubulin staining based fluorescence microscopy,Other,25084144.0,
2954,1186368,1,1,,103168084,10607,Active,,,,,Inhibition of microtubule bundle formation in human A549 cells assessed as cell detachment at 200 ug/mL incubated for 1 hr by alpha-tubulin staining based fluorescence microscopy,Other,25084144.0,
2955,1186370,1,1,,103168084,10607,Active,,,0.0001,IC50,Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay,Confirmatory,25084144.0,
2956,1186371,1,1,,103168084,10607,Active,,,0.0004,IC50,Cytotoxicity against human MCF7 cells in presence of 10 mM DTT after 48 hrs by SRB assay,Confirmatory,25084144.0,
2957,1186372,1,1,,103168084,10607,Active,,,0.059000000000000004,IC50,Cytotoxicity against human A549 cells after 48 hrs by SRB assay,Confirmatory,25084144.0,
2958,1187057,1,1,,103168084,10607,Unspecified,,,,,Cytotoxicity against rat L6 cells,Other,25103602.0,
2959,1187288,1,1,,103168084,10607,Active,,,0.1,IC50,Cytotoxicity against human HeLa cells after 48 hrs by MTT assay,Confirmatory,25113878.0,
2960,1187289,1,1,,103168084,10607,Active,,,0.03,IC50,Cytotoxicity against human K562 cells after 48 hrs by MTT assay,Confirmatory,25113878.0,
2961,1187290,1,1,,103168084,10607,Active,,,0.17,IC50,Cytotoxicity against human K562/A02 cells after 48 hrs by MTT assay,Confirmatory,25113878.0,
2962,1187291,1,1,,103168084,10607,Unspecified,,,,,"Resistance index, ratio of IC50 for human K562/A02 cells to IC50 for human K562 cells",Other,25113878.0,
2963,1188220,1,1,,103168084,10607,Active,,,0.51,GI50,Antiproliferative activity against human MIAPaCa2 cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,25131956.0,
2964,1188221,1,1,,103168084,10607,Active,,,0.31,GI50,Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,25131956.0,
2965,1188222,1,1,,103168084,10607,Active,,,0.74,GI50,Antiproliferative activity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,25131956.0,
2966,1188223,1,2,,103168084,10607,Active,75053726.0,,0.83,IC50,Inhibition of bovine brain tubulin polymerization by fluorescence analysis,Confirmatory,25131956.0,
2967,1188223,1,2,,103168084,10607,Active,75053735.0,,0.83,IC50,Inhibition of bovine brain tubulin polymerization by fluorescence analysis,Confirmatory,25131956.0,
2968,1188223,1,2,,103168084,10607,Active,118573906.0,281555.0,0.83,IC50,Inhibition of bovine brain tubulin polymerization by fluorescence analysis,Confirmatory,25131956.0,
2969,1193502,1,1,,103168084,10607,Active,,,0.017,IC50,Cytotoxicity against rat L6 cells,Confirmatory,25740635.0,
2970,1199925,1,1,,103168084,10607,Active,,,0.012,CC50,Cytotoxicity against rat L6 cells,Confirmatory,25642604.0,
2971,1200315,1,1,,103168084,10607,Inactive,,,,,Antiproliferative activity against human U87 cells assessed as reduction in cell viability up to 100 uM after 48 hrs by MTT assay,Other,25671501.0,
2972,1200316,1,1,,103168084,10607,Inactive,,,,,Antiproliferative activity against human A549 cells assessed as reduction in cell viability up to 100 uM after 48 hrs by MTT assay,Other,25671501.0,
2973,1224824,1,1,,174007436,10607,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
2974,1224825,1,1,,174007436,10607,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
2975,1224834,3,1,,144210120,10607,Inconclusive,,,0.0544,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
2976,1224834,3,1,,170464788,10607,Inconclusive,,,0.0266,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
2977,1224835,1,1,,144210120,10607,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
2978,1224835,1,1,,170464788,10607,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
2979,1224836,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2980,1224836,1,1,,170464788,10607,Inconclusive,,,0.075,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2981,1224837,1,1,,144210120,10607,Inconclusive,,,0.1086,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2982,1224837,1,1,,170464788,10607,Inconclusive,,,0.0944,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2983,1224838,1,1,,144210120,10607,Active,66775687.0,9970.0,0.0485,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2984,1224838,1,1,,170464788,10607,Active,66775687.0,9970.0,0.0596,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2985,1224839,1,1,,144210120,10607,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2986,1224839,1,1,,170464788,10607,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2987,1224840,3,1,,144210120,10607,Inconclusive,,,0.0544,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
2988,1224840,3,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
2989,1224841,3,1,,144210120,10607,Inactive,325495545.0,2101.0,19.3115,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2990,1224841,3,1,,170464788,10607,Inactive,325495545.0,2101.0,0.2113,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2991,1224842,3,1,,144210120,10607,Active,325495545.0,2101.0,15.3397,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2992,1224842,3,1,,170464788,10607,Active,325495545.0,2101.0,0.1679,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2993,1224843,1,1,,144210120,10607,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2994,1224843,1,1,,170464788,10607,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2995,1224844,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
2996,1224844,1,1,,170464788,10607,Inconclusive,,,0.0601,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
2997,1224845,1,1,,144210120,10607,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
2998,1224845,1,1,,170464788,10607,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
2999,1224846,1,1,,144210120,10607,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
3000,1224846,1,1,,170464788,10607,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
3001,1224847,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
3002,1224847,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
3003,1224848,3,1,,144210120,10607,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3004,1224848,3,1,,170464788,10607,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3005,1224849,3,1,,144210120,10607,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3006,1224849,3,1,,170464788,10607,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3007,1224857,2,1,,170464788,10607,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
3008,1224857,2,1,,174007436,10607,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
3009,1224859,2,1,,170464788,10607,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
3010,1224859,2,1,,174007436,10607,Inactive,,,13.2066,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
3011,1224863,1,1,,316919633,10607,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
3012,1224864,1,2,,316934940,10607,Inactive,,,,,HCS microscopy assay (F508del-CFTR),Screening,27732613.0,
3013,1224865,1,2,,56463668,10607,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
3014,1224867,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
3015,1224867,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
3016,1224868,1,1,,144210120,10607,Active,,,0.0489,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
3017,1224868,1,1,,170464788,10607,Inconclusive,,,0.0535,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
3018,1224869,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
3019,1224869,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
3020,1224870,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
3021,1224870,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
3022,1224871,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
3023,1224871,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
3024,1224872,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
3025,1224872,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
3026,1224873,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
3027,1224873,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
3028,1224874,1,1,,144210120,10607,Active,,,0.0489,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
3029,1224874,1,1,,170464788,10607,Inconclusive,,,0.0674,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
3030,1224875,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
3031,1224875,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
3032,1224876,1,1,,144210120,10607,Inconclusive,,,21.8644,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
3033,1224876,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
3034,1224877,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
3035,1224877,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
3036,1224878,1,1,,144210120,10607,Inconclusive,,,21.8644,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
3037,1224878,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
3038,1224879,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
3039,1224879,1,1,,170464788,10607,Inconclusive,,,0.0338,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
3040,1224880,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
3041,1224880,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
3042,1224881,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
3043,1224881,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
3044,1224882,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
3045,1224882,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
3046,1224883,1,1,,144210120,10607,Inconclusive,,,19.4866,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
3047,1224883,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
3048,1224884,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
3049,1224884,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
3050,1224885,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
3051,1224885,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
3052,1224886,1,1,,144210120,10607,Inconclusive,,,0.0389,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
3053,1224886,1,1,,170464788,10607,Inconclusive,,,0.0477,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
3054,1224887,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
3055,1224887,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
3056,1224888,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
3057,1224888,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
3058,1224889,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
3059,1224889,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
3060,1224890,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
3061,1224890,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
3062,1224892,1,1,,144210120,10607,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3063,1224892,1,1,,170464788,10607,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3064,1224893,1,1,,144210120,10607,Inconclusive,66775687.0,9970.0,0.0485084,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3065,1224893,1,1,,170464788,10607,Inconclusive,66775687.0,9970.0,0.043812800000000006,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3066,1224894,1,1,,144210120,10607,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
3067,1224894,1,1,,170464788,10607,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
3068,1224895,1,1,,144210120,10607,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3069,1224895,1,1,,170464788,10607,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3070,1224896,1,1,,144210120,10607,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
3071,1224896,1,1,,170464788,10607,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
3072,1228180,1,1,,103168084,10607,Active,,,0.012,IC50,Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay,Confirmatory,25871440.0,
3073,1233441,1,1,,103168084,10607,Active,,,7.92,IC50,Cytotoxicity against human SK-N-SH cells assessed as cell viability by SRB assay,Confirmatory,26022842.0,
3074,1233442,1,1,,103168084,10607,Active,,,2.55,IC50,Cytotoxicity against human A549 cells assessed as cell viability by SRB assay,Confirmatory,26022842.0,
3075,1233443,1,1,,103168084,10607,Active,,,1.92,IC50,Cytotoxicity against human HeLa cells assessed as cell viability by SRB assay,Confirmatory,26022842.0,
3076,1233444,1,1,,103168084,10607,Active,,,3.34,IC50,Cytotoxicity against human MCF7 cells assessed as cell viability by SRB assay,Confirmatory,26022842.0,
3077,1233445,1,1,,103168084,10607,Unspecified,75053726.0,,,,Inhibition of bovine brain tubulin polymerization assessed as increase in fluorescence intensity at 5 uM relative to control,Other,26022842.0,
3078,1233445,1,1,,103168084,10607,Unspecified,118573906.0,281555.0,,,Inhibition of bovine brain tubulin polymerization assessed as increase in fluorescence intensity at 5 uM relative to control,Other,26022842.0,
3079,1233446,1,1,,103168084,10607,Unspecified,,,,,Induction of cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 5 uM after 24 hrs by flow cytometry,Other,26022842.0,
3080,1233448,1,1,,103168084,10607,Unspecified,,,,,Induction of cell cycle arrest in human A549 cells assessed as accumulation at G0 phase at 5 uM after 24 hrs by flow cytometry,Other,26022842.0,
3081,1233449,1,1,,103168084,10607,Unspecified,,,,,Induction of cell cycle arrest in human A549 cells assessed as accumulation at G1 phase at 5 uM after 24 hrs by flow cytometry,Other,26022842.0,
3082,1233450,1,1,,103168084,10607,Unspecified,,,,,Induction of cell cycle arrest in human A549 cells assessed as accumulation at S phase at 5 uM after 24 hrs by flow cytometry,Other,26022842.0,
3083,1233712,1,1,,103168084,10607,Active,,,0.079,IC50,Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell proliferation incubated for 72 hrs by SRB assay,Confirmatory,26086179.0,
3084,1233713,1,1,,103168084,10607,Active,,,0.017,IC50,Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 72 hrs by SRB assay,Confirmatory,26086179.0,
3085,1233714,1,1,,103168084,10607,Active,,,0.084,IC50,Antiproliferative activity against mouse NIH/3T3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by SRB assay,Confirmatory,26086179.0,
3086,1236507,1,1,,103168084,10607,Active,,,0.021,EC50,Cytotoxicity against mouse J774A.1 cells assessed as inhibition of cell viability after 72 hrs by MTT assay,Confirmatory,25749014.0,
3087,1240908,1,1,,103168084,10607,Active,,,0.002,IC50,Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay,Confirmatory,26237241.0,
3088,1246960,1,1,,103168084,10607,Unspecified,,,128.61,IC50,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,Confirmatory,26292628.0,
3089,1246961,1,1,,103168084,10607,Inconclusive,,,,IC50,Cytotoxicity against human DU145 cells after 48 hrs by MTT assay,Confirmatory,26292628.0,
3090,1246962,1,1,,103168084,10607,Inconclusive,,,,IC50,Cytotoxicity against human RWPE1 cells after 48 hrs by MTT assay,Confirmatory,26292628.0,
3091,1246963,1,1,,103168084,10607,Inconclusive,,,,IC50,Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay,Confirmatory,26292628.0,
3092,1246964,1,1,,103168084,10607,Inconclusive,,,,IC50,Cytotoxicity against human HGC cells after 48 hrs by MTT assay,Confirmatory,26292628.0,
3093,1246965,1,1,,103168084,10607,Inconclusive,,,,IC50,Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay,Confirmatory,26292628.0,
3094,1254673,1,1,,103168084,10607,Active,,,0.022000000000000002,IC50,Cytotoxicity against rat L6 cells after 70 hrs by resazurin dye-based fluorometric analysis,Confirmatory,,
3095,1255396,1,1,,103168084,10607,Unspecified,,,,EC50,Cytotoxicity against rat L6 cells incubated for 72 hrs by alamar blue staining based microscopy,Confirmatory,26408453.0,
3096,1259241,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
3097,1259241,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
3098,1259242,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
3099,1259242,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
3100,1259243,1,1,,144210120,10607,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
3101,1259243,1,1,,170464788,10607,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
3102,1259244,1,1,,144210120,10607,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
3103,1259244,1,1,,170464788,10607,Inconclusive,348019627.0,2099.0,0.1333,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
3104,1259247,1,1,,144210120,10607,Inconclusive,124375976.0,367.0,0.544273,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
3105,1259247,1,1,,170464788,10607,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
3106,1259248,1,1,,144210120,10607,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
3107,1259248,1,1,,170464788,10607,Inconclusive,348019627.0,2099.0,0.133332,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
3108,1259252,1,1,,174007436,10607,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
3109,1259253,1,1,,174007436,10607,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
3110,1259255,1,1,,174007436,10607,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
3111,1259256,1,1,,174007436,10607,Inconclusive,169655958.0,,0.0042,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
3112,1259310,1,1,,104170173,10607,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
3113,1259310,1,1,,321949546,10607,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
3114,1259310,1,1,,332877816,10607,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
3115,1259310,1,1,,333494085,10607,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
3116,1259313,1,1,,56463668,10607,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
3117,1259318,1,1,,56422495,10607,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
3118,1259325,1,2,,336954269,10607,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
3119,1259344,1,1,,144204425,10607,Inconclusive,,,0.0251,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
3120,1259355,1,1,,144204425,10607,Active,,,0.0079,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
3121,1259356,1,1,,144204425,10607,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
3122,1259357,1,1,,50103983,10607,Inconclusive,,,0.0132,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (A2780, Spheroid)",Confirmatory,,
3123,1259358,1,1,,50103983,10607,Active,,,0.0187,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (SN12C, Adherent)",Confirmatory,,
3124,1259359,1,1,,50103983,10607,Active,,,0.0021,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (Panc1, Spheroid)",Confirmatory,,
3125,1259360,1,1,,50103983,10607,Inconclusive,,,0.2957,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (SN12C, Spheroid)",Confirmatory,,
3126,1259361,1,1,,50103983,10607,Active,,,,Activity at 9.921 uM,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (A278, Adherent)",Confirmatory,,
3127,1259362,1,1,,50103983,10607,Inconclusive,,,0.0053,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (Panc1, Adherent)",Confirmatory,,
3128,1259364,1,1,,144210120,10607,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
3129,1259364,1,1,,170464788,10607,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
3130,1259365,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
3131,1259365,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
3132,1259366,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3133,1259366,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3134,1259367,1,1,,144210120,10607,Inconclusive,,,0.0043,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3135,1259367,1,1,,170464788,10607,Active,,,0.1059,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3136,1259368,1,1,,144210120,10607,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3137,1259368,1,1,,170464788,10607,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3138,1259369,1,1,,144210120,10607,Active,109731339.0,2737.0,0.0054,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3139,1259369,1,1,,170464788,10607,Active,109731339.0,2737.0,0.0168,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3140,1259377,1,1,,144210120,10607,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3141,1259377,1,1,,170464788,10607,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3142,1259378,1,1,,144210120,10607,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3143,1259378,1,1,,170464788,10607,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3144,1259379,1,1,,144210120,10607,Inconclusive,,,0.0172,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3145,1259379,1,1,,170464788,10607,Inconclusive,,,0.0047,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3146,1259380,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3147,1259380,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3148,1259381,1,1,,144210120,10607,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
3149,1259381,1,1,,170464788,10607,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
3150,1259382,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3151,1259382,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3152,1259383,1,1,,144210120,10607,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
3153,1259383,1,1,,170464788,10607,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
3154,1259384,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
3155,1259384,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
3156,1259385,1,1,,144210120,10607,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
3157,1259385,1,1,,170464788,10607,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
3158,1259386,1,1,,144210120,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3159,1259386,1,1,,170464788,10607,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3160,1259387,1,1,,144210120,10607,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
3161,1259387,1,1,,170464788,10607,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
3162,1259388,1,1,,144210120,10607,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
3163,1259388,1,1,,170464788,10607,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
3164,1259389,1,1,,124637718,10607,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
3165,1259390,1,1,,144210120,10607,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3166,1259390,1,1,,170464788,10607,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3167,1259391,1,1,,144210120,10607,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
3168,1259391,1,1,,170464788,10607,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
3169,1259392,1,1,,144210120,10607,Active,109731339.0,2737.0,0.00634575,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3170,1259392,1,1,,170464788,10607,Inconclusive,109731339.0,2737.0,0.0211317,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3171,1259393,1,1,,144210120,10607,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
3172,1259393,1,1,,170464788,10607,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
3173,1259394,1,1,,144210120,10607,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3174,1259394,1,1,,170464788,10607,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3175,1259395,1,1,,144210120,10607,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3176,1259395,1,1,,170464788,10607,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3177,1259396,1,1,,144210120,10607,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3178,1259396,1,1,,170464788,10607,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3179,1259400,1,1,,170464788,10607,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
3180,1259401,1,1,,144210120,10607,Inconclusive,325495545.0,2101.0,17.8848,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3181,1259401,1,1,,170464788,10607,Inconclusive,325495545.0,2101.0,0.8095939999999999,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3182,1259402,1,1,,144210120,10607,Active,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3183,1259402,1,1,,170464788,10607,Active,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3184,1259403,1,1,,144210120,10607,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3185,1259403,1,1,,170464788,10607,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3186,1259404,1,1,,144210120,10607,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3187,1259404,1,1,,170464788,10607,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3188,1259406,1,1,,363920380,10607,Unspecified,,,,,BK Channel Variant Modulator Selectivity Assay,Screening,,
3189,1259406,1,1,1.0,363920380,10607,Inactive,26638650.0,3778.0,0.019581499999999998,LogChange(F380Y),BK Channel Variant Modulator Selectivity Assay,Screening,,
3190,1259406,1,1,2.0,363920380,10607,Inactive,4758626.0,3779.0,0.00362853,LogChange(F380Y/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
3191,1259406,1,1,3.0,363920380,10607,Inactive,5031823.0,10242.0,0.00366298,LogChange(F380Y/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
3192,1259406,1,1,4.0,363920380,10607,Inactive,26051275.0,27345.0,0.0253223,LogChange(F380Y/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
3193,1259406,1,1,5.0,363920380,10607,Inactive,160410009.0,389816.0,0.0135155,LogChange(F380Y/Slo1WT/gamma1),BK Channel Variant Modulator Selectivity Assay,Screening,,
3194,1259406,1,1,6.0,363920380,10607,Inactive,26638650.0,3778.0,-0.0185438,LogChange(R275C),BK Channel Variant Modulator Selectivity Assay,Screening,,
3195,1259406,1,1,7.0,363920380,10607,Inactive,4758626.0,3779.0,0.0124154,LogChange(R275C/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
3196,1259406,1,1,8.0,363920380,10607,Inactive,5031823.0,10242.0,0.029144200000000002,LogChange(R275C/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
3197,1259406,1,1,9.0,363920380,10607,Inactive,26051275.0,27345.0,0.0118706,LogChange(R275C/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
3198,1259406,1,1,10.0,363920380,10607,Inactive,5031823.0,10242.0,0.00945939,LogChange(R275C/Slo1WT/beta2),BK Channel Variant Modulator Selectivity Assay,Screening,,
3199,1259407,1,1,,363898515,10607,Inactive,,,,,CCRIS mutagenicity studies,Other,,
3200,1259407,1,1,,363902341,10607,Inactive,,,,,CCRIS mutagenicity studies,Other,,
3201,1259408,1,1,,363895673,10607,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
3202,1259413,1,2,,104170173,10607,Inactive,47605623.0,173990.0,,,Modulators of fzo-1,Other,,
3203,1259416,1,2,,855658,10607,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
3204,1259416,1,2,,340081000,10607,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
3205,1259416,1,2,,375174794,10607,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
3206,1259421,1,1,,340081000,10607,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
3207,1259421,1,1,,375174794,10607,Inconclusive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
3208,1259423,1,2,,354753758,10607,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
3209,1259423,1,2,,354801038,10607,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
3210,1259423,1,2,,355028094,10607,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
